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Abstract 
 
This thesis aims to explore the applicability of Electron Paramagnetic Resonance (EPR) 
spectroscopy in the pharmaceutical field. EPR is a powerful biophysical tool that allows the 
detection and characterisation of paramagnetic species, such as free organic radicals and metal 
complexes. EPR is widely used across all disciplines but to date has been much underutilised 
in the pharmaceutical industry. 
In the first part of this work, EPR techniques were applied to characterise the degradation 
products originating from irradiation sterilization of two common excipients, L-histidine and 
D-mannitol. Radicalic degradants can form as a result of several degradation pathways and 
industrial processes, including γ-radiation sterilization. A quantification of the radical species 
formed upon γ-irradiation was performed, indicating a much higher radical concentration for 
D-mannitol compared to L-histidine at pharmaceutically relevant irradiation doses. Cold 
irradiation analysis allowed the study of the low temperature stable species and their evolution 
into the r.t. stable ones. Three low temperature persistent radical species of D-mannitol were 
identified for the first time. The reactivity of the radicals in solution was also investigated. Spin 
trapping experiments allowed trapping of radicals from both L-histidine and D-mannitol. An 
unusual, and potentially hazardous, radical regeneration mechanism was observed for 
L-histidine, which was suggested to be due to the sterile metal needles used for transferring the 
sample solution in the EPR tubes.  
The second part of this work was concerned with the investigation of the radicalic mechanism 
of action of a promising photo-activable platinum(IV) anticancer complex. It has been 
previously suggested that the cytotoxicity of the said compound is associated to the photo-
release of azidyl radicals, which can be quenched in the presence of the amino acid 
L-tryptophan. By the use of the spin trapping methodology, an intermediate indole radical was 
isolated and identified from photo-activation of the anticancer complex in the presence of both 
L-tryptophan and melatonin. The same photo-protective effect was observed also in the 
presence of a tryptophan-containing peptide. Thus, this work contributed to the overall 
understanding on photo-irradiated platinum anticancer complexes and their generated photo-
products.  
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Chapter 1  
Principles of EPR 
 
In this Chapter, the background theory behind the Electron Paramagnetic Resonance (EPR) 
techniques used in this work is presented. Far from representing a comprehensive background 
of all the areas covered, the following sections will provide sufficient elements for a full 
understanding of the results presented in the upcoming chapters. 
 
1.1 Uses of EPR 
EPR, also known as ESR (Electron Spin Resonance) or EMR (Electron Magnetic Resonance) 
is a powerful technique for the study of paramagnetic species, which include transition metal 
ions, defect centres and free radicals. The concept of EPR is very similar to the more familiar 
Nuclear Magnetic Resonance (NMR) technique, both dealing with the interaction between 
electromagnetic radiation and magnetic moments, which for NMR arise from nuclei while for 
EPR arise from electrons.1  
Modern applications of EPR can be found across all the disciplines, from chemistry to physics, 
to medicine and biology. In the polymer industry, EPR is used to study polymerisation reactions 
and polymer stability.2–4 EPR has also been successfully applied to study the kinetics of 
chemical reactions involving paramagnetic species.5,6 In medicine, EPR provides unique 
insights into the redox biochemistry of several conditions related to oxidative stress.7 EPR 
techniques for in vivo oximetry allow characterisation of a wealth of physiological and 
pathophysiological systems with minimal invasiveness and high precision.8 Important 
applications of EPR are also found in catalysis.9,10 EPR finds applications also in the food 
industry, where it is used for the study of food antioxidant properties,11,12 of flavour stability of 
beer13,14 and to assess the effects of industrial processes such as radiation sterilization15–17 and 
thermal treatment on foodstuffs.18 
To date, EPR has been much underutilised in the pharmaceutical industry. Nonetheless, several 
studies have shown the potential of this technique in this field. EPR has been used to study the 
radical species formed from oxidative degradation19 and photodegradation20 of active 
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pharmaceuticals ingredients (APIs) in the solid state, as well as the oxidation of various 
pharmaceutical compounds in solution with the spin trapping methodology.21–23 EPR 
techniques have also been used for studying the effects of irradiation on drug delivery 
systems.24,25 EPR spectroscopy also finds applications in drug design, for the development of 
pharmaceutical compounds which rely on a radical-based mechanism of action.26–28 
In the sections below the fundamental theory of EPR is discussed in order to provide key notions 
for the understanding of the work presented in the following chapters. 
 
1.2 The Zeeman effect 
The Zeeman effect describes the interaction of an unpaired electron with a magnetic field B0. 
When an electron is placed in a magnetic field, the magnetic moment of the electron μe will 
either align with the magnetic field (parallel state, lower energy) or against the magnetic field 
(antiparallel state, higher energy). Since the electron possesses a spin S = 1/2, and considering 
the negative charge of the electron, the parallel state is characterised by a magnetic quantum 
number ms = −1/2 and the antiparallel state by a ms = +1/2. The energy difference between these 
two states is defined as:29 
∆𝐸 = 𝑔  𝜇B  𝐵0  ∆𝑚S = 𝑔  𝜇𝐵  𝐵0     Eq. 1.1 
where: g is the g-factor (see section 1.4); μB is the Bohr magneton, the natural unit for expressing 
the electron’s magnetic moment; Δms = 1.  
In EPR, the energy required to drive a transition between the two spin states can be provided 
by an electromagnetic radiation and is given by: 
∆𝐸 = ℎ  𝜈 = 𝑔  𝜇B  𝐵0      Eq. 1.2 
where: h is the Planck’s constant and ν is the frequency of the applied electromagnetic radiation, 
typically microwaves (MW). Accordingly, in the absence of a magnetic field (B0 = 0) the two 
spin states are degenerate so that no energy difference can be measured (Figure 1.1). Instead, 
as the applied magnetic field increases (B0 ≠ 0), the energy of the two spin states linearly 
diverges with the field.  
Differently from modern NMR spectroscopy, where all the NMR transitions are simultaneously 
excited by a short radiofrequency pulse and the resulting signal is Fourier transformed to 
produce a time-domain spectrum (FT-NMR), most of modern EPR spectrometers continue to 
operate in continuous wave (CW), with the electromagnetic radiation kept constant and the 
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magnetic field being swept. Applications of FT-EPR are if fact limited by the impossibility of 
applying sufficiently wide bandwidth pulses to drive all EPR transitions at the same time, and 
by the difficulties in detecting the resulting signal after the deadtime. In CW EPR, when the 
magnetic field reaches a value for which the energy difference between the two spin states 
matches the energy of the electromagnetic radiation, also defined as “field of resonance”, the 
energy is absorbed and an EPR signal is detected (Figure 1.1). The study of such energy 
transitions with EPR spectroscopy can provide a wealth of information on paramagnetic 
species. On the contrary, systems where electrons occur in pairs (diamagnetic), will present a 
net magnetic moment equal to zero and therefore will be EPR silent. 
 
Figure 1.1 The electron Zeeman effect for a S = 1/2 system subjected to an increasing B0 (figure adapted from ref. 
29). 
 
1.3 The spin Hamiltonian 
A system consisting of a single electron spin is the simplest case that can be considered. The 
effects of the presence of additional electron and nuclear spins in the system are described by 
the spin Hamiltonian ?̂?. A simplified version of the spin Hamiltonian, relevant for this work, 
is described by:1 
?̂? = 𝜇B𝑺 · 𝒈 · 𝑩𝟎 + 𝑺 · 𝑫 · 𝑺 + ∑ 𝑺 · 𝑨 · 𝑰𝒊
𝑁
𝑖=1
− 𝜇𝑁  𝑔𝑁𝑰𝑵 𝑩𝟎 + 𝑰𝑵 · 𝑷𝑵 · 𝑰𝑵 
Eq. 1.3 1           2        3     4   5 
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The terms labelled from 1 to 5 represent: 
1. Electronic Zeeman interaction 
2. Zero-field interaction (for S ≥ 1) 
3. Hyperfine interaction 
4. Nuclear Zeeman interaction, significantly smaller than its electronic counterpart 
5. Quadrupole interaction (for I ≥ 1), often weaker than both the electronic Zeeman and 
hyperfine interactions. 
Considering that the spin systems studied in this thesis are characterised by S = 1/2, the spin 
Hamiltonian can be simplified as follows: 
𝑯 = 𝜇𝐵𝑺 · 𝒈 · 𝑩𝟎 + ∑ 𝑺 · 𝑨 · 𝑰𝒊
𝑁
𝑖=1
− 𝜇𝑁  𝑔𝑁𝑰𝑵 𝑩𝟎 
Eq. 1.4 
1.4 The g-factor 
The g-factor is for EPR the analogue of the chemical shift (δ) for NMR. This parameter is 
independent on the microwave frequency and therefore represents a unique fingerprint for 
paramagnetic species. The g-factor is described in Eq. 1.5.  
𝑔 = ℎ 𝜈 / 𝜇 𝐵0    Eq. 1.5  
For carbon-centred radicals, the value of g is usually close to the value of the free electron 
ge = 2.0023, while heteroatoms shift the g-factor to different values. As an example, an unpaired 
electron in the proximity of an oxygen atom gives g-values in the range of 2.004–2.006. Metal 
ions can instead be characterised by very different g-factors, shifted to both lower (e.g. 1.9 for 
the vanadyl ion) and higher values (e.g. 2.3 for Cu2+) compared to ge.29 For paramagnetic 
species with partially or totally restricted motion, such as radicals trapped in crystalline 
reticulate or in viscous liquids, g-anisotropy might be observed, meaning that the g-factor, and 
therefore the appearance of the EPR spectrum, depends on the orientation of the paramagnetic 
species with respect to the magnetic field. 
 
1.5 Hyperfine interaction 
A second important parameter that characterises EPR spectra is the hyperfine interaction. The 
hyperfine splitting represents the equivalent of the J coupling in NMR. Certain nuclei in a 
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molecule possess a nuclear magnetic moment μN, which produces a local magnetic field at the 
electron, BI. Such magnetic field can either oppose or add to the magnetic field of the laboratory 
magnet. When BI adds to the external magnetic field, the field of resonance is thereby lowered; 
instead, when BI opposes to the magnetic field, the field of resonance is found at higher values. 
An example is given in Figure 1.2. For an electron coupling to a nucleus with spin I = 1/2 such 
as hydrogen, the EPR absorption signal splits into two distinct signals, each of them BI away 
from the original signal. The hyperfine splitting constant aH represents the distance between 
these two peaks, therefore corresponding to 2BI. An additional spin 1/2 nucleus would then split 
each line into two additional lines. Therefore, for a set of n spin 1/2 nuclei coupled to the 
electron, the total number of lines in the spectrum will be 2n. The general rule defines that, for 
n symmetry equivalent nuclei of spin I, the number of hyperfine lines in the EPR spectrum is 
equal to 2nI + 1. 
The nuclear hyperfine interaction can reveal a wealth of information regarding the surroundings 
of the unpaired electron. The interpretation of the hyperfine splitting can determine the identity 
and number of atoms coupling to the electron, thus allowing in some cases to unveil the 
molecular structure of the paramagnetic species. Similarly to the g-factor, the hyperfine 
splitting displays anisotropy in solid and viscous liquid samples depending on the geometry of 
the molecule. 
 
 
Figure 1.2 The effect of the magnetic field of a nucleus on the field experienced by an electron spin. The local 
magnetic field from the nucleus either opposes to or enhances the field of the laboratory magnet, causing the splitting 
of the EPR lines (adapted from ref. 29). 
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1.6 Multi-frequency EPR 
Most EPR experiments are performed at X-band, ca. 9–10 GHz. The choice of this frequency 
has both historical and practical reasons. Historically, the development of RADAR during 
World War II made a surplus of X-band military equipment available to the early EPR pioneers 
in the 1950s.1 
From a practical side, X-band is a rather convenient frequency for EPR experiments. Firstly, 
the fields required for running experiments at this frequency can conveniently be obtained from 
electromagnets. Additionally, in terms of sensitivity, EPR at X-band represents a good 
compromise between the sample size (ca. 3 cm wavelengths) and the Boltzmann factor. In fact, 
an increasing of the Boltzmann factor and sample size results in an increased spectrometer 
sensitivity. Unfortunately, the effect of the frequency on these two factors is diametrically 
opposite. In fact, as the Boltzmann factor is higher at higher frequencies, the sample size 
decreases, and vice versa. At X-band, a not very high Boltzmann factor is counterbalanced by 
a relatively large sample size, thus making X-band analyses convenient in terms of sensitivity.  
The analysis of a sample at multiple frequencies can provide extremely valuable information. 
As it can be deduced from Eq. 1.3, the appearance of an EPR spectrum is determined by both 
magnetic field dependent (the electronic and nuclear Zeeman) and magnetic field independent 
(hyperfine interaction and ZFS) components. Multi-frequency studies allow resolving the 
contributions from these two types of interaction, thus implementing the understanding of the 
paramagnetic species under study.  
High frequencies are generally defined as frequencies higher than X-band, while low 
frequencies represent the frequency below ~9 GHz. The most commonly used bands are listed 
in Table 1.1. 
Each of the Hamiltonian parameters offers specific information on the samples under study. 
The analysis of the g-factor provides information over the identity of the paramagnetic species, 
together with insights on the electronic state and symmetry of the paramagnetic site. The 
nuclear hyperfine interactions allow determination of the identity, number and distance of the 
nuclei in proximity to the paramagnetic centre. The zero-field splitting (ZFS) can also give 
important information on systems with S ≥ 1, but it is not the case of this work and therefore 
will not be discussed further. 
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Table 1.1 Field for resonance for a g = 2.0023 sample at different microwave frequencies. 
Microwave band Microwave 
frequency (GHz) 
Field of resonance 
for g = ge (mT) 
Sample tube 
O.D. (mm) 
L 1 36 30 
S 3 107  
X 9.8 350 4 
K 24 856  
Q 34 1213 2 
W 94 3354 0.9 
mm-wave 263 9384 0.3 
 
At high frequencies the field dependent term is emphasised and becomes more dominant. High 
frequencies can be convenient for identifying multiple paramagnetic species characterised by a 
similar g-factor. Indeed, the difference in field of resonance ΔB will be approximately 
proportional to the microwave frequency, thereby making possible to distinguish species with 
similar g-factors, as long as ΔB becomes greater than the linewidth. Also, high frequencies 
might allow the anisotropic components of a spectrum to be distinguished, giving valuable 
information on the symmetry of the paramagnetic centre. 
On the contrary, at low frequencies the magnetic field independent components are dominating 
the spectrum. Therefore, at low enough frequencies it can be possible to extract information on 
the nuclear hyperfine coupling of the system, as the g-anisotropy is less accentuated. 
Theoretically, going very low or very high in frequency should allow a direct determination of 
the Hamiltonian parameters such as g-factor and hyperfine coupling components. In practice, 
this is rarely obtained as several factors can interfere with the analysis, including linewidths, 
anisotropy and second order effects (at lower frequencies). A solution to this problem is to 
perform experiments at multiple frequencies, thus obtaining a data set with all the limiting cases 
that can allow extraction of the required spin Hamiltonian parameters through spectral 
simulation. 
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1.7 Spin trapping 
1.7.1 Spin trapping reaction 
Free radicals are known to be involved in a number of metabolic processes, thus drawing a 
great interest in biology and medicine. EPR is generally considered the gold standard for the 
detection of free radicals. Nevertheless, direct detection of these paramagnetic species is often 
impeded by multiple factors. Firstly, their concentration may be below the detection limit of 
the spectrometer. Additionally, if their spin relaxation times are too short, their linewidth will 
be too broad to be observable, which is the case of e.g. hydroxyl radical (•OH) or singlet oxygen 
(O2•−).30–32 
Spin trapping is a technique that has been developed to overcome these limitations. It consists 
in the addition reaction of the radical of interest (R•) to a diamagnetic compound, the spin trap 
(ST), in order to produce a relatively long-lived free radical product, the spin adduct (ST-
R•).30,33  
 
This is usually a nitroxide, which is a relatively stable chemical species thanks to the mesomeric 
stabilization of the unpaired electron (Figure 1.3).30 Once formed, the spin adduct would then 
hopefully accumulate to a high enough concentration to be studied by EPR. Therefore, spin 
trapping is a valuable technique for the study of free radicals where direct detection of the 
paramagnetic species is not possible. 
 
Figure 1.3 Mesomeric structures of a nitroxide with the unpaired electron localized on the nitrogen atom (left) and 
the oxygen atom (right). 
 
1.7.2 Choice of spin trapping agent 
Two kinds of spin trapping agents are available, the nitrone and nitroso spin traps. They have 
the ability to trap carbon-, nitrogen-, oxygen- and sulphur-based radicals. Nitrone compounds, 
such as DMPO (Figure 1.4), DEMPO, PBN, POBN are typically used for the detection of 
oxygen-centred radicals (Figure 1.5).34 The radical adds to the carbon atom adjacent to the 
nitrone nitrogen, inducing the formation of relatively stable spin adducts. The hyperfine 
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splitting parameter of the β-hydrogen can also provide considerable information about the 
radical trapped.30 
 
Figure 1.4 The nitroso spin trap 2-methyl-2-nitroso propane (MNP, left) and the nitrone spin trap 5,5-dimethyl-1-
pyrroline N-oxide (DMPO, right). 
 
 
Figure 1.5 Trapping of a radical (R•) species by a nitrone compound. 
 
Nitroso compounds, such as MNP (Figure 1.4), can provide much more information in the 
hyperfine splitting parameters than the nitrone compounds, as the radical binds directly to the 
nitroso nitrogen (Figure 1.6). On the other hand, adducts formed from reaction with oxygen-
centred radicals are quite unstable, so they are mostly utilised for the trapping of carbon-centred 
species.30 This work focused in particular on the use of the nitroso spin trapping agent MNP for 
the trapping of carbon-centred radicals. 
 
 
 
Figure 1.6 Trapping of a radical (R•) species by a nitroso compound. 
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Chapter 2  
Sterilization of Pharmaceuticals 
 
The first part of this work focuses on the characterisation of the degradants formed from 
irradiation sterilization of pharmaceutical excipients. In this Chapter, a description of the 
procedures used for the sterilization of drug products in the pharmaceutical industry is 
presented. The role of EPR spectroscopy in the detection of degradation products from 
pharmaceuticals is also outlined. At the end of the Chapter, the motivation for study and a thesis 
outline are also presented. 
 
2.1 Sterilization in the pharmaceutical industry 
In microbiology, the term sterilization defines the process of inactivation of microorganisms. 
The effectiveness of a sterilization process is measured in relation to the sterility assurance level 
(SAL), which is a parameter that defines the probability of the survival of one viable 
microorganism in a unit being subjected to the sterilization process. Currently, a SAL of 10−6 
is the standard generally accepted by the pharmacopoeias,1 meaning that the probability of 
survival of a viable microorganism in a sterilized product must not be higher than one in a 
million. A product that has been subject of such process is defined as “sterile”. The oldest and 
most recognised method for assuring sterility is heat, but many other sterilization processes 
have been developed, and will be shortly described in the following paragraphs. 
2.1.1 Dry heat sterilization 
Dry heat is often used in the pharmaceutical industry and represents the method of choice for 
the sterilization of heat-stable materials. These usually include items such as glassware, 
stainless-steel equipment, closed containers, powders and oils.2 Compared to steam sterilization 
(see next paragraph) it generally requires higher temperatures and/or longer exposure times. 
The times and temperatures required for reaching the desired SAL varies depending on the 
pharmacopoeia of reference. As an example, according to the U.S. Pharmacopoeia (USP) items 
that undergo dry heat sterilization should be kept at a temperature of 160–170 °C for a period 
of 2 to 4 hours.3 
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2.1.2 Steam sterilization 
Also known as autoclaving, steam sterilization is the most widely used sterilization method. It 
consists of exposing the products to a defined combination of temperature and humidity such 
as to inactivate the microorganisms. Typically, materials are exposed to pressurised saturated 
steam at 121 °C for 15 minutes, but temperature and time can vary depending on the stability 
of the materials to sterilize.4 Nevertheless, this method is unsuitable for the sterilization of heat- 
or moisture-sensitive compounds and active ingredients. 
2.1.3 Ethylene oxide sterilization 
An alternative for the sterilization of heat-sensitive materials is represented by ethylene oxide 
(EtO) sterilization. This highly reactive gas is typically used at lower temperatures compared 
to dry heat and steam sterilization (ca. 50 – 60 °C) and in the presence of water.4 EtO is mainly 
used for the sterilization of medical devices, and only secondarily for pharmaceutical products. 
Packaging of the sterilized material is limited to that allowing penetration of the gas. Important 
issues related the use of this sterilization method concern safety in the industrial site and safety 
of the sterilized materials. In fact, some packaging materials have been shown to retain the gas 
representing a potential hazard. Therefore, the residual EtO has necessarily to be removed, 
usually through post sterilization aeration with sterile air, in order to avoid direct contact of the 
gas which has been classified as carcinogenic and mutagenic.4 
2.1.4 Filtration sterilization 
Filtration is a safe technique that consists in the physical removal of microorganisms and can 
be an alternative for aqueous solutions of thermolabile substances. However, this procedure 
doesn’t allow processing of the product in its final packaged form (terminal processing) and as 
such requires operation in aseptic conditions, therefore resulting in a rather costly and complex 
process.4,5 
 
2.2 Radiation sterilization 
Commercial radiation sterilization has been used for more than 60 years, since the first electron 
accelerator that was developed by the Ethicon Division of Johnson & Johnson in New Jersey 
in 1956 for the commercial radiation sterilization of surgical sutures.6 Currently, approximately 
50% of disposable medical devices in North America are radiation sterilized6 and the demand 
for the radiation sterilization of single-use medical devices in the United States grows at a rate 
of approximately 7% per year.7 
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2.2.1 Ionising radiation 
Radiation can be classified as either ionising or non-ionising, the former having sufficient 
energy to cause the release of orbital electrons from atoms and disruption of covalent bonds. 
Electron beams, X-rays and γ-rays are all forms of ionising radiations, while UV, visible, IR 
and radiofrequencies are all non-ionising radiations.  
Both UV and IR are utilised for sterilization purposes, the former exerting its germicidal action 
by excitation of atoms at cellular level and the latter by heat generation. However, the 
penetrating power of these non-ionising radiation types is rather low and makes them not 
suitable for terminal sterilization. 
2.2.2 γ-irradiation sterilization 
Amongst the different types of radiation, γ-sterilization is gaining popularity, covering in 2003 
approximately 40% of the sterilization market and being the method of choice for the 
sterilization of single-use medical devices.8 Part of its success relies on the progressive decrease 
in the use of EtO as a terminal sterilization method and on the development of radiation-stable 
polymers for packaging, such as polyvinyl chloride (PVC), polycarbonates and polypropylene, 
which are able to prevent the brittleness and brown-yellow post-sterilization coloration.8 This 
tendency is reflected in scientific literature, with works on ‘gamma sterilization’ being 
increasingly published over the last 40 years (Figure 2.1).  
 
 
Figure 2.1 Summary of gamma sterilization published literature (from ref. 9). 
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The interaction of γ-rays with matter is a process that can be divided into three stages:3 
1. The physical stage (~10−18 – 10−15 s): involves the absorption of the energy of the 
ionising radiation by the irradiated material. The effect of such energy transfer is the 
production of electronically excited molecules, ions and free electrons.  
2. The physio-chemical stage (~10−14 – 10−12 s): during this stage the excited molecules 
and ions dissipate their energy through a number of processes including bond rupture, 
luminescence and transfer of energy to neighbouring molecules. At this stage, free 
radicals are formed. 
3. The chemical stage (~10−12 – 10−3 s): ions and radicals formed in the previous stage 
react with other molecules. Examples of reactions at this stage include atomic 
abstraction, radical recombination, oxidation, depolymerisation, crosslinking and 
addition to π-bonds.3,4 
The lethal action of ionising radiations has been proposed to be due to disruption of DNA, 
occurring either directly (target theory), or indirectly by interaction of DNA with newly formed 
free radicals (diffusion theory). 
An irradiation dose of 25 kGy is generally accepted to assure sterility,3 although lower doses 
can be used, depending on the bioburden of the components, in order to reduce the impact of 
the sterilization process on the sterilized materials.10 
The use of γ-irradiation for sterilization purposes has numerous advantages in respect to the 
other methods.5,11,12 To begin, it enables the sterilization of thermolabile or chemically reactive 
drugs. Its high penetrating power allows terminal sterilization of the products, assuring better 
sterility and less pitfalls than non-terminal processes and a higher penetration compared to 
electron beams and X-rays. Cost wise, it is also more convenient than processes such as 
filtration and working in aseptic conditions. On the other hand, γ-sterilization can produce 
chemical and physical alterations in the irradiated material, which must be assessed to ensure 
the safety of the sterilized products.13 
2.2.3 γ-sterilization of pharmaceuticals 
As the popularity of γ-irradiation sterilization increases, the interest in the γ-sterilization of 
pharmaceutical products is also constantly growing. Numerous reviews have been published in 
the past, covering the effects of γ-sterilization on several APIs and drug delivery systems4,5,12–
18 and will not be here reported. From the said reviews, it clearly emerges that the effects of 
γ-sterilization on pharmaceutical compounds are rather varied and therefore difficult to predict. 
In fact, it is not possible to make predictions on the impact of radiation sterilization on a 
molecular structural base, as just minor changes in the molecular structure can have significant 
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influence in the outcome of the sterilization.11 Thus, the impact of radiation sterilization on a 
specific compound must be assessed every single time.  
 
2.3 EPR in the detection of pharmaceutical degradants 
As described in Chapter 1, electron paramagnetic resonance (EPR) is the technique of choice 
for the study of free radicals. Since the interaction of γ-rays and matter results in the formation 
of free radicals, EPR spectroscopy has been used in the past to provide proof of whether a drug 
has been irradiated or not.19–21 Radicals can originate from processes other than irradiation, and 
unirradiated samples often present an EPR signal.11,19 Materials exposed to UV radiation can in 
fact give an EPR signal,22,23 likewise mechanistic actions such as grinding or milling can 
produce EPR active species.24–26 The difference is usually given by the intensity of the EPR 
signal, which is much higher in γ-irradiated materials. In fact, UV radiation induces the 
production of paramagnetic species only on the surface of the irradiated material, while for 
thermal processes the radical yield is rather low.20  
Other techniques have been utilized to characterize degradation products formed upon 
irradiation of pharmaceuticals, but all show some limitations. Thermoluminescence, for 
example, can be used to analyse irradiated products in the solid state by detecting radio-induced 
ions trapped in the solid matrix. Some signals are characteristic of irradiated drugs, but 
depending on the compound under study the relevant peaks can be one or multiple, and can be 
dose dependent or not. Therefore, each compound is a different case and requires a specific 
study. In case of mixtures, it also would not be possible to unequivocally attribute the detected 
signal to one component or another, hence a general detection protocol cannot be produced.20,21 
Protocols for the detection of irradiated foodstuffs containing lipids with gas phase 
chromatography (GC) can potentially be applied to lipid containing formulations, e.g. creams. 
However, the complexity of such products does not usually allow the use of this technique, 
which cannot distinguish more than three/four different lipids at the same time.21 
 
2.4 Pharmaceutical excipients 
The formulation of a drug product involves the use of excipients, which represent the non-active 
part of the drug that is included in the manufacturing process or contained in a finished 
pharmaceutical product dosage form.27 These pharmaceutically inactive substances are needed 
to improve the properties of the drug, either by enhancing the therapeutic effect of the API or 
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by facilitating the manufacturing process.28 Parenteral (i.e. injectable) products, which are the 
subject of the first part of this thesis, are often formulated as freeze-dried cakes. These cakes 
are obtained through a process called freeze-drying, also known as lyophilisation. This process 
consists of freezing the solution that contains all the ingredients of the formulation, followed 
by removal of (most of) the water content, initially by sublimation and later by desorption. This 
procedure allows formulation of drugs which are thermolabile or unstable in aqueous 
solutions.3,27 The lyophilised cake is then reconstituted in a physiological solution immediately 
prior to injection into the patient. 
A summary of the types and functions of the most common freeze-dried excipients is reported 
in Table 2.1: 
Table 2.1 Summary of types and functions of freeze-dried excipients. 
Excipient Functions Examples 
Bulking agents Act as filling material 
Mannitol, lactose, 
sucrose, trehalose, 
sorbitol, glucose 
Buffering agents 
Control the pH of the reconstituted 
solution 
Histidine, citric 
acid, sodium 
citrate, sodium 
phosphate, tris 
base, arginine 
Solubilising agents Aid the reconstitution of the drug 
EDTA, alpha 
cyclodextrin, 
polysorbate 80 
Antimicrobials 
Prevent microbial growth during shelf 
life 
Benzyl alcohol, 
phenol, methyl 
paraben 
Tonicity modifiers 
Make solution isotonic with human 
plasma 
Dextran, mannitol, 
glycerol 
 
Typically, the total amount of excipients in a dosage form is greater than the amount of the 
API(s). The choice of excipients in a formulation is paramount, as they can both stabilise or 
destabilise the product.19 Indeed, the action of a pharmaceutical product depends on the stability 
not only of the APIs, but also of the excipients. Adverse effects can in fact be caused by 
excipients or their impurities, either directly or by reaction with the active part of the drug.29 
Thus, assessing the stability of these inactive components after they undergo potentially 
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destructive industrial processes is crucial to determine the safety of the processed 
pharmaceutical product. 
 
2.5 Motivation of study 
This thesis aims to explore the applicability of EPR spectroscopy in areas of pharmaceutical 
R&D where this powerful tool is still much underutilised.  
Several industrial pharmaceutical processes result in degrading the products being processed to 
some extent. Often, the energy released in the said processes induces the formation of radicalic 
degradants. In particular, sterilization with γ-rays can form free radicals in relatively high 
concentrations.3,4,13 The safety of these highly reactive species must be assessed to avoid 
adverse effects following administration of the drug product to the patient. γ-sterilization is of 
particular interest for a variety of parenteral drugs which are thermolabile and as such cannot 
be sterilized with the classic autoclaving process. Since the effects of γ-sterilization cannot be 
predicted beforehand, as even very similar compounds usually have rather different responses 
to irradiation, the stability of each new irradiated pharmaceutical product must be assessed. 
Nevertheless, the number of excipients that can be utilised in parenteral formulations is limited. 
Thus, having a complete characterisation of the degradants formed upon irradiation of the most 
common excipients would be a great advantage towards the study of a multi-component system. 
EPR is considered the gold standard for the study of free radicals, being characterised by a high 
sensitivity and specificity towards paramagnetic species. This technique therefore allows to 
quantify, identify and assess the reactivity of free radicals produced upon γ-sterilization of 
parenteral drugs. Interestingly, it was shown that the same radical species are detected in 
starches after γ-irradiation, UV radiation or grinding.20,21 Hence, it appears that the 
characterization of the degradation products originated from γ-irradiation is not only limited to 
the study of this pharmaceutical process, but is in fact useful for a number of processes in the 
pharmaceutical industry. In the first part of this work, the effects of γ-sterilization on two very 
common excipients, L-histidine and D-mannitol, are studied. 
Approximately 50% of anticancer treatments nowadays involve the use of platinum-based 
compounds.30 Despite many important results in the development of this class of anticancer 
drugs, the development of resistance remains a major issue and pushes to the search for new 
anticancer candidates.31 trans,trans,trans-[Pt(N3)2(OH)2(pyridine)2] is a promising photo-
activable diazo anticancer compound, which has been shown to have a dual mechanism of 
action involving both platination to DNA and oxidative attack carried out by photo-released 
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azidyl radicals.32 Additionally, the cytotoxic activity of this platinum(IV) complex was found 
to be tuned by the presence of L-tryptophan, an effect that was ascribed to the quenching of 
azidyl radicals by this aromatic amino acid with consequent formation of a transient 
L-tryptophan radical, although such species had not being previously detected. EPR spin 
trapping methodology offers the possibility to unveil the details of the interaction between these 
transient species, leading to an increased mechanistic understanding of the activity of the 
platinum(IV) compound to improve the drug design of such anticancer drugs. Additionally, 
EPR studies can help to identify the intracellular target of the photo-released azidyl radicals, 
which to date remains unknown. 
 
2.6 Thesis outline 
An outline of the remainder of this thesis is as follow: 
• In addition to the theoretical basis for the experiments performed that has been 
discussed in Chapter 1 and the background information of this chapter, Chapter 3 
provides the experimental aspects of the techniques used in this thesis. Details on the 
instrumentation used and on the experimental procedures are outlined. 
• Chapter 4 discusses the effects of γ-irradiation on the amino acid L-histidine. Solid 
state irradiated crystals and powders are studied with EPR in the range of 77–295 K. 
Particular focus is given to the spin trapping experiments, reporting an unusual 
regeneration mechanism of the radical species in solution. 
• Chapter 5 focuses on studying the irradiation effects on the excipient D-mannitol, 
characterising the radical species formed at low temperature and following their 
evolution into the r.t. stable species. Spin trapping experiments are also reported, 
together with data from complementary techniques. 
• In Chapter 6, a short introduction to metallo-organic anticancer compounds is 
presented. The chapter then investigates the mechanism of action of a promising photo-
activable anticancer Pt-complex, with the identification of transient intermediates 
through spin trapping experiments. The target of photo-released RNS is also studied. 
• Finally, Chapter 7 offers a summary of the presented work and the direction of future 
investigations. 
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Chapter 3  
Experimental Methods 
 
In this Chapter the main materials, experimental procedures and instrumentation used 
throughout the thesis will be described. More specific experimental details will be discussed in 
the following chapters. 
 
3.1 Experimental 
3.1.1 Materials 
L-histidine free base, D-mannitol, deuterium oxide (D2O, ≥ 99.96%), acetonitrile (ACN), 
2-methyl-2-nitrosopropane (MNP) in the form of dimer, ethylenediaminetetraacetic acid 
(EDTA) were all purchased from Sigma Aldrich. 5,5-Dimethyl-1-pyrroline-N-oxide (DMPO) 
was purchased from Enzo Life Sciences. DMPO and MNP dimer were stored at −20 °C. Ethanol 
(99.7–100%) absolute and toluene were purchased from VWR. 
 
3.2 Crystal growth 
Single crystals were grown from saturated aqueous solutions by slow evaporation at room 
temperature (r.t.). Saturated solutions were prepared by mixing an excess of powder to Milli-Q 
water. The solutions were then filtered with 0.22 μm Millipore syringe filters and transferred 
into crystallising dishes. The dishes were covered with a pierced aluminium foil and left to 
desiccate at r.t. until complete evaporation of the water. The structures of the crystals were 
determined by single crystal X-ray diffraction on a Rigaku Oxford Diffraction Gemini R. 
3.2.1 Deuteration 
In order to obtain partially deuterated samples, powders were dissolved in D2O and 
subsequently reprecipitated by slow addition of ethanol under mild stirring. The powders were 
then filtered with a filter funnel. The procedure was repeated for a total of 3 times, after which 
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the powders were left to desiccate until complete evaporation of the residual solvent. Part of 
the powders were dissolved once again in D2O to form a saturated solution, and were left to 
crystallise as previously described. Partially deuterated crystals and powders were stored in 
sealed vials containing nitrogen gas. The procedure resulted in the deuteration of fast proton 
exchange chemical groups such as amino, carboxyl and hydroxide groups. 
 
3.3 γ-irradiation 
All γ-irradiations were performed at Dalton Cumbrian Facility (UK) using a Foss Therapy 
Model 812 60Co self-contained high dose rate γ-irradiator. 
3.3.1 Room temperature irradiation 
Powder and crystal samples were sealed in headspace glass vials with PTFE/butyl septa and 
evacuated. γ-irradiation was performed supplying a dose rate of approximately 2.3 kGy/h, 
which was measured by a Radcal 10X6-0.18 ion chamber. Samples received a total dose of 
either 25, 125 or 250 kGy, with an estimated error of ±5% of the total irradiation dose. 
3.3.2 γ-irradiation in liquid nitrogen 
Samples were inserted in 4 mm o.d. EPR quartz tubes (Wilmad-LabGlass 707-SQ-250M), 
which were flame sealed after being evacuated for a few minutes. As crystals grow 
preferentially in one direction forming plates, they could be inserted in the quartz tubes only in 
one orientation, hence low temperature experiments could not be performed along all the three 
orientations of the crystal samples. The sample tubes were then tied together by means of cable 
ties, and placed at the centre of a liquid nitrogen dewar. A polystyrene lid with a hole in the 
centre was placed at the top of the dewar to keep the tubes in position. The dewar was then 
filled with liquid nitrogen and placed in the irradiation chamber. The samples were irradiated 
while submerged in liquid nitrogen for a total dose of approximately 25 kGy, with an irradiation 
rate of approximately 2.3 kGy/h. The nitrogen dewar was periodically refilled to keep the 
samples always submerged in liquid nitrogen. Before each refilling, the samples were 
temporarily moved into a second liquid nitrogen dewar, while the liquid nitrogen left in the first 
dewar was eliminated as ozone (O3) can form with γ-irradiation in open air1 and can result in 
explosions.2 When the irradiation was completed, samples were quickly transferred into a 
transportable Statebourne Bio 10 nitrogen dewar and transported back to the laboratory for the 
EPR analysis. 
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3.3.3 Removal of quartz background signal 
As the irradiation of quartz results in the formation of a number of EPR-active defects which 
can interfere with the analysis,3 the tubes were annealed by using the sliding technique.4 
Samples were slid to the other end of the EPR quartz tube and the empty end of the tube was 
annealed with a oxygen/propane flame torch, resulting in the elimination of the quartz EPR 
signal (Figure 3.1). The samples were then slid back to the original position. During this 
operation, the samples were kept in liquid nitrogen in order to maintain their temperature at 
77 K. 
 
Figure 3.1 γ-irradiated quartz tube before (black) and after (red) annealing with a flame torch for ca. 30 seconds. 
 
3.4 X-irradiation 
X-irradiation was performed in normal atmosphere on a Bruker D5005 Cu Kα X-ray powder 
diffractometer. The radiation dose rate varied depending on the position of the anode X-ray 
tube in respect to the sample holder. During a standard X-ray diffraction experiment, both the 
X-ray source and the detector are rotating about a specific angle in respect to the sample, in 
order to obtain a diffraction pattern. In our experiment, the X-ray source was kept fixed in 
position for all the duration of the irradiation. When irradiating powder samples, the tube was 
positioned to make an angle of 60° with the plane of the sample holder, such as to irradiate as 
much surface of the sample holder as possible. Instead, when irradiating crystals, the position 
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of the X-ray tube was changed to an angle of 80°, thus concentrating the beam into the centre 
of the sample holder, where the crystal sample was positioned (Figure 3.2).  
To quantify the irradiation dose rate for each of the two configurations, alanine pellets were 
X-irradiated for either 0.5, 1 and 2 hours. The EPR signal intensity, directly proportional to the 
irradiation dose received, was measured on a Bruker Alanine Dosimeter Reader. The dose rate 
in the powder configuration (60° to the plane of the sample holder) was found to be of 
0.67(7)  kGy/h, while the dose rate in the crystal configuration (80°) was 0.72(7) kGy/h. 
 
 
Figure 3.2 Schematic representation of the X-ray diffractometer, showing the rotation of the X-ray source in respect 
to the sample holder, depending on the type of sample to irradiate. For the irradiation procedure the position of the 
detector was not relevant. 
 
3.5 Instrumentation 
3.5.1 The EPR spectrometer 
The main components of a continuous wave (CW)-EPR spectrometer are reported in Figure 
3.3. An iron-core electromagnet provides a homogeneous magnetic field at the sample. A 
variable power supply unit (PSU) in the console controls the magnets and allows the magnetic 
field to be swept steadily and reproducibly through the magnetic field range of interest. As the 
magnetic field produced is not inherently linear to the current and affected by hysteresis, a 
temperature-stabilised Hall probe is mounted inside the magnet. The probe is calibrated against 
a known NMR signal and allows accurate control of the field by correcting the current generated 
through a feedback loop. A 2,2-diphenyl-1-picrylhydrazyl (DPPH) standard was used for 
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calibration of the g-factor. The microwave frequency was recorded on each spectrometer using 
an EIP-545A microwave frequency counter. 
The microwave bridge contains both the microwave source, generally a Gunn diode, and the 
detector. The microwave source provides microwaves at a stable frequency and power. Specific 
microwave frequencies are classified into bands, as discussed previously. The microwave 
power can be controlled by an attenuator. After attenuation, the microwaves go through a 
circulator, a three port device that allows transmission of microwaves from one port to the next 
in rotation, thus directing the radiation to the resonator. The resonator is defined as “critically 
coupled” when the maximum power is transferred from the microwave source to the resonator. 
The EPR spectrometer detects the changes in amount of microwave radiation reflected back 
from the cavity. The reflected microwaves are directed to the detector diode through the 
circulator. Microwaves are also sent to the detector via a reference arm, which is used to bias 
the detector allowing it to operate in its linear regime. The current is therefore converted into a 
digital signal with an analogue-to-digital converter. Before digitalization of the signal, phase 
sensitive detection is employed to increase the sensitivity.  
 
Figure 3.3 Diagram of the componets of a typical EPR spectrometer. The components of the microwave bridge 
include (a) source, (b) high-power attenuator, (c) circulator, (d) bias attenuator, (e) phase shifter, (f) diode detector. 
Partially adapted from ref. 5. 
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The magnetic field is modulated at typically 100 kHz, causing modulation of the EPR signal. 
A lock-in amplifier allows demodulation of the signal to extract the component in phase with 
the field modulation. The signal amplitude at the modulation frequency is proportional to the 
slope of the EPR absorption signal, thus the detected signal is displayed as the first derivative 
of the absorption. 
In order to increase the sensitivity of the EPR experiment, the sample is placed in the resonator. 
Resonators are components of the spectrometer that possess the ability to increase the signal by 
concentrating the microwave magnetic field at the sample while minimising the microwave 
electric field at this position. Several types of resonators are available, including cavity 
resonators, dielectric and loop gap resonators.  
The cavity resonator is a metallic chamber of size comparable to the wavelength of the applied 
microwaves. Coupling to an X-band cavity is obtained by varying the effective size of a hole 
called the iris, which controls how much of the microwave power is allowed into the cavity and 
how much is reflected back. This is done by the iris by matching the impedances (i.e. the 
resistance to the waves) of the cavity and the waveguide. The effective size of the iris is varied 
by varying the position of an iris screw. When the impedances are matched, the cavity is 
critically coupled. When the sample absorbs microwave energy, the impedance of the cavity 
changes and the cavity is no longer critically coupled. Consequently, the microwaves are 
reflected back to the detector, resulting in an EPR signal. 
3.5.1.1 W-band EPR 
W-band experiments were performed on a Bruker Elexsys E680 FT/CW EPR spectrometer 
operating at 94 GHz. The setup of the W-band EPR spectrometer includes a custom resonator 
characterised by a horizontal sample access and a Bruker 300 MHz NMR magnet. Powder 
samples were meticulously crushed in a mortar in order to facilitate the insertion into 0.9 mm 
o.d. Suprasil EPR sample tubes (Wilmad-LabGlass WG-213ST9S-RB), which were then 
placed in the resonator for the r.t. analysis. 
3.5.1.2 mm-wave EPR 
Millimeter-wave experiments were performed on a Bruker Elexsys E780 EPR spectrometer 
operating at 263 GHz. The system is equipped with a quasi-optical front end featuring reflection 
and induction detection. The standard probe head was used in non-resonant configuration, with 
the sample inserted in a standard X-band tube. The signal was detected in quadrature, providing 
the real/imaginary, dispersion/absorption signals in CW. The acquisition of the data in the 
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correct phase was found to be challenging, thus the phase was adjusted afterwards in MATLAB 
by manually minimising the imaginary signal. 
 
3.5.2 Low temperature 
Low temperature experiments were conducted on a Bruker EMX CW spectrometer operating at 
X-band (9.8 GHz) using a Bruker VT 2000 variable temperature unit equipped with a heating 
element (Figure 3.4). To operate at cryogenic temperatures, nitrogen gas was flowed into a long 
copper tube arranged in coils which were inserted in a liquid nitrogen dewar and submerged in 
liquid nitrogen. The cooled nitrogen gas was passed over a long quartz transfer line containing 
a heating element, positioned below the resonator. The gas was directed into a quartz insert in 
the resonator, where the sample was placed. A second nitrogen line was connected to the back 
of the waveguide and r.t. nitrogen gas was flowed through the resonator to prevent condensation 
and keep temperature constant. The temperature was monitored by means of a thermocouple 
located below the resonator, feeding back to the temperature control unit. In order to analyse 
samples previously γ-irradiated in liquid nitrogen, the system was pre-cooled down to ca. 80 K.  
 
 
Figure 3.4 Schematic representation of the setup used for the low temperature EPR experiments, with key 
components labelled. 
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The samples were thereafter quickly transferred from the storage liquid nitrogen dewar into 
the cooled EPR cavity. Annealing of the samples in steps allowed monitoring of the evolution 
of the EPR spectra from (assumed) primary radical species into secondary, tertiary, 
quaternary species and so on. A uniaxial goniometer placed at the top of the cavity allowed 
the acquisition of roadmaps for the analysis of single crystals. 
 
3.5.3 Spin trapping 
All EPR spectra were recorded at room temperature (ca. 291 K) on a Bruker EMX CW 
spectrometer operating at X-band (9.8 GHz). Either a flat cylindrical cavity (ER 4103TM) 
operating in the TM110 mode, or a super high Q cylindrical cavity (ER 4122SHQE) operating 
in the TE011 mode was used. Both of these cavities are particularly suited for the analysis of so 
called lossy samples, i.e. exhibiting a high dielectric loss such as water containing samples.6,7 
The interaction of the electric field of the microwaves with lossy samples causes the samples 
to be heated by the absorption of microwaves, reducing the Q of the cavity and the sensitivity 
of the spectrometer as a consequence. Cylindrical cavities are therefore designed in such a way 
to minimize the interaction between the sample and the microwave electric field, while 
maximizing the interaction with the magnetic field. The mode of the cavities is illustrated in 
Figure 3.5 and Figure 3.6.  
 
 
 
Figure 3.5 The field distribution in a TM110 cylindrical cavity (reproduced from ref. 8). 
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Figure 3.6 The field distribution in a TE011 cylindrical cavity. a) Side profile of magnetic field. b) Axial profile of 
magnetic field in the centre of cavity. c) Side profile of electric field. d) Axial profile of electric field in the centre 
of cavity (reproduced from ref. 8). 
 
Typical EPR parameters were: time constant 5.12 ms; conversion time 10.24 ms; number of 
points 1024; sweep width 10 mT; microwave power 6.3 mW; microwave frequency 9.8 GHz; 
modulation amplitude 0.1 mT. To avoid distortion of the spectral lines, time constant was set 
to values lower than ca. 1/10 the time it takes to scan through the narrowest line of the 
spectrum.5 The data were acquired in incremental mode in order to obtain kinetic information 
concerning the radical species detected.  
 
3.5.3.1 Phosphate buffer solution 
The phosphate buffer (p.b.) 1 M concentrated solution was prepared mixing 72% of a solution 
of Na2HPO4 1 M with 28% of a solution of NaH2PO4 1 M. The pH of the resulting solution was 
measured with a pH meter and adjusted to pH 7.2 by adding either of the two solutions. The 
concentrated p.b. buffer was then diluted 1:20 in the sample solution. 
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3.5.3.2 Sample preparation 
The spin trap solution of MNP was prepared solubilising the solid dimer in ACN at a 
concentration of either 0.8 M or 1.6 M and subsequently diluting 1:20 into the aqueous buffered 
solutions to give a final concentration of 40 or 80 mM. 
The spin trap solution of DMPO was prepared in concentration of 0.2 M in water and then 
diluted 1:20 into the aqueous solutions to give a final concentration of 10 mM. 
Samples were inserted into quartz EPR capillaries (Wilmad-LabGlass 712-SQ-100M) using 
either a glass Pasteur pipette or a syringe with sterile stainless, chromium-nickel steel needle 
(Braun Sterican 4665643; 21G, 120mm).  
Milli-Q water (18.2 MΩ·cm) buffered at pH 7.2 with p.b. 50 mM was utilised for all the spin 
trapping experiments.  
 
3.5.4 ENDOR 
Electron Nuclear DOuble Resonance (ENDOR) is a technique that allows detection of the NMR 
intensities through simultaneous irradiation of the EPR lines, thus providing extremely valuable 
information towards the identification of the molecular structure of paramagnetic species.9 
ENDOR spectra were recorded on a CW X-band Bruker ESP 300E spectrometer equipped with 
an ESP360 DICE ENDOR unit, operating at 100 kHz field modulation in an X‑band Bruker 
EN 801 ENDOR cavity. ENDOR spectra were recorded at 50 K and were obtained using 2 dB 
RF attenuation from an ENI A-300 RF amplifier, at 100 kHz RF modulation depth and 2 mW 
microwave power. 
 
3.5.5 1H NMR 
1H NMR experiments were performed on a Bruker Avance III 600 MHz spectrometer at r.t. (ca. 
298 K). Spectra were recorded with a standard 1H NMR zg30 pulse program and acquired with 
64 transients into 32 k data points with a spectral width of 20 ppm. Samples were prepared by 
dissolving either non-irradiated or irradiated powders in D2O for a concentration of ca. 15 
mg/ml. The solutions were centrifuged at 10K rpm to eliminate any undissolved particle. The 
samples were then transferred into 5 mm o.d. standard NMR tubes purchased from Wilmad-
LabGlass. Spectra were processed with an exponential line-broadening of 0.2 with J values 
quoted in Hz. The NMR spectra were internally calibrated to 1,4 dioxane (3.75 ppm in D2O). 
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3.5.6 ESI-MS analysis 
Electrospray ionization (ESI) mass spectrometry (MS) was performed on a Shimadzu LC-MS 
8030 triple quadrupole mass detector coupled to a Shimadzu Nexera 2 UHPLC system. The 
samples were injected in the system in the absence of a separation column, and eluted into the 
MS system in 10% of acetonitrile in water, both containing 0.1% formic acid at a flow rate of 
0.5 mL/min. Solutions of non-irradiated and γ-irradiated powder samples at different doses (25 
and 250 kGy) were prepared at a concentration of 10 mM. Typically, 2 μL of the sample was 
injected into the LC-MS system. Samples were run both in positive and negative mode in a 
mass range of 50–1000 m/z. The spectra of non-irradiated and irradiated samples were then 
compared in order to determine the presence of new signals ascribable to degradation products 
generated from the irradiation process. 
 
3.5.7 XRF 
X-ray fluorescence (XRF) analysis was conducted using an Energy Dispersive (ED)-XRF 
system (NEX CG, Rigaku, Japan) operating an X-ray tube with Pd anode at 50 kV with a 1 mA 
current and utilising an Cu secondary target (Kα = 8.046).  All spectra were measured under 
moderate vacuum (12 Pa) for a sampling time of 150 s, and background subtracted. The 
interrogation area of the X-Ray source on the sample is elliptical and ca. 1.2 cm in diameter, 
thus in order to make the measurements, 3 of the 12 cm needles were cut into smaller (1.2 cm) 
segments and placed into the centre of a sample holder to ensure they came into contact with 
the X-ray beam. 
 
3.6 Quantitative EPR 
In the absence of microwave power saturation, the EPR signal intensity is proportional to the 
number of spins in the system, which is in turn proportional to the radical concentration of the 
sample under study. Although absolute quantification of the EPR signal through a calibrated 
spectrometer is possible,10 it is however challenging and difficult to pursue. Thus, in most cases 
quantification of the spectrum of an unknown paramagnetic sample is achieved by comparison 
with the spectrum of a sample of known spin concentration.5 To determine the unknown spin 
concentration of a sample (s) from a known reference (Ref), the conditions under which the 
spectra were acquired must be taken into account: 
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Where: 
• I : the double integrated intensity of the EPR spectrum; 
• g : the g-value of the paramagnetic species; 
• η : the filling factor; 
• Q : the loaded quality factor of the resonator; 
• T : the temperature; 
• S : the spin of the system; 
• Bm : the modulation amplitude; 
• P : the microwave power (where √𝑃 ∝ 𝐵1, assuming no microwave power 
saturation); 
• G : the receiver gain; 
• t : the conversion time; 
• N : the number of scans. 
 As previously discussed, the Q of the resonator is an important parameter to consider, as the 
EPR signal intensity is proportional to Q. When a lossy sample is inserted in an EPR cavity, 
part of the microwave power is not stored in the cavity but dissipated, hence decreasing the 
value of Q.  Since the Q value provided by Bruker WinEPR spectrometer software is not always 
very accurate, in this work references were selected in such a way to possess a Q comparable 
to the one of the samples under analysis. 
 
3.6.1.1 Quantification of persistent radicals in the solid state 
For the quantification of the persistent radicals formed in the powders upon γ-irradiation, 
solutions of the free radical 2,2,6,6-tetramethyl-piperidine-1-oxyl (TEMPO) in toluene were 
used. TEMPO’s main EPR spectral feature is a triplet, which is due to the coupling with the 
nitroxide nitrogen (14N, I = 1). Toluene was selected for being a non-lossy solvent, and as such 
the Q of the resonator remained approximately unvaried when measuring solid samples and 
references. Solutions of TEMPO in toluene were prepared in concentrations of 0.01, 0.1, 1, 10 
and 50 mM. Both samples and references were inserted into 4 mm o.d. tubes (Wilmad-LabGlass 
707-SQ-250M) and placed in the EPR cavity. In order to account for the same η, the tubes of 
both samples and references were filled and positioned in the spectrometer in such a way to 
cross the entire length of the cavity. The EPR spectrum of each samples was recorded. The 
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spectra were baseline corrected and double integration was performed. The resulting calibration 
curve is shown in Figure 3.7. 
 
Figure 3.7 Calibration curve for the double integrated intensity of TEMPO in toluene at r.t. Inset: molecular structure 
of TEMPO. 
 
3.6.1.2 Quantification of spin adducts 
In this work, aqueous solutions containing the free radical 4-hydroxyl-2,2,6,6-tetramethyl-
piperidine-1-oxyl (TEMPOL) were used to quantify the formed spin adducts, as previously 
reported.11 The choice of TEMPOL over TEMPO for quantifying spin adducts in aqueous 
solutions is due to the poor solubility of the latter in water. TEMPOL’s main EPR spectral 
feature is a triplet, which is due to the coupling with the nitroxide nitrogen (14N, I = 1).  
For quantitative measurements, it is crucial that the standard sample is analysed in experimental 
conditions as close as possible to the system under study.5 Thus, the same experimental 
conditions were replicated including solvent, temperature, sample tubes, and tube position in 
the EPR cavity. 
TEMPOL solutions in either i) water, ii) p.b. or iii) 20% of ethanol in p.b. were prepared in 
concentrations of 0.1, 0.5, 1, 5, 12.5, 25, 50, 75, 100, 200 and 300 μM. The EPR spectrum of 
each solution was recorded. The spectra were baseline corrected and simulated with EasySpin.12 
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Double integration was then performed on the simulated spectra. The resulting calibration curve 
is shown in Figure 3.8. 
 
Figure 3.8 Calibration curve for the double integrated intensity of TEMPOL in p.b. 50 mM at pH 7.2 at r.t. Inset: 
molecular structure of TEMPOL. 
 
3.7 EPR simulations 
Simulations of the experimentally acquired EPR spectra were performed for identifying and 
quantifying the detected paramagnetic species.  
The analysis of the extracted spectral parameters allows the characterisation of a paramagnetic 
species and, where possible, its identification by comparison with previously published 
parameters for the said species. 
In order to quantify the signal of an EPR active species it is necessary to perform a double 
integration of the spectrum and compare it with a known standard. Quantification of EPR 
spectra by direct double integration of the data can be challenging and requires some 
precautions. For instance, if the S/N ratio is relatively low, the double integrated spectrum will 
include the signal deriving from the noise, therefore distorting the quantification. Additionally, 
direct double integration of the spectrum will not allow separation of the contributions of 
multiple species present in the spectrum or of a background signal. In order to overcome these 
limitations, in this work the paramagnetic species of interest were simulated and double 
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integrated. All the simulations of the EPR spectra were performed with the MATLAB package 
EasySpin.12 EasySpin enables the simulation of EPR spectra by defining the spin Hamiltonian 
parameters of the system under study. The least-squares fitting technique can be then used to 
fit the line shape on the EPR spectrum from the starting parameters. Additional details regarding 
the EPR simulations performed are reported in the specific chapters. 
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Chapter 4  
Irradiation of L-histidine Free Base 
 
The following publication is based on the present Chapter: 
Vallotto, C., Williams, H.E., Murphy, D.M., Ayres, Z.J., Edge, R., Newton, M.E. & Wedge, 
C.J. An Electron Paramagnetic Resonance (EPR) spectroscopy study on the γ‑irradiation 
sterilization of the pharmaceutical excipient L‑histidine: regeneration of the radicals in 
solution. Int. J. Pharm. 533, 315-319 (2017). 
 
This Chapter investigates the effects of γ-radiation sterilization on the parenteral excipient 
L-histidine free base. The irradiation process induces the formation of a deamination radical 
which is persistent in the solid state. The reactivity of the radical species in solution was 
evaluated with spin trapping experiments. The radicals were found to regenerate in solution in 
the presence of trace metals through a Fenton-type reaction. 
 
Figure 4.1 Chemical structure of L-histidine. 
 
4.1 Introduction 
4.1.1 Use of L-histidine in parenteral formulations 
The amino acid L-histidine (L-his) is an excipient typically used in parenteral formulations as 
a buffering agent and a stabilizer for subcutaneous, intramuscular and peritoneal injections.1,2 
In protein formulations, antibodies in particular, it is preferred over other buffers such as citrate 
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buffer, which can cause a painful reaction when injected subcutaneously and sodium succinate, 
which lacks a good buffer capacity at low strength, hence requiring the other excipients of the 
formulation to be decreased in order to maintain the osmolarity in a desired range (1 mM 
histidine = 1 mOsm; 1 mM sodium succinate = 3 mOsm).1 Additionally, histidine has been 
shown to provide stabilizing non-covalent interactions with antibodies in the solid state, 
reducing the alterations of the antibodies’ secondary structure upon freeze-drying.3 
4.1.2 Scavenging properties of histidine 
Histidine has also shown antioxidant properties, being a scavenger of the hydroxyl radical 
(•OH) and singlet oxygen (1O2).4,5 The scavenging characteristics of histidine towards hydroxyl 
radical were found to rely on its ability to interfere with metal ions involved in redox reactions 
and responsible for the production of this highly reactive oxygen species (ROS). Studies 
involving L-his effects on lipid peroxidation reported the ability of the amino acid to coordinate 
with iron, suggesting this to be the reason for its physiologic antioxidant effects.6,7 Histidine is 
also generally recognized as the most active singlet oxygen scavengers amongst the amino 
acids,8 through a mechanism that involves direct interaction of the imidazole ring with singlet 
oxygen.4 
Histidine residues have also been found to participate in the radical mediated degradation of 
proteins. In fact, protein bound histidine residues have been shown to mediate free radical 
cleavage of the peptide bond backbone in monoclonal antibodies.9 
4.1.3 Solid state radicals 
It has previously been shown that irradiation of L-his induces the formation of stable radical 
species in the solid state.10–12 X-irradiated single crystals of L-his free base had been 
investigated by EPR spectroscopy in the range of 77–300 K.12 Nitrogen temperature irradiation 
was found to induce the formation of a carboxyl anion by addition of a proton to the carboxylic 
carbon. By annealing to room temperature (r.t.), the anion radical was then fully converted into 
the deamination radical, as typically occurs for many amino acids.13–17 The counter ion of the 
histidine salt was found to have a clear influence on the formation of the radical species, as the 
main radical at r.t. for irradiated histidine hydrochloride samples was proved to be the result of 
H addition at carbon C2 (see Figure 4.1) of the imidazole ring. 10,11 
4.1.4 Spin trapped L-histidine radicals 
Studies involving the spin trapping of radicals formed in the solid state have been previously 
reported for several organic compounds, including amino acids.18–21 Previous studies report 
γ-radiolysis experiments on solutions of L-his, where the amino acid was dissolved in a solution 
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of MNP and subsequently irradiated. EPR analysis of the irradiated solution showed that the 
deaminated L-his radical was trapped with MNP.22 
 
4.2 Experimental 
Below are the experimental sample preparation and instrumentation set up specific to this 
Chapter. More details regarding instrumentation and the irradiation setup are described in 
Chapter 3. 
4.2.1 Instrumentation 
All EPR spectra were recorded on a X-band Bruker EMX CW EPR spectrometer at ambient 
temperature (ca. 295 K) unless otherwise stated. X-ray fluorescence (XRF) analysis was 
performed on a Rigaku NEX CG Energy Dispersive(ED)-XRF, using a Cu secondary target. 
More specific details regarding the EPR acquisition and spin quantification are described in 
Chapter 3. 
4.2.2 Sample preparation 
4.2.2.1 Growth and analysis of L-histidine single crystals 
Single crystals of L-his free base were grown from a saturated aqueous solution by slow 
evaporation at room temperature, as described in Chapter 3. Their structure was determined 
by single crystal X-ray diffraction on a Rigaku Oxford Diffraction Gemini R and was found to 
be orthorhombic with space group P212121 (a = 5.1480(3) Å, b = 7.2330(4) Å, c = 18.8122(11) 
Å), in agreement with previously published structures (Figure 4.2).12,23 
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Figure 4.2 Crystallographic structure of the single crystal of L-his viewed along a, b and c crystallographic axes. 
 
4.2.2.2 Spin trapping experiments 
Spin trapping experiments were performed dissolving γ-irradiated powders either in i) an 
aqueous solution of the spin trapping agent; ii) water, adding the spin trap later (after 3 mins 
unless otherwise stated); iii) an aqueous solution of EDTA 1 mM, adding the spin trap after 3 
mins. In order to obtain the maximum concentration of L-his in solution in the case of i), an 
excess of powder was added to a solution of MNP. The solution was then vortexed for 1 min, 
the supernatant was separated from the undissolved powder by centrifugation and analysed. 
The concentration of L-his in solution was therefore considered to be close to saturation 
(≈ 0.27 M).24 When testing the regeneration of the radical in ii) and iii), the excess of powder 
was added to a solution lacking the spin trapping agent, and the supernatant was separated from 
the undissolved powder before the addition of the 0.8 M stock solution of MNP, diluted 1:20 
into the aqueous buffered solution. 
More specific details regarding EPR acquisition and spin adduct quantification are described in 
Chapter 3. 
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4.2.3 EPR Simulations 
EPR spectral simulations were performed in Matlab using the EasySpin package.25 The routine 
pepper was used for the solid state simulation, while the garlic routine (appropriate for the fast-
motional regime) was used for all the solution experiments. 
Simulation of the MNP-histidine spin adduct was performed considering axial hyperfine 
couplings and g-tensor, using the minimum number or parameters necessary to allow dynamic 
effects to be included in the simulation. The phenomenological lineshape used contained 
Lorentzian (0.029 mT) and Gaussian (0.017 mT) components and dynamics were considered 
in the fast motional regime, τc ≈ 5.4 ns; the said parameters were optimized from fitting. 
EPR parameters of the MNP di-adduct di-tert-butyl nitroxide (DTBN) were obtained by fitting 
a spectrum acquired from a solution of MNP which had been illuminated overnight with a 
465 nm LED (7.1 mW cm-2), in order to promote the formation of DTBN. Hyperfine couplings 
arising from both the nitroxidic nitrogen and statistical abundance of nearest neighbour 13C 
nuclei were included and considered to be fully isotropic. An isotropic g-tensor was used; 
dynamic effects were found not to affect the spectrum and were therefore neglected. 
 
4.3 Results 
4.3.1 Non-irradiated L-histidine powder control 
Photodegradation and oxidation can induce the formation of EPR active radical species in 
pharmaceuticals products.26,27 To investigate the presence of background EPR signal in the 
purchased high purity (≥ 99%) L-his free base powder, a spectrum of the non-irradiated powder 
was acquired at r.t. No EPR signal was detected, indicating the absence of persistent radical 
degradation products above the detection limit (~ nM concentration). 
4.3.2 γ-irradiated L-histidine powder EPR spectra 
Next, the effects of r.t. γ-irradiation on L-his powder were evaluated. The irradiation of the 
powder was performed as described in Chapter 3. 
 The EPR analysis of the irradiated powder samples revealed the formation of persistent radical 
species, as shown in Figure 4.3. The EPR spectrum consisted of multiple overlapping lines, 
whose hyperfine couplings were suggestive of the presence of carbon-centred radical species. 
However, the complexity of the EPR spectrum did not allow a direct identification of the 
radicals formed upon irradiation.  
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Figure 4.3 also shows that the same radical species are observed irrespective of the radiation 
dose employed. Quantification of the EPR spectra was performed as described in Chapter 3 
and indicated a radical concentration of 2.46(2), 10.00(2) and 13.72(1) mM respectively for the 
samples receiving a total dose of 25, 125 and 250 kGy (±5%). This non-linear correlation 
between the radical concentration and the radiation dose was previously reported for other 
excipients28 and suggests that above certain irradiation doses other processed are involved, 
limiting the radical formation.  
The saturation behaviour of the powder sample was also investigated by varying the operating 
microwave power in the range 0.006–200 mW (Figure 4.4). As the microwave power was 
increased, the spectral features started to saturate at different rates, which is suggestive of the 
presence of more than one radical species. 
 
 
Figure 4.3 Radiation dose dependence of r.t. γ-irradiated L-his powder. Total irradiation dose of 25 kGy (blue), 
125 kGy (red) and 250 kGy (yellow). CW EPR spectra were normalised to the intensity of the most intense peak to 
show that the same radical species are formed. Inset: concentration of radical species detected for each irradiated 
sample. 
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Figure 4.4 (A) CW EPR microwave power saturation spectra of r.t. γ-irradiated L-his powder. Each spectrum was 
scaled by the square root of the microwave power such that in a non-saturating regime the intensity of each spectrum 
would be equal. (B) EPR power saturation curves for the main peaks of the γ-irradiated L-his powder spectrum. 
 
 
4.3.3 X-ray vs γ-ray irradiation 
To investigate the influence of the radiation source on the radical formation, a sample of L-his 
powder was X-irradiated and compared to the γ-irradiated samples. Verifying that the same 
radical species can be formed from an X-ray source is of particular interest considering that 
X-ray irradiation facilities are generally more commonly available than γ-irradiation sources, 
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the latter being subjected to more safety restrictions. Any X-ray diffractometer for the analysis 
of powder and polycrystalline materials with a sufficient radiation dose rate can be conveniently 
utilized for a quick irradiation experiment. Figure 4.5 shows that very little difference can be 
observed between γ- and X-irradiated powder samples, which could be ascribed to a slightly 
different relative concentration of the multiple radical species formed upon irradiation in each 
sample. 
 
Figure 4.5 Effect of the radiation source on the EPR spectrum. L-his powder was irradiated at r.t. using X-rays 
(black) and γ-rays (red); the difference between the spectra is shown below (black dotted). Irradiation dose 10 kGy 
(X-rays), 25 kGy (γ-rays). The spectra were acquired in the same conditions and manually scaled to overlap. 
 
4.3.4 Single crystal analysis 
In order to identify the radical species produced upon irradiation, single crystal analysis was 
considered. The analysis of a single crystal over a powder sample is generally eased by the fact 
that a single orientation is selected so that, when dealing with anisotropic hyperfine couplings 
or g-tensors, the multiple resonance lines which are due to anisotropy are not present altogether 
in the spectrum as for a powder spectrum. Therefore, by orienting the crystal towards one of 
the main crystallographic axes, the resulting EPR spectrum is generally much simpler and easier 
to interpret. 
Figure 4.6 shows the EPR spectrum of an X-irradiated L-his single crystal oriented along the c 
axis. The main features of the spectrum are eight lines which can be readily attributed to the 
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couplings with an α-proton and two inequivalent β-protons. This is consistent with the main 
radical species being the product of deamination (Figure 4.7), as previously reported.12 
Additional lines can also be observed in the spectrum suggesting the presence of a second, as 
yet unidentified, radical species, as also suggested by the microwave power saturation spectrum 
of the powder. Whilst these features are similar in appearance to the satellite lines known to 
arise from 13C (I = 1/2), their intensity is inconsistent with the natural abundance of this isotope. 
The spectrum of the irradiated crystal was simulated with EasySpin25 (Figure 4.6). However, 
an acceptable simulation of the irradiated powder was not obtained due to presence of other 
radical species. 
 
Figure 4.6 (a) X-band EPR spectrum of L-his single crystal with magnetic field parallel to the c axis after 
X-irradiation at r.t. with line diagram of the deaminated radical species; (b) EasySpin25 simulation (Table 4.1); (c) 
difference between (a) and (b). 
  
 
 
Figure 4.7 Radiolytic deamination of L-his. 
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To verify that the radical species formed upon irradiation are the same for the crystal and the 
powder, a single crystal of L-his was X-irradiated and subsequently crushed. An EPR spectrum 
of the crushed crystal was then acquired (Figure 4.8). The comparison between the spectrum of 
the crushed crystal and the one of the irradiated powder confirmed that in both cases the 
deamination radical was the main species produced, although minor differences between the 
spectra can be observed, which can be attributed to the formation of other species from the 
crushing or to the different irradiation dose. The complexity of the powder spectra did not allow 
separation of the contribution of this additional species from the main radical. 
 
Figure 4.8  (a) EPR spectrum from crushed X-irradiated (13 kGy) L-his single crystal and (b) L-his γ-irradiated 
(25 kGy) directly in powder form. Spectra were scaled to the same intensity. 
 
4.3.5 Single crystal roadmaps 
In the presence of anisotropic spin-Hamiltonian tensors, the EPR spectrum of a single crystal 
will depend on the orientation of the crystal in the magnetic field B0. Roadmaps are spectra 
where the magnetic field is plotted in the x-axis against the angle between B0 and a reference 
direction, plotted in the y-axis. If the Hamiltonian parameters of the said species are known, 
any possible orientation of the crystal in the magnetic field can be simulated. Understanding 
the symmetry of an unknown paramagnetic species can provide useful information for the 
identification of the same. 
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Roadmaps for the γ-irradiated single crystal of L-his rotating about the three main 
crystallographic directions are shown in Figure 4.9, Figure 4.10 and Figure 4.11. The spectra 
were fitted using the parameters previously published by Westhof.12 The g-tensors were not 
reported in literature and have therefore been obtained by fitting the powder spectra, using as 
g-frame the frame given for the α-proton (see Table 4.1). The resulting simulation is in 
reasonably good agreement with the experimental data. 
 
 
 
Table 4.1 Hyperfine parameters (mT) reported from Ref 12 and g-values determined experimentally for the 
deaminated L-his radical. 
 Principal values 
Direction cosines 
a b c 
𝒂𝜶
𝐇 
-0.85 0.7675 0.2889 0.5723 
-1.86 -0.3941 0.9167 0.0657 
-3.02 -0.5056 -0.2760 0.8174 
𝒂𝜷𝟏
𝐇  
0.91 0.9463 0.2048 0.2383 
0.52 -0.3138 0.6569 0.6856 
0.65 -0.3138 -0.7256 0.6879 
𝒂𝜷𝟐
𝑯  
4.14 0.8936 -0.4457 -0.0534 
4.37 0.3693 0.7975 -0.4772 
3.95 0.2553 0.4067 0.8772 
g-value 
2.0049(2) a 0.7675 0.2889 0.5723 
2.0031(2) a -0.3941 0.9167 0.0657 
2.0042(2) a -0.5056 -0.2760 0.8174 
a determined by comparison with a DPPH standard 
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Figure 4.9 Roadmap spectra of the r.t. γ-irradiated single crystal of L-his with the crystallographic c axis 
perpendicular to B0 and rotating in the ab plane. Each spectrum was shifted by its MW frequency of acquisition. 
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Figure 4.10 Roadmap spectra of the r.t. γ-irradiated single crystal of L-his with the crystallographic b axis 
perpendicular to B0 and rotating in the ac plane. Each spectrum was shifted by its MW frequency of acquisition. 
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Figure 4.11 Roadmap spectra of the r.t. γ-irradiated single crystal of L-his with the crystallographic a axis 
perpendicular to B0 and rotating in the bc plane. Each spectrum was shifted by its MW frequency of acquisition. 
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4.3.6 Multi-frequency EPR 
Multi-frequency EPR can be used to identify and characterise unknown species as described in 
Chapter 1. Irradiated L-his powder was analysed at X-band (9.8 GHz), W-band (94 GHz) and 
263 GHz (Figure 4.12) in order to extract the Hamiltonian parameters of the spectra. As can be 
inferred from the powder and crystal spectra, the paramagnetic species produced upon 
irradiation of L-his possess a near isotropic g-factor. The analysis of the W-band spectrum of 
X-irradiated L-his powder confirmed the presence of a rather small g-anisotropy. In fact, a ~10-
fold increase of the microwave frequency (and therefore of the magnetic field) at W-band 
produced only relatively minor change in the EPR spectrum (Figure 4.12b), with most of the 
spectral lines still overlapping. With an additional ~3-fold increase of the microwave frequency 
(263 GHz), it is almost possible to distinguish the three anisotropic components x, y and z, the 
high-field component in particular (Figure 4.12c). 
 
 
Figure 4.12 Multi-frequency EPR analysis of X-irradiated (40 kGy) L-his powder. (a) X-band, 9.8 GHz. (b) W-band, 
95 GHz. (c) mm-wave, 263 GHz. 
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A simultaneous simulation of two of the three spectra (X- and W-band, or X-band and 
263 GHz) was attempted, but no successful outputs were obtained for two main reasons. Firstly, 
a satisfactory determination of the magnetic field at high frequency using a field reference 
proved to be challenging and not possible to obtain, as some offset will always be present due 
to the instrumental setup. Secondly, it was not possible to discern the contribution of the other 
unknown paramagnetic species from that of the main deamination radical, which was believed 
to detrimentally influence the fit. Additionally, obtaining a correct phase during data acquisition 
on the 263 GHz spectrometer was challenging and not always successful, a factor which was 
also believed to negatively condition the simulations. The best simulation obtained is reported 
in Figure 4.13, where X-band and 263 GHz spectra have been simultaneously simulated. The 
starting parameters for the simulations are the parameters reported in Table 4.1. Both the 
g-factor and hyperfine couplings were varied, maintaining g- and hyperfine coupling directions 
unchanged. The parameters extracted from simulation are reported in Table 4.2. 
 
Figure 4.13 Multi-frequency EPR analysis of X-irradiated (40 kGy) L-his powder with simulated spectra (red dashed 
dotted line) overlapped to the experimental data (black solid line). (a) X-band, 9.8 GHz. (b)  mm-wave, 263 GHz. 
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Table 4.2 Hyperfine parameters (mT) and g-values extracted from simultaneous simulation of X-band and 263 
GHz data for the deaminated L-his radical. 
 Principal values 
𝒂𝜶
𝐇 -0.96(3) -1.88(3) -2.98(3) 
𝒂𝜷𝟏
𝐇  0.87(3) 0.50(3) 0.75(3) 
𝒂𝜷𝟐
𝑯  4.10(3) 4.46(3) 3.97(3) 
g-value 2.0048(2) a 2.0030(2) a 2.0043(2) a 
a determined by comparison with a DPPH standard 
 
4.3.7 Cold irradiation 
Irradiation of L-his single crystals and powders was performed in liquid nitrogen as described 
in Chapter 3. The aim of the experiment was to analyse the primary radicals formed upon 
irradiation and follow their evolution into the room temperature stable species. It is worth 
noticing that at “liquid nitrogen temperature” some chemical reactions of active species and 
local physical processes cannot be stopped, and would require a “helium temperature” range to 
be studied.29-34 In the absence of information on the processes undergoing at temperatures below 
77 K, in this study the species detected at liquid nitrogen temperature, which are described in 
the current and the following Chapters, will be referred to as the “primary species”. 
Characterizing these alleged “primary species” and their behaviour in this temperature range is 
an essential first step towards the consideration of multi-component systems. 
Details concerning irradiation in liquid nitrogen are described in Chapter 3. 
4.3.7.1 Carboxyl radical 
The CW EPR spectrum obtained from irradiation of a single crystal of L-his in liquid nitrogen 
and measured at ca. 80 K is shown in Figure 4.14A. When the crystal was oriented along the c 
axis, the main features of the spectrum consisted of a broad 3-line signal. Smaller satellite peaks 
were also visible. As the crystal was rotated in the yz plane, the 3 lines get closer until collapsing 
into a broad single line, suggesting anisotropy of the hyperfine coupling and/or g-value (Figure 
4.15). The microwave power saturation spectra in Figure 4.17 shows that, as the microwave 
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power is increased, the 3 lines characteristic of the spectrum are lost together with the satellite 
peaks, being replaced by a single, broad line. The 3-line spectrum had been previously ascribed 
to the radical formed from the addition of a hydrogen atom to the carboxylic group (Figure 
4.16), which occurs for both histidine free base, used in this study,12 and histidine HCl.11 The 
unpaired electron is considered to be mainly located on the carboxylic carbon, and the main 
3-line signal would therefore arise from the coupling to this proton and to the proton directly 
bound to the carboxylic carbon, producing a doublet of doublets with the 2 central lines partial 
overlaid. Nevertheless, it was not possible to perform a reasonable simulation with the 
parameters described in the literature. 
 
 
 
Figure 4.14 X-band EPR spectrum of (A) single crystal of L-his and (B) L-his powder γ-irradiated in liquid nitrogen 
and acquired at 80 K. The crystal is oriented along the c axis. 
 
 
The powder spectrum of L-his irradiated in liquid nitrogen and measured at 85 K is shown in 
Figure 4.14B. The main features of the spectrum consisted of a single, broad line, with a 
shoulder emerging on top of it. Other less intense, broad side peaks can also be observed as for 
the single crystal spectrum. These minor features disappeared as the microwave power was 
increased (Figure 4.18). 
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Figure 4.15 Roadmap spectrum of the γ-irradiated single crystal of L-his at 80 K with the crystallographic c axis 
perpendicular to B0 and rotating on the ab plane. 
 
 
Figure 4.16 Formation of the carboxylic anion. 
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Figure 4.17 Microwave power saturation spectra of L-his single crystal at 80 K. The crystal is oriented along the c 
axis. Microwave power progressively increasing from 3.2 μW (light gray) to 12.6 mW (black). 
 
 
Figure 4.18 Microwave power saturation spectra of L-his powder, acquired at 80 K. Microwave power progressively 
increasing from 3.2 μW (light gray) to 12.6 mW (black). 
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4.3.7.2 Formation of the deamination radical – 120 K 
No changes in the spectrum were observed when the samples were annealed up to 110 K. 
Further annealing to 120 K resulted in the irreversible loss of the carboxyl radical and the 
production of the deamination radical, as observed for both crystal (Figure 4.19) and powder 
spectra (Figure 4.20) upon r.t. irradiation. The crystal spectrum in particular showed how the 
satellite peaks ( ) appeared not to be involved in the spectral evolution, supporting the 
hypothesis of a second distinct species that does not undergo any rearrangement in this 
temperature range.  
 
 
 
 
Figure 4.19 Annealing of γ-irradiated L-his single crystal to 120 K. The crystal was found not to be perfectly aligned 
along one of the main crystallographic directions during the annealing and was realigned afterwards.  show 
satellite peaks which appear not to be involved in the spectral evolution 
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Figure 4.20 Annealing of γ-irradiated L-his powder from 80 K (light gray) to 120 K (black). 
 
 
4.3.7.3 Rearrangement of the deamination radical – 120 K to r.t. 
The annealing of the sample further proceeded in steps to reach the temperature of 170 K. In 
this range the deamination radical is known to undergo a conformational change due to the 
change of hybridization of the α-carbon from sp3 to sp2, as a result of the elimination of the 
amino group that occurred at 120 K.12 The resulting EPR spectrum is the same as that obtained 
by irradiating the sample at r.t. The above mentioned change is most clearly exhibited by the 
powder spectrum as shown in Figure 4.21.  
Further annealing to r.t. did not result in other spectral changes of the main radical species 
(Figure 4.22), other than a decrease of the signal intensity due to the change of the Boltzmann 
population with temperature. Interestingly, at 200 K two broad, low intensity peaks can be 
observed at the side of the main spectrum, which quickly disappear by further annealing. The 
said peaks were therefore ascribed to a different, unidentified transient species. This can be seen 
more clearly from Figure 4.23. The figure shows how, not only satellite peaks formed, but also 
other peaks of the main deaminated histidine spectrum are affected by the presence of this 
transient species. 
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Figure 4.21 Annealing of γ-irradiated L-his powder from 120 K (light gray) to 170 K (black). 
 
  
 
Figure 4.22 Annealing of γ-irradiated L-his powder from 170 K (light gray) to r.t. (black). show side peaks 
appearing at 200 K and subsequently disappearing upon further annealing. 
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Figure 4.23 Irradiated L-his powder spectra at 170 K (blue), 200 K (red), and 250 K (yellow) showing the formation 
of a transient species at 200 K. 
 
4.3.8 Dissolution experiments 
Dissolution of the irradiated L-his powder was undertaken to study the reactivity of the radical 
species in solution, thereby mirroring the treatment of excipients in parenteral formulations 
reconstituted before injection. Knowing the behaviour of the radicals in solution is necessary 
to assess the safety of the irradiated drugs and the stability of the pharmaceutical products. 
 
4.3.8.1 Spin trapping with MNP 
Following dissolution of the irradiated powder in water, no EPR signal was detected (Figure 
4.24), as expected for a short-lived carbon centred radical. However, when the irradiated 
powder was dissolved in a spin-trap solution of MNP (80 mM), a persistent spin-adduct signal 
was detected with a concentration of ca. 0.25 μM (Figure 4.25). The observed 18-line spectrum 
was assigned to the coupling of the unpaired electron with the nitroxidic nitrogen of the spin 
trapping agent, along with one α-proton and two almost equivalent β-protons of the trapped 
radical species. The hyperfine couplings extracted by simulation of the spectra are in good 
agreement with previous work in which the deaminated L-his radical was either formed from 
γ-irradiation of histidine in the solid21 or solution state22 followed by spin trapping in solution 
with MNP (Table 4.3). This 18-line signal was not obtained by dissolving non-irradiated L-his 
powder in a solution containing the spin trapping agent MNP (Figure 4.24b), indicating that the 
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trapped adduct species was indeed formed as a result of the irradiation process. The low-
intensity 3-line background signal evident in Figure 4.24b was assigned to the formation of an 
MNP di-adduct, labelled di-tert-butyl nitroxide (DTBN), which commonly occurs in low 
concentration with this particular spin trapping agent.22  
 
Figure 4.24 Control X-band EPR spectra. (a) 250 kGy γ-irradiated L-his powder dissolved in water buffered with 
p.b. 50 mM at pH 7.2; (b) non-irradiated L-his powder dissolved in a spin trap solution of MNP 80 mM buffered 
with p.b. 50 mM at pH 7.2. 
 
Figure 4.25 X-band CW EPR spectrum of  (a) 250 kGy γ-irradiated L-his powder dissolved in a spin trap solution 
of MNP (80 mM) and (b) simulated EPR spectrum (obtained using EasySpin25) and line diagram of the MNP-his 
spin adduct. 
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Table 4.3 Hyperfine parameters (mT) and g-values for spin trapped deaminated L-his radical. 
  𝒂𝐍𝐎
𝐍  𝒂𝜶
𝑯 𝒂𝜷𝟏
𝑯  𝒂𝜷𝟐
𝑯  g⟘ g⫽ 
This study 
𝑎⟘ 1.771(5) 0.400(5) 0.079(5) 0.048(5) 
2.0057(2) a 2.0052(2) a 
𝑎⫽ 1.442(5) 0.333(5) 0.057(5) 0.046(5) 
Previous 
work21 
𝑎iso 1.54 0.41 0.06 0.06 -
 b - b 
Previous 
work22 
𝑎iso 1.545 0.392 0.05 0.05 -
 b - b 
a determined by comparison with a DPPH standard; b not determined. 
 
 
4.3.8.2 Radical regeneration 
If the irradiated powder is firstly dissolved in water and the spin trap MNP added subsequently 
(i.e., only after the dissolution of the powder), then the spin-adduct signal of the trapped radical 
is still detectable (Figure 4.26a); due to lower intensity the modulation depth was increased, 
hence the β-proton coupling is not resolved. The concentration of the spin adduct was estimated 
to be ca. 0.1 μM, although in this experiment MNP was used at a concentration of 40 mM 
instead of 80 mM to minimize the formation of DTBN background signal. A second, though 
less intense, 4-line signal with a 1:2:2:1 pattern can also be observed in the spectrum.  
The MNP-histidine spin-adduct has been detected following addition of MNP one hour after 
dissolution of the irradiated powder in water (Figure 4.27). Such a long persistence time of the 
radical in solution is inconsistent with the expected reactivity of carbon centred radicals, and is 
in contrast with the inability to directly detect the radical in the absence of a spin trapping agent 
which implies a short radical lifetime. It is therefore proposed that, rather than invoking long 
radical lifetimes in solution to account for the observed spin adduct signals, the deaminated 
histidine radical must be regenerated in solution. If for example iron is present in solution, 
together with a strong oxidant, Fenton-type reactions may take place leading to the formation 
of ROS.35 Such ROS species could facilitate the continuous regeneration of the deaminated 
histidine radical which is readily and subsequently trapped by MNP at some prolonged time-
interval following dissolution. 
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Figure 4.26 X-band EPR spectra of L-his powder dissolved (a) in water with MNP 40 mM added 3 mins after 
dissolution and transferred by using a syringe with metal needle; (b) in water containing EDTA (1 mM) followed by 
processing as (a); (c) same as (a) but transferred by using a glass Pasteur pipette. 
 
 
Figure 4.27 Regeneration of the deamination radical when γ-irradiated L-his powder is dissolved in water with later 
addition of the spin trapping agent. MNP (40 mM) added (a) 2.5 mins, (b) 10 mins, (c) 30 mins and (d) 60 mins after 
dissolution and transferred by using a syringe with metal needle. 
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To test this hypothesis irradiated L-his powder was dissolved in an aqueous solution containing 
the chelating agent EDTA (1 mM), and MNP was subsequently added to this solution 3 mins 
after dissolution of L-his. As shown in Figure 4.26b, the EPR signal from the L-his radical-
adduct could not be detected when the chelating agent was present in the solution. In our initial 
experiments a syringe with a sterile metal needle was used to transfer the solution to the quartz 
capillary for EPR measurement. However, when a glass pipette was used instead of a syringe 
containing a metal needle to transfer the sampled solution into the EPR quartz capillary tube, 
only DTBN background was detected (Figure 4.26c). Additionally, the amount of spin-adduct 
formed by direct dissolution of the powder in the spin trap solution was found to be four times 
higher (ca. 1 μM) if the glass pipette was used instead of the syringe and needle to transfer the 
sample solution in the EPR tube. An X-ray fluorescence analysis of the metal needles showed 
the presence of large amounts of iron, together with chromium, manganese, nickel and trace 
level of other metals (Figure 4.31). It therefore appears that the deaminated radical trapped after 
dissolution in water and later addition of MNP is a result of a Fenton-type reaction catalysed 
by trace metals contained in the syringe needle. Furthermore, such behaviour appears to be 
characteristic of L-his, as other excipients like D-mannitol did not show any radical 
regeneration properties (see Chapter 5).  
According to these considerations, the 4-line spectrum of the previously unidentified radical 
species can be attributed to the formation of MNP-OH spin adduct (Figure 4.30), further 
supporting the assertion that Fenton-type reactions are operative. These Fenton-type reactions 
would also explain why the concentration of the MNP-histidine spin-adduct was found to be 
significantly lower when using the syringe and needle for sample transfer rather than the glass 
pipette, as the ROS produced might have quenched the formation of the spin-adduct. 
 
The kinetics of formation of the MNP-his spin adduct when using a glass pipette or a syringe 
with metal needle are shown respectively in Figure 4.28 and Figure 4.29. The observation of 
the kinetics shows how the regeneration of the deamination radical reached an equilibrium in 
the initial part of the experiment, to then start decaying after ca. 40 min (Figure 4.28). Such 
equilibrium was related to the presence of strong oxidant species, which keep the Fenton-type 
chemistry running until depletion. 
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Figure 4.28 EPR quantification of the MNP-his spin adduct (●) and DTBN (○), generated from dissolution of 
γ-irradiated L-histidine powder in a solution of MNP (40 mM) prepared in p.b. 50 mM at pH 7.2 and with the sample 
solution being transferred with a glass pipette. 
 
 
 
Figure 4.29 EPR quantification of the MNP-his spin adduct with the sample solution being transferred with a syringe 
with metal needle, directly dissolving γ-irradiated L-histidine powder in a solution of MNP (40 mM) (■); first 
dissolving the powder in an aqueous solution and adding the spin trap after 2 minutes (♦) . 
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Figure 4.30 X-band EPR spectra of (a) 250 kGy γ-irradiated L-his powder dissolved in water with MNP (40 mM) 
added 2.5 mins after dissolution and transferred by using a syringe with metal needle and (b) EasySpin25 simulation 
with line diagrams for the deamination radical (upper) and the hydroxyl radical (lower) spin adducts. 
 
Table 4.4 EPR hyperfine couplings (mT) and g values for the trapped deaminated L-his radical (MNP-his), hydroxyl 
radical (MNP-OH) and the MNP di-adduct di-tert-butyl nitroxide (DTBN), comparing the parameters determined in 
this study with previously published ones. 
Radical  𝒂𝐍𝐎
𝐍  𝒂𝜶
𝐇 𝒂 𝐂
𝟏𝟑
 g-value 
MNP-his 
This study 1.57(1) 0.34(1) - 2.0055(2) a 
Ref. 22 1.55 0.39 - - b 
MNP-OH 
This study 1.45(1) 1.44(1) - 2.0054(2) a 
Ref. 36 1.44 1.44 - - b 
DTBN 
This study 1.75(1) - 0.48(1) 2.0056(2) a 
Ref. 22 1.72 - -b -b 
a determined by comparison with a DPPH standard; b not determined. 
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4.3.8.3 XRF analysis on the metal needles 
XRF analysis on the metal needles was performed as described in Chapter 3. Six key metals 
were identified: Fe-Kα (6.405 KeV); Cr-Kα (5.415 KeV); Co-Kα (6.931 KeV); Ni-Kα 
(7.480 KeV); Zr-Kα (15.775 KeV) and Mn-Kα (5.900 KeV). Qualitatively, the data suggest 
that there is significantly higher Fe in the needles than the other metals. The presence of these 
metals is consistent with the manufacturer information describing the needles as stainless, 
chromium-nickel steel. 
 
 
Figure 4.31 Background subtracted XRF spectra for the metal needles. 
 
4.3.9 MS analysis 
Mass spectrometry (MS) analysis was performed on irradiated and non-irradiated samples 
aiming to detect signals from the species originating from the irradiation process. Samples of 
non-irradiated, 25 kGy and 250 kGy γ-irradiated L-his were prepared and analysed as 
described in Chapter 3. The spectra obtained in positive and negative mode analysis are 
shown respectively in Figure 4.32 and Figure 4.33.  
 
Table 4.5 reports the assignment of the main peaks. However, in neither spectrum was it 
possible to identify an m/z which could be directly attributed to the deaminated L-his fragment 
or a molecule deriving from it.  
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Figure 4.32 Positive mode MS analysis of non-irradiated, 25 kGy and 250 kGy γ-irradiated L-his. 
 
 
 
Figure 4.33 Negative mode MS analysis of non-irradiated, 25 kGy and 250 kGy γ-irradiated L-his. 
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Table 4.5 Main assignments of the peaks detected from the MS analysis. 
Observed m/z Proposed assignment 
POSITIVE MODE 
79.30 Background  
83.20 Background 
156.10 [His + H]+ 
311.20 [2 x His + H]+ 
NEGATIVE MODE 
154.10 [His − H]− 
268.10 Not assigned 
309.20 [2 x His − H]− 
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4.3.10 Liquid NMR analysis 
Liquid NMR analysis was performed on both a non-irradiated and a 250 kGy γ-irradiated 
samples of L-his. The sample preparation and analysis details are described in Chapter 3. As 
can be seen from Figure 4.34 and Figure 4.35, no major differences were found between the 
spectra.  
 
 
Figure 4.34 1H-NMR analysis of non-irradiated L-his. 
 
dd,β2 
dd,α 
dd,2 
dd,5 
H2O 
dd,β1 
Chapter 4. Irradiation of L-histidine Free Base 
 
74 
 
 
 
 
Figure 4.35 1H-NMR analysis of 250 kGy γ-irradiated L-his. 
 
  
4.4 Discussion 
4.4.1 Solid state persistent radicals at r.t. 
The analysis of γ-irradiated L-his powder and crystals showed the formation of persistent 
radical species, being stable for several months. Powder samples were γ-irradiated delivering a 
dose in the range of 25−250 kGy, showing that the same radical species were observed at all 
doses, with the intensity of the EPR spectra increasing when the doses increase (Figure 4.3). 
Twenty-five kGy is typically considered the minimum dose necessary to achieve the desired 
sterility assurance level (SAL), but can be adapted depending on the system to sterilize.37 
Higher irradiation doses such as 125 and 250 kGy are generally considered too extreme to be 
applied to pharmaceuticals, but can be particularly useful for analytical purposes, on the 
condition that the degradation products formed at these doses and at lower, industrially relevant 
dd,β1 dd,α 
dd,2 
dd,5 
H2O 
dd,β2 
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doses are the same. Quantification of the radicals produced upon irradiation was performed 
with a TEMPO standard, showing that in this range the total radical yield is not proportional to 
the radiation dose delivered. 
The influence of the type of ionising radiation source on the radical formation was also studied. 
X-irradiation was found to produce the same radical species as γ-irradiation. The comparison 
between the X- and γ-irradiated powder samples highlighted minor differences, which were 
attributed to additional, minor paramagnetic species also formed upon irradiation. The relative 
concentration between the main deamination radical and the said species could be influenced 
by the conditions at which the irradiation was conducted, such as by the presence/absence of 
O2, humidity, light. As an example, it has been shown that the presence of O2 can influence the 
radical formation and decay to a great extent.38 Indeed, X-irradiation was performed in open 
air, while the samples that received γ-rays were inserted in glass vial and evacuated, as 
described in Chapter 3. 
Single crystal analysis allowed the main radical species formed to be unequivocally ascribed to 
the product of deamination of L-his. Deamination is indeed a typical decomposition pathway 
for many amino acids.13–17 Roadmap simulations were performed combining previously 
published hyperfine coupling tensors and g-tensors extracted from the powder spectra. The 
simulations were found to be in reasonably good agreement with the experimental data. The 
differences between simulation and experimental data were attributed to small errors on the 
previously published hyperfine tensors. 
The presence of additional unknown radical species has been suggested from different 
experiments. Most clearly, the single crystal spectra showed the presence of satellite peaks 
which were ascribed to a different paramagnetic species. Microwave power saturation spectra 
of the irradiated powder also suggested the presence of a second radical in the spectrum. 
Similarly, the difference in the CW EPR spectra between X- and γ-irradiated powder can be 
ascribed to a different concentration of the radical species formed upon irradiation due to 
different irradiation conditions. The presence of these additional radical species also prevented 
the extraction of more precise Hamiltonian parameters through multi-frequency fitting of the 
powder spectra. 
4.4.2 Low temperature stable species 
Irradiation in liquid nitrogen was performed in order to obtain valuable information on the 
primary radicals formed upon irradiation and their evolution into the r.t. stable species. 
Identifying the primary species formed and their behaviour in this temperature range is a 
necessary first step towards the study of multi-component systems, where transient radical 
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species can potentially interact with and degrade other components. This is of particular interest 
in pharmaceutical formulations that generally contain a number of different excipients, 
typically representing the major components of the pharmaceutical product, and one or more 
APIs. Therefore, for APIs in particular, not only direct degradation caused by irradiation, but 
also indirect degradation due to interaction with radical species formed from other drug 
components must be taken into account. In order to do that, the nature and behaviour of transient 
radical species of all the drug components in a formulation must be considered.  
L-his powders and crystals were therefore irradiated in liquid nitrogen and analysed from 80 K 
to r.t. At 80 K, the crystal showed the presence of a 3-line signal, which was assigned to the 
carboxyl anion formed from addition of a H• to the carboxylic group, as previously reported.11,12 
The unpaired electron is believed to be preferentially located on the carboxylic carbon, hence 
the EPR spectrum of the single spectra was interpreted as a doublet of a doublet with the two 
central lines overlapping, originating from a coupling with the hydrogen bound to the α-carbon 
and the hydrogen added to the carboxylic group. 
The carboxylic anion was found to be stable up to 120 K, at which temperature it evolves into 
the deamination radical, as was observed in both crystal and powder analysis. Further annealing 
to 170 K induced a conformational change which was previously reported to be due to the 
change in hybridization of the α-carbon from sp3 to sp2 as a consequence of the deamination 
occurred at 120 K.12 The powder spectrum observed at 170 K corresponds to the spectrum 
detected at r.t. Nevertheless, when the temperature was increased in steps from 170 K to r.t., 
the presence of an unreported, transient radical species was detected at 200 K which 
disappeared on further annealing.  
No significant differences were found between the CW EPR spectra obtained from r.t. 
irradiation of the sample and irradiation in liquid nitrogen followed by annealing to r.t. 
Lowering the temperature at which the irradiation is performed was reported to decrease the 
radical formation as a result of lowering the activity of the free radicals, and was therefore 
suggested as a method to reduce the degradation that occurs in sterilized pharmaceuticals,37 but 
this was not subject of the present study. 
4.4.3 Dissolution experiments 
After characterizing the radical species persistent in the solid state and studying the evolution 
of the primary species from 77 K to r.t., the dissolution process of the irradiated powder samples 
was investigated. Assessing the behaviour of the radiation-formed degradants in solution is key 
for excipients such L-his that are largely used in parenteral formulation, whose administration 
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often involves the dissolution of a lyophilised product and its injection into the patient. Injection 
of free radical containing solutions can in fact have direct toxicological consequences.39,40  
The radical species produced upon irradiation were found to have a short lifetime in solution, 
as expected for this type of carbon centred radicals. By the use of the spin-trapping agent MNP, 
the L-his deamination radical was trapped and characterized. The radical was demonstrated to 
be formed as a result of the irradiation process, since no radicals were trapped from dissolution 
of non-irradiated L-his powder in a solution containing the spin-trapping agent MNP.  
Unexpectedly, the same radical species could still be trapped when the spin-trap was added 
after dissolution of the powder, and could be detected up to one hour after dissolution process. 
This finding was in contrast with the short lifetime of the radical species previously assessed. 
It was therefore proposed that a Fenton-type reaction was occurring, leading to the continuous 
regeneration of the radical. Fenton-type reactions may take place in the presence of trace metals 
and strong oxidants (Figure 4.36), leading to the formation of ROS which could then facilitate 
the regeneration of the histidine radical, readily trapped by the spin trapping agent.  
 
 
Figure 4.36 Irradiation of L-his powder with formation of strong oxidants (labelled in blue) involved in the 
regeneration of L-his radicals in solution. The ROS produced from the Fenton reaction (in red) are scavenged by 
L-his, with the consequent formation of L-his radicals readily trapped by MNP to form species detected by EPR 
(magenta). 
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This hypothesis was verified when, by adding a chelating agent to the reaction mixture, the 
regeneration of the radical was suppressed. The source of trace metals was found to be the 
medical needle which was used with a syringe to transfer the sample solution into the EPR 
quartz capillary tube, as showed by an XRF analysis on the needles. In fact, using a glass Pasteur 
pipette in place of the syringe for transferring the sample, the radical regeneration was 
suppressed. Strong oxidant species such as •OH and H2O2 that could be involved in the Fenton-
type reaction can easily originate from the irradiation process from radiolysis of water.41 The 
fact that the same regeneration properties were not observed for other excipients such as 
D-mannitol (see Chapter 5) was attributed to the antioxidant characteristics of the histidine 
molecule, as previously described,4–8 that make it more susceptible to the oxidative attack of 
ROS. 
As mentioned earlier, the presence of strong oxidants is required for the Fenton chemistry to 
occur. Such oxidants can easily form as a result of the irradiation process. In fact, the primary 
effect of exposing L-his to ionising radiations is the ejection of an electron from the molecule 
itself.42 Thus, in addition to the formation of a histidine radical, in the presence of air, the ejected 
electron can also combine with molecular oxygen leading to the formation of a superoxide 
radical. This reactive oxygen species can in turn lead to the generation of other ROS such as 
hydrogen peroxide and histidine hydroperoxides. All these species can be responsible for 
initiating the observed Fenton chemistry in solution and the consequent production of additional 
ROS. The well-known scavenging properties of L-his towards ROS4,5,43 suggest that these 
reactive species are quenched by histidine in solution, hence further generating deamination 
radicals which are readily trapped by MNP. 
This results are of great significance in the use of irradiated sterilization of excipients in 
parenteral formulations, for which the reconstitution process or drug delivery might involve use 
of similar medical needles providing sufficient trace metals for radical regeneration. Special 
attention should therefore be taken when dealing with drug components, either excipients or 
APIs, with known antioxidant properties, as the same regeneration mechanism can potentially 
take place. 
 
4.4.4 Recombination of radicals in solution 
EPR techniques can indeed provide extremely valuable information on the effects of radiation 
sterilization on pharmaceutically relevant substances, allowing the characterization of radical 
species formed upon irradiation and investigating the behaviour of these degradants in solution. 
Such organic radicals are known to have a very limited life time in solution, and would therefore 
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recombine quickly after dissolution. Figure 4.37 shows possible decomposition pathways for 
histidine when it is directly irradiated in solution. As can be seen from the scheme, multiple 
reactions can occur, leading to the formation of a number of different molecules. In particular, 
imidazolelactic acid is reported to form after deamination of the molecule induced by 
irradiation. Such compound could then undergo several molecular rearrangements, producing 
either urocanic acid or imidazoleacetaldehyde which could then be further oxidized to 
imidazoleacetic acid. 
MS and NMR analysis were performed in the attempt to obtain information regarding the fate 
of histidine radicals after dissolution. Neither analyses revealed the presence of newly formed 
degradants. This can be attributed to the limited sensitivity of such techniques, which did not 
allow signals of species other than the main compound to be discerned.  
 
 
Figure 4.37 Suggested decomposition scheme for histidine from irradiation in solution, revised from ref. 44. 
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4.5 Conclusions 
The effects of irradiation sterilization on the parenteral excipient L-his have been analysed by 
CW EPR spectroscopy and the spin-trapping methodology. Although studies on X-irradiated 
histidine crystals have been previously reported,10-12 the experiments presented in this study are, 
to the best of our knowledge, the first report on the effects of γ-irradiation on solid L-his. Whilst 
the identity of the irradiation induced deamination radical formed has been confirmed 
previously through both direct analysis of the X-irradiated solid12 and through spin-trapping 
experiments,21,22 in this work the fate of the irradiation products in solution has been further 
explored. As expected upon dissolution of the irradiated powder in a physiological solution, the 
radical species were found to have a short lifetime; however, spin-trapping experiments show 
not only the formation of C-centred radical adducts, but also the regeneration of radical species 
long after the initial dissolution of the irradiated material. Fenton-type chemistry, catalysed by 
trace metals from a standard sterile syringe needle, was implicated in this process. This appears 
to be the first report on a Fenton reaction driving radical regeneration in a medical context. 
Knowing the behaviour of the reactive degradation products in solution is essential when 
dealing with excipients intended for parenteral formulations. Avoiding the regeneration of the 
radicals in solution is necessary in order to eliminate the potential for radical-induced 
degradation of other drug components, APIs in particular, in a complete pharmaceutical 
formulation. Unintentional injection of free radical containing solutions into patients could also 
have direct toxicological issues. Whilst a thorough analysis of each irradiation sterilized product 
remains necessary, assessing the effects of γ-irradiation on single drug ingredients is an 
essential first step towards the analysis of multi-component systems. In this Chapter it has been 
shown that not only the degradants formed directly by the irradiation procedure, but also the 
subsequent products of potentially complex solution mechanisms, must be taken into account.  
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Chapter 5  
Irradiation of D-mannitol 
 
This Chapter investigates the effects of γ-radiation sterilization on the parenteral excipient 
D-mannitol. Room temperature irradiation was found to induce the formation of at least two 
persistent radical species. The primary radical species formed by irradiation in liquid nitrogen 
were characterized and their evolution into the room temperature species was studied. The 
reactivity of the radical species in solution was evaluated with spin trapping experiments. MS 
and NMR analysis were performed in order to gather further information on the degradants 
formed upon irradiation. 
 
Figure 5.1 Chemical structure of D-mannitol, highlighting the axis of C2 symmetry (orange). 
 
5.1 Introduction 
5.1.1 Industrial use of D-mannitol 
D-mannitol (C6H14O6, MW 182.17) is a naturally occurring sugar alcohol found in animals and 
plants, largely used in the pharmaceutical and food industries. It is also known simply as 
mannitol, manna sugar, mannite, mannitolum and, being approved as a food additive, it 
corresponds to the E number E421.1 Chemically, it is a hexahydric alcohol, isomer of sorbitol 
to which it differs only for the planar orientation of the hydroxyl group on carbon 2 (Figure 
5.2). This structural difference confers to the two sugars substantially different properties, the 
most important being the response to moisture that makes mannitol non-hygroscopic in contrast 
to sorbitol, which is instead hygroscopic.2 The molecule of mannitol presents a C2 symmetry, 
with the C2 two-fold symmetry axis at a right angle to the aliphatic chain (Figure 5.1). 
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In food applications, mannitol is mainly used as a bulking agent. In pharmaceuticals 
preparations, it is primarily used as a diluent in tablet formulations (10–90% w/w) thanks to its 
non-hygroscopicity, a property that makes it suitable to be used with moisture-sensitive active 
ingredients. In lyophilized preparations, mannitol (20–90% w/w) is included to produce a 
homogeneous cake, improving the appearance of the lyophilized plug in a vial.2 
 
Figure 5.2 Structures of D-mannitol (left) and sorbitol (right). 
 
5.1.2 Mannitol in lyophilized formulations 
Mannitol is considered the most widely used bulking agent in lyophilized formulations. Its large 
use depends on its many positive properties such as promoting crystallinity, thus stabilizing the 
final product, and also for its high eutectic point and matrix properties.3 In protein containing 
formulations, mannitol also displayed significant protection of the protein against aggregation 
when used in small enough quantity not to promote excessive crystallization.4 It is also 
preferred to reducing sugars in protein formulation as a cryo- or lyoprotectant for its 
characteristic of not reacting with proteins via the Maillard reaction.3 
5.1.3 Therapeutic properties of D-mannitol 
Administered parenterally, mannitol exerts multiple therapeutic effects by elevating blood 
plasma osmolarity and consequently elevating the flow of water from tissues. As such it is used 
as an osmotic diuretic, a diagnostic agent for kidney function, an adjunct in the treatment of 
acute renal failure, an agent to reduce intracranial pressure, in the treatment of cerebral edema 
and to reduce intraocular pressure. Orally, it is not significantly absorbed from the 
gastrointestinal tract, but can cause osmotic diarrhoea if consumed in large doses.2 
5.1.4 EPR studies on D-mannitol 
The irradiation of mannitol leads to the formation of persistent paramagnetic species which 
have not yet been identified. The same radicals produced by γ-irradiation were also found to be 
produced by grinding.5,6 The complex unresolved EPR spectrum of irradiated mannitol was 
found to change in the first days after the irradiation due to the presence of unstable short-lived 
radical species,6 which is characteristic of different saccharides.7–9 Microwave (MW) saturation 
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studies of the stable EPR spectra suggested the presence of at least two different paramagnetic 
species. Mannitol had recently been proposed for dosimetric purposes, showing a linear dose 
response in the range of 1 Gy to up to 10 kGy and an EPR spectrum stable for several months, 
characteristics which make it suitable as a dosimetric material.6 
The following work aims to characterize the radical species formed upon irradiation of 
D-mannitol, studying the evolution of the primary species formed into the r.t. stable species. 
The spin trapping methodology was applied to study the dissolution of the irradiated powder 
and MS and NMR analysis were used to investigate the recombination of the radical in solution.  
 
5.2 Experimental 
Below are the experimental sample preparation and instrumentation set up specific to this 
Chapter. More details regarding instrumentation and the irradiation setup are described in 
Chapter 3. 
 
5.2.1 Sample preparation 
5.2.1.1 Growth and analysis of D-mannitol single crystal 
D-mannitol single crystals were grown from a saturated aqueous solution by slow evaporation 
at room temperature, as described in Chapter 3. Their structure was determined by single 
crystal X-ray diffraction on a Rigaku Oxford Diffraction Gemini R and was found to be 
orthorhombic with space group P212121 (a = 5.5376(1) Å, b = 8.5976(2) Å, c = 16.8069(4) Å), 
in agreement with previously published structures (Figure 5.3).10,11 
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Figure 5.3 Crystallographic structure of the single crystal of D-mannitol viewed along a, b and c crystallographic 
axes. 
 
5.2.1.2 Spin trapping experiments 
Spin trapping experiments were performed dissolving γ-irradiated powders in an aqueous 
solution containing the spin trapping agent MNP. The concentration of D-mannitol in solution 
was approximately 0.27 M (unless otherwise stated), to match the concentration used for 
L-histidine in Chapter 4. The solution was vortexed for 1 min and the powder readily 
dissolved. The solution was then centrifuged and inserted in a 1 mm i.d. EPR quartz tube for 
the analysis. The regeneration of the radical in solution was also tested, solubilizing the powder 
in water first and adding the spin trapping agent after ca. 3 mins. 
Samples were analysed on a Bruker EMX spectrometer with a cylindrical cavity (ER 4122 
SHQE), starting the acquisition ca. 6 mins after the addition of the spin trapping agent. More 
specific details regarding EPR acquisition and spin adduct quantification are described in 
Chapter 3. 
 
5.2.2 EPR simulations 
Simulation of the MNP-mannitol spin adduct was performed by including the only hyperfine 
coupling arising from the nitroxidic nitrogen, which was considered to be fully isotropic. An 
isotropic g-tensor was used; dynamic effects were found not to affect the spectrum and were 
therefore neglected. 
Further details regarding EPR simulations are reported in Chapter 4. 
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5.3 Results 
5.3.1 Non-irradiated D-mannitol powder control 
As previously mentioned, EPR active species can be formed in mannitol not only from 
irradiation, but also from other industrial processes.5,6 To investigate the presence of a 
background EPR signal on the purchased high purity (99%) D-mannitol powder, a spectrum of 
the non-irradiated powder was acquired at r.t. No EPR signal was detected, indicating the 
absence of persistent radicalic degradation products above the detection limit (~ nM 
concentration). 
 
5.3.2 γ-irradiated D-mannitol powder EPR spectra 
The effects of r.t. γ-irradiation on D-mannitol powder were then evaluated. The irradiation of 
the powder was performed as described in Chapter 3.  
The EPR analysis of the irradiated powder samples revealed the formation of persistent radical 
species, as shown in Figure 5.4. Four main features could be observed in the spectrum, 
suggesting a coupling with multiple protons. The microwave (MW) power saturation spectra in 
Figure 5.5 shows how, as the MW power is increased, the four main features disappear and 
another species consisting on a broad singlet emerges from the spectrum. 
Figure 5.4 also shows that the same radical species are observed irrespective of the radiation 
dose delivered. Quantification of the paramagnetic species was performed as described in 
Chapter 3 and indicated a radical concentration of 6.05(2), 11.46(2), 13.88(2) mM for the 
samples receiving respectively a total dose of 25, 125 and 250 kGy (±5%), suggesting a non-
linear correlation between the radical concentration and the radiation dose in this range. This 
finds correspondence with a previous work where the linearity between the irradiation dose 
received and the EPR signal of D-mannitol was found to be maintained only up to 10 kGy. 
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Figure 5.4 Radiation dose dependence of γ-irradiated D-mannitol powder. Total irradiation dose of 25 kGy (blue), 
125 kGy (red) and 250 kGy (yellow). Inset: concentration of radical species detected for each irradiated sample. 
 
 
 
Figure 5.5 Microwave power saturation spectra of γ-irradiated (250 kGy) D-mannitol powder. 
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5.3.3 Multi-frequency EPR 
Multi-frequency EPR analysis was undertaken to obtain information on the r.t. persistent 
species formed upon irradiation of D-mannitol. X-irradiated D-mannitol powder was analysed 
at X-band (9.8 GHz), W-band (94 GHz) and 263 GHz (Figure 5.6). All the spectra are 
dominated by a broad line on top of which additional signals can be observed. The 263 GHz 
spectrum in particular, allows the presence of multiple spectral components to be appreciated, 
which can be attributed to multiple radical species. The assignment of the said species cannot 
be easily done since, although the lines are much more differentiated compared to the X-band 
spectrum, some of them are still partially overlapping, impeding a direct attribution of the 
spectral features to a specific radical. The distribution of the lines over a wide magnetic field 
range could be an indication of species characterised by rather different g-values, but could also 
reflect the presence of anisotropic g-factors for some of them. 
 
Figure 5.6 Multi-frequency EPR analysis of X-irradiated D-mannitol powder, receiving a dose of ca. 29 kGy. (a) 
X-band, 9.8 GHz. (b) W-band, 95 GHz. (c) mm-wave, 263 GHz. 
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5.3.4 Cold irradiation 
5.3.4.1 Radical I – 80 K 
The EPR spectra of γ-irradiated D-mannitol protonated and partially deuterated (see Chapter 
3 for details on deuteration) crystals at 80 K are shown in Figure 5.7A. At this temperature, 
when the crystals were oriented along one of the main crystallographic directions, a broad 
doublet was detected for both samples. Such paramagnetic species, hereafter labelled as 
radical I, exhibited a relatively small hyperfine anisotropy in the yz plane, as can be observed 
from the roadmap obtained from rotation of the crystal around the x axis (Figure 5.8). 
Furthermore, the overall anisotropy of the hyperfine coupling appeared to be small, as can be 
inferred from the spectra of protonated and partially deuterated powders (Figure 5.7B). The 
isotropic hyperfine coupling and g-factor parameters for the crystals were extracted by 
simulations with Easyspin12 and are reported in Table 5.1. 
. 
 
 
 
Figure 5.7 CW EPR spectra of D-mannitol protonated and partially deuterated single crystals (A) and powders (B) 
at 80 K after γ-irradiation in liquid nitrogen. The crystals are oriented along one of the main crystallographic axes. 
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Figure 5.8 Roadmap of partially deuterated D-mannitol single crystal at 80 K, oriented along one of the main 
crystallographic axes and rotating in the yz plane. 
 
Figure 5.9 (a) CW EPR spectrum of partially deuterated D-mannitol single crystal at 80 K oriented along one of the 
main crystallographic axes. (b) Easyspin12 simulation using the parameters reported in Table 5.1. 
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Table 5.1 EPR isotropic hyperfine couplings (MHz), g-values and peak-to-peak line width (mT) for radical I 
extracted from EasySpin12 simulation of protonated and partially deuterated single crystals at 80 K. 
  𝒂𝜷
𝐇 g-value lwpp 
Radical I 
Protonated 73.0(5) 2.0039(2) a 0.63(2) 
Deuterated 72.7(5) 2.0032(2) a 0.48(2) 
a determined by comparison with a DPPH standard. 
 
 
5.3.4.2 Radical II – 120 K 
As the temperature was raised from 80 K to 120 K, the EPR spectrum underwent significant 
changes. In particular, two additional peaks clearly emerged in the single crystal spectrum at 
higher g-values, as indicated in Figure 5.10 ( ). The formation of these peaks was found to be 
irreversible, as no changes were detected by decreasing the temperature back to 80 K. The same 
peaks were detected for both the protonated and partially deuterated crystals (Figure 5.12).  
 
Figure 5.10 Annealing of γ-irradiated D-mannitol partially deuterated single crystal from 80 K (light gray) to 120 K 
(black).  show additional peaks emerging upon annealing. The crystal is oriented along one of the main 
crystallographic axes. 
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A comparison between the spectra observed at 80 K and 120 K (Figure 5.11), highlighted how 
a small fraction of this species seemed to be already present before the annealing. It is also 
worth noticing that the lines of radical I are broadening when the new peaks emerge from the 
spectrum, as can be seen in particular on the high field line (Figure 5.10). Such broadening was 
interpreted as the presence of additional peaks almost overlapping to the lines of radical I. This 
interpretation is supported by the observation of the crystal roadmap at 120 K (Figure 5.13).
 
Figure 5.11 Comparison between the EPR spectra of the partially deuterated single crystal at 80 K and 120 K, 
oriented along one of the main crystallographic axes. 
 
 
Figure 5.12 CW EPR spectra of D-mannitol protonated and partially deuterated single crystals (A) and powders (B) 
after γ-irradiation in liquid nitrogen and annealing to 120 K. The crystals are oriented along one of the main 
crystallographic axes. 
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When the crystal rotates in the yz plane, additional lines are emerging from the peaks of radical 
I as can be seen by comparison with the roadmap acquired at 80 K, which was characterized by 
a rather small anisotropy. The new paramagnetic species detected at 120 K, hereafter labelled 
as radical II, was therefore interpreted as a doublet of doublets, originating from the coupling 
of an unpaired electron with two non-equivalent protons. Along with these considerations, the 
crystal spectrum was fitted to extract the EPR parameters which are reported in Table 5.2. 
Minimization of the spectral parameters of radical I was performed in order to obtain a better 
fit.  The simulation obtained in Figure 5.14 resulted in good agreement with the experimental 
data.  
 
 
Figure 5.13 Roadmap of partially deuterated D-mannitol single crystal at 120 K (black) and 80 K (dashed dotted 
blue), oriented along one of the main crystallographic axes and rotating in the yz plane. 
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Figure 5.14 (a) CW EPR spectrum of partially deuterated D-mannitol single crystal spectrum at 120 K oriented 
along one of the main crystallographic axes. (b) Easyspin12 simulation. (c) simulated contribution of radical I (blue) 
and radical II (red) using the parameters reported in Table 5.2. The relative weights of radical I and radical II are 
respectively ca. 60% and 40%. 
 
 
Table 5.2 EPR isotropic hyperfine couplings (MHz), g-values and peak-to-peak line width (mT) for radical I and 
radical II extracted from EasySpin12 simulation of protonated and partially deuterated single crystals at 120 K. 
  𝒂𝜶
𝐇 𝒂𝜷
𝐇 g-value lwpp 
Radical I 
Protonated 73.9(3) - 2.0040(2) a 0.45(2) 
Deuterated 73.8(3) - 2.0034(2) a 0.51(2) 
Radical II 
Protonated 36.8(3) 71.9(3) 2.0061(2) a 0.45(2) 
Deuterated 40.1(3) 71.9(3) 2.0053(2) a 0.45(2) 
a determined by comparison with a DPPH standard. 
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5.3.4.3 Radical III – 170 K 
When the temperature was further raised, no appreciable changes were registered until 170 K. 
At this temperature, significant alterations were detected in the EPR spectrum, as is shown in 
Figure 5.15. In particular, two new peaks emerge at ~332 mT and ~334 mT (indicated by ). 
Additionally, a broadening of the low field line is observed ( ), while the intensity of the peak 
at 333 mT appears to decrease much less than the other peaks ( ). The presence of a new 
species is also highlighted by comparison of the roadmap spectra of the deuterated crystal at 
120 and 170 K (Figure 5.16). Once again, no major differences were detected between 
protonated and partially deuterated crystal samples, implying that the main protons involved in 
the interaction do not belong to a hydroxylic group (Figure 5.17). The EPR spectrum was fitted 
including an additional 4-line species, hereafter labelled as radical III (Figure 5.18). 
Minimization of the spectral parameters of radical I and radical II was allowed in order to 
obtain a better fit. The resulting simulation of radical III returned isotropic hyperfine values of 
ca. 62 and 47 MHz, and a g-value of 2.0043 (Table 5.3).  
 
Figure 5.15 Further annealing of γ-irradiated D-mannitol partially deuterated single crystal from 120 K (light gray) 
to 170 K (black). Triangles highlight spectral changes taking place upon annealing. The crystal is oriented along one 
of the main crystallographic axes. 
 
 
 
 
Chapter 5. Irradiation of D-mannitol 
 
99 
 
 
Figure 5.16 Roadmap of partially deuterated D-mannitol crystal at 170 K (black) and 120 K (dashed dotted blue) 
oriented along one of the main crystallographic axes and rotating in the yz plane. 
 
Figure 5.17 CW EPR spectra of D-mannitol protonated and partially deuterated crystals (A) and powders (B) after 
γ-irradiation in liquid nitrogen and annealing to 170 K. The crystals are oriented along one of the main 
crystallographic axes. 
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Table 5.3 EPR isotropic hyperfine couplings (MHz), g-values and peak-to-peak line width (mT) for radical I, radical 
II and radical III extracted from EasySpin12 simulation of protonated and partially deuterated single crystals at 
170 K. 
  𝒂𝜶
𝐇 𝒂𝜷
𝐇 g-value lwpp 
Radical I 
Protonated 74.3(3) - 2.0040(2) a 0.49(2) 
Deuterated 74.7(3) - 2.0036(2) a 0.53(2) 
Radical II 
Protonated 39.0(3) 73.0(3) 2.0058(2) a 0.42(2) 
Deuterated 40.3(3) 74.9(3) 2.0052(2) a 0.49(2) 
Radical III 
Protonated 47.5(3) 61.7(3) 2.0043(2) a 0.42(2) 
Deuterated 47.0(3) 62.0(3) 2.0042(2) a 0.36(2) 
a determined by comparison with a DPPH standard. 
 
 
Figure 5.18 (a) CW EPR spectrum of partially deuterated D-mannitol single crystal at 170 K oriented along one of 
the main crystallographic axes.  (b) Easyspin12 simulation. (c) simulated contribution of radical I (blue), radical II 
(red) and radical III (yellow) using the parameters reported in Table 5.3. The relative weights of radical I, radical 
II and radical III are respectively ca. 46%, 32% and 22%. 
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5.3.4.4 170 – 200 K 
Further annealing of the samples to 200 K resulted in small change in the EPR spectrum, shown 
in Figure 5.19. The changes include a new peak emerging at ~ 331 mT and a broadening of the 
peak at ~335 mT ( ). Though only minor differences were observed between the EPR spectra 
of protonated and partially deuterated crystals, appreciable differences can be seen between the 
powder spectra (Figure 5.20).  
Although a thorough interpretation of the spectrum was found to be challenging, the minor 
differences registered at 200 K in respect to 170 K were tentatively attributed to changes in the 
concentration of the main components of the EPR spectrum, radical I, radical II and radical 
III. In particular, the simulation of the spectrum of the deuterated mannitol crystal suggested 
that, while all the species are decreasing as the temperature is raised, radical II and radical III 
are decreasing considerably more than the large doublet associated to radical I. The resulting 
simulation was found to be in good agreement with the experimental data (Figure 5.21). Instead, 
a satisfactory simulation of the protonated mannitol crystal was not obtained. 
 
Figure 5.19 Annealing of γ-irradiated D-mannitol partially deuterated single crystal from 170 K (light gray) to 200 
K (black).  highlight new peaks emerging upon annealing.  The crystal is oriented along one of the main 
crystallographic axes. 
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Figure 5.20 CW EPR spectra of D-mannitol protonated and partially deuterated crystals (A) and powders (B) after 
γ-irradiation in liquid nitrogen and annealing to 200 K. The crystals are oriented along one of the main 
crystallographic axes. 
 
Figure 5.21 (a) CW EPR spectrum of partially deuterated D-mannitol single crystal at 200 K oriented along one of 
the main crystallographic axes. (b) Simulation obtained with EasySpin.12 (c) Single components of the simulated 
spectrum: radical I (blue), radical II (red) and radical III (yellow). The relative weights of radical I, radical II and 
radical III are respectively ca.. 62%, 22% and 16%. 
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Table 5.4 EPR isotropic hyperfine couplings (MHz), g-values and peak-to-peak line width (mT) for radical I, radical 
II and radical III extracted from EasySpin12 simulation of partially deuterated single crystals at 200 K. 
 𝒂𝜶
𝐇 𝒂𝜷
𝐇 g-value lwpp 
Radical I 76.3.(3) - 2.0033(2) a 0.68(2) 
Radical II 44.4(3) 76.7(3) 2.0048(2) a 0.52(2) 
Radical III 47.2(3) 60.7(3) 2.0040(2) a 0.36(2) 
a determined by comparison with a DPPH standard. 
 
 
5.3.4.5 200 – 240 K 
As the annealing of the samples proceeded in steps, changes in the EPR spectrum were 
registered when reaching 240 K. The spectrum of the partially deuterated crystal at 240 K is 
dominated by a broad doublet progressively emerging as the temperature increase, which 
displayed similar features to those of radical I (Figure 5.22). This was supported by the analysis 
of the roadmap, which clearly showed a highly isotropic interaction dominating the spectrum 
(Figure 5.23). The same roadmap acquired at a higher MW power in partially saturated 
conditions showed how other minor species, also visible in the central part of the spectrum, are 
mostly hidden by the main radical doublet ( ). Since the contribution of such species was low, 
it was not possible to obtain a reasonable simulation of all the species involved.  
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Figure 5.22 Annealing of γ-irradiated D-mannitol partially deuterated single crystal from 200 K (light gray) to 240 K 
(black).  highlight spectral features of a minor species hidden by the main doublet. The crystal is oriented along 
one of the main crystallographic axes. 
 
The comparison of the partially deuterated and protonated powder spectra highlighted again 
some differences between the two (Figure 5.24). In particular, both powder spectra seem to be 
dominated by a broad doublet, though the broadening of the protonated sample is clearly larger 
than the partially deuterated one. Such difference can be once again associated to a coupling to 
an hydroxylic proton. The protonated and partially deuterated crystals displayed instead a more 
pronounced difference. This was partially attributed to a different orientation of the two crystals 
in respect to the magnetic field. Nevertheless, it is also worth noticing that, as shown in the 
roadmap spectra, the partially deuterated crystal spectrum never resembles the protonated one, 
irrespective of the orientation of the former. As for the powder spectra, this is suggestive of the 
presence of hydroxylic proton couplings in the additional radical species contributing to the 
EPR spectrum. 
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Figure 5.23 Roadmap of partially deuterated D-mannitol crystal at 240 K (left) and partially saturated spectrum 
(right), oriented along one of the main crystallographic axes and rotating in the yz plane. 
 
Figure 5.24 D-mannitol protonated and partially deuterated crystals (A) and powders (B) after γ-irradiation in liquid 
nitrogen and annealing to 240 K. The crystals are oriented along one of the main crystallographic axes. 
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5.3.4.6 240 – 260 K 
Proceeding with the annealing of D-mannitol, at 260 K it was possible to observe additional 
changes in the spectrum (Figure 5.25). The broad β-proton coupling that dominated the 
spectrum at 240 K seemed to contribute less as the temperature was raised to 260 K. The central 
features of the spectrum were found to be more dominant at this temperature, with the three 
low intensity peaks detected at 240 K broadening and eventually becoming almost 
indistinguishable. This can be clearly seen by comparing the partially deuterated powder spectra 
at 240 and 260 K, with the latter displaying a pronounced central feature previously almost 
invisible. An additional feature emerged in the partially deuterated crystal spectrum at low field, 
while the presence of another one can be inferred from the asymmetrical broadening of the high 
field line ( ). Again, protonated and partially deuterated crystal spectra appeared rather 
different (Figure 5.26), most likely because of the different orientation of the two in respect to 
the magnetic field. 
 
 
Figure 5.25 Annealing of γ-irradiated D-mannitol partially deuterated single crystal from 240 K (light gray) to 260 
K (black). highlight asymmetrical broadening of the high field line. The crystal is oriented along one of the main 
crystallographic axes. 
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Figure 5.26 CW EPR spectra of D-mannitol protonated and partially deuterated crystals (A) and powders (B) after 
γ-irradiation in liquid nitrogen and annealing to 260 K. The crystals are oriented along one of the main 
crystallographic axes. 
 
 
Figure 5.27 Roadmap of partially deuterated D-mannitol crystal at 260 K (left) and partially saturated spectrum 
(right) oriented along one of the main crystallographic axes and rotating in the yz plane. 
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5.3.4.7 260 – 295 K 
Finally, the samples were annealed to r.t., ca. 295 K. Clear changes were detected in this 
temperature range as new peaks emerged from the spectrum. A comparison between the 
irradiated crystals, which were carefully reoriented along one of the main crystallographic 
directions, showed very little differences between the two (Figure 5.29A and Figure 5.30), 
implying that no exchangeable protons are involved. The spectrum is dominated by what seems 
to be a 4-line pattern, with additional peaks that can be distinguished on top of each feature. 
The MW power saturation spectra of the crystals (Figure 5.31) also highlighted the presence of 
a 1:2:1 three-line feature which clearly emerges at high microwave power. 
 
 
Figure 5.28 Annealing of γ-irradiated D-mannitol partially deuterated single crystal from 260 K (light gray) to 295 K 
(black). The crystal is oriented along one of the main crystallographic axes. 
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Figure 5.29 CW EPR spectra of D-mannitol protonated and partially deuterated crystals after reorientation along 
one of the main crystallographic orientations (A) and powders (B) after γ-irradiation in liquid nitrogen and annealing 
to 295 K. The crystals are oriented along one of the main crystallographic axes. 
 
Figure 5.30 Roadmap of protonated (black) and partially deuterated (blue) D-mannitol crystal at 295 K, oriented 
along one of the main crystallographic axes and rotating in the yz plane. 
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Figure 5.31 Microwave power saturation spectra of γ-irradiated D-mannitol protonated (A) and partially deuterated 
(B) crystals. Each spectrum was scaled by the square root of the microwave power. The crystals are oriented along 
one of the main crystallographic axes. 
 
5.3.5 CW ENDOR 
CW ENDOR experiments were performed on the low temperature irradiated crystal and powder 
samples in order to obtain information on the molecular structure of the radical species in the 
temperature range 77–295 K. Despite many attempts at different temperatures and experimental 
conditions, only signals related to small couplings (< 2 MHz) were observed, which were not 
useful towards the determination of the structure of the paramagnetic species under 
investigation. The absence of signals from large couplings was ascribed to the spin 
concentration of the samples that was insufficient for the CW ENDOR analysis. 
 
5.3.6 Dissolution experiments 
Dissolution experiments were performed to mimic the reconstitution of parenteral formulations 
before injection, thus obtaining valuable information on the reactivity of the radical species in 
solutions. The radical regeneration phenomenon observed for L-histidine and described in 
Chapter 4 was also investigated in the case of D-mannitol. 
5.3.6.1 Spin trapping with MNP 
Firstly, irradiated D-mannitol powder was dissolved in pure water buffered with phosphate 
buffer (p.b.) 50 mM at pH 7.2. The solution was transferred to a 1 mm i.d. EPR quartz tube and 
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was then inserted into the spectrometer to start the acquisition. As for the case of L-histidine 
(Chapter 4), no EPR signal was detected (Figure 5.32a), meaning that the lifetime of the radical 
species formed after irradiation is too short to be detected directly, as can be expected from this 
type of organic radical. 
 
 
Figure 5.32 Control X-band EPR spectra. (a) 250 kGy γ-irradiated D-mannitol powder dissolved in water buffered 
with p.b. 50 mM at pH 7.2; (b) non-irradiated D-mannitol powder dissolved in a spin trap solution of MNP (80 mM). 
 
Next, the dissolution of the powder in a spin trap solution was investigated. When non-
irradiated powder was dissolved in a solution of MNP, only background signal was detected 
(Figure 5.32b). The 3-line signal that can be observed in Figure 5.32b was again assigned to 
the formation of di-tert-butyl nitroxide (DTBN), as can occur using this spin trapping agent.13 
When irradiated powder was used instead, a persistent spin-adduct was detected at a 
concentration of ca. 1 μM (Figure 5.33a). The detected signal consisted of a broad triplet, 
almost overlapping the DTBN background signal, which arises from coupling to the nitroxidic 
nitrogen. No further splittings were observed, even by lowering the modulation amplitude by a 
factor of 10 (from 0.1 mT to 0.01 mT, Figure 5.34), suggesting the absence of α-protons where 
the radical binds to MNP. The nitrogen hyperfine coupling and g-factor of the trapped species 
were extracted by simulations with EasySpin12 (Figure 5.33). The fact that such spin adduct 
could not be detected by dissolving non-irradiated powder in a solution of MNP (Figure 5.32b) 
indicates that the trapped species is a product of the irradiation process. 
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Table 5.5 EPR hyperfine couplings (mT) and g-values for the trapped mannitol radical and the MNP di-adduct 
DTBN, comparing the parameters determined in this study with previously published ones. 
Radical  𝒂𝐍𝐎
𝐍  𝒂 𝐂
𝟏𝟑
 g-value 
MNP-mannitol This study 1.55(1) - 2.0055(2) a 
DTBN 
This study 1.71(1) 0.46(1) 2.0053(2) a 
Ref. 13 1.72 - b - b 
a determined by comparison with a DPPH standard; b not determined. 
 
Figure 5.33 X-band CW EPR spectrum of (a) 250 kGy γ-irradiated D-mannitol powder dissolved in a spin trap 
solution of MNP (80 mM). (b) simulated EPR spectrum (obtained using Easyspin12). (c) single components of the 
simulated spectrum, consisting of the MNP-mannitol adduct (blue) and DTBN (red). The line diagrams of DTBN 
(upper) and of the MNP-mannitol spin adducts (lower) are also represented. 
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Figure 5.34 Spin trapping of irradiated D-mannitol powder in MNP (80 mM), detected by decreasing the modulation 
amplitude to 0.01 mT. 
 
5.3.6.2 Testing radical regeneration for D-mannitol  
Next, the regeneration process that was observed for L-histidine in Chapter 4 was tested also 
for D-mannitol. The irradiated powder was therefore dissolved in water and the spin trap MNP 
was added after a time lag of 3 minutes. The sample was transferred to the EPR tube with a 
syringe with sterile steel needle.  
 
Figure 5.35 Dissolution of irradiated (a) and non-irradiated (b) mannitol powder in water with later (3 mins) addition 
of the spin trapping agent MNP. 
 
As can be seen in Figure 5.35a, no major signals were detected for D-mannitol other than the 
DTBN background signal. The same process was repeated with non-irradiated powder (Figure 
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5.35b). The comparison between the two spectra highlighted that other rather weak signals 
(≪ 0.1 μM) can be observed in the case of irradiated D-mannitol, which might suggest that 
some species have been trapped. However, the intensity of the signals detected are negligible 
if compared to the amount of regenerated radicals trapped in the case of L-histidine. 
 
5.3.6.3 Spin trapping with DMPO 
Spin trapping with the nitrone spin trapping agent DMPO was also tested in order to obtain 
complementary information on the reactivity of the radical species in solution. Despite the use 
of a high purity  (≥ 98%) recent DMPO batch, the control spectra exhibited a complex EPR 
spectrum ascribable to the presence of multiple paramagnetic species (Figure 5.36a). The 
presence of such background signal interfered with the analysis, preventing the identification 
of spin-trap adducts formed from D-mannitol radical species. 
 
Figure 5.36 X-band CW EPR spectra of solutions of (a) DMPO (0.2 M) and (b) 250 kGy γ-irradiated D-mannitol 
powder dissolved in a spin trap solution of DMPO (0.2 M), both prepared in p.b. 50 mM at pH7.2. 
 
5.3.7 MS analysis 
Mass spectrometry (MS) analysis was undertaken in an attempt to obtain information regarding 
the mass of the degradation product originating from the irradiation process. In order to do that, 
samples of non-irradiated, 25 kGy and 250 kGy γ-irradiated D-mannitol were prepared and 
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analysed as described in Chapter 3. The spectra obtained in positive and negative mode 
analysis are shown respectively in Figure 5.37 and Figure 5.38. Table 5.6 reports the assignment 
of the main peaks. Whilst positive mode analysis did not highlight any new signal originating 
as a result of the irradiation process, in negative mode both peaks at 179.1 m/z and 361.2 m/z 
were exclusively detected for the irradiated samples. The 179.1 m/z signal was attributed to a 
molecule of D-mannitol where one of the hydrogen atoms bound to the aliphatic chain had been 
extracted upon irradiation, which when subsequently dissolved recombined in solution by 
eliminating an adjacent proton to form a double bond. The molecular mass of the said radical 
would therefore be 2 units lower than a non-degraded mannitol molecule, 180.2 instead of 182.2 
m/z. The 179.1 m/z detected in negative mode would therefore correspond to a negatively 
charged mannitol ion that loses an additional hydrogen from one of the hydroxyl groups. The 
mass of the non-degraded negatively charged mannitol ion corresponding to 181.2 m/z was also 
detected in the spectrum. The higher m/z signals at 361.2 and 363.2 can be associated to the 
same species detected at 179.2 and 181.2 which have formed a non-covalent bond with another 
molecule of D-mannitol. This can indeed happen at high sample solution concentrations, when 
in a droplet of the nebulized sample two molecules are binding non-covalently and are detected 
as such. The same effect is observed in positive mode, where both a sodiated single molecule 
of D-mannitol and two non-covalently bonded molecules, one of which is sodiated, are detected 
respectively at 205.10 m/z and 387.20 m/z. 
 
 
Figure 5.37 Positive mode MS analysis of non-irradiated (blue), 25 kGy (red) and 250 kGy (yellow) γ-irradiated 
D-mannitol. 
 
Chapter 5. Irradiation of D-mannitol 
 
116 
 
 
Figure 5.38 Negative mode MS analysis of non-irradiated (blue), 25 kGy (red) and 250 kGy (yellow) γ-irradiated 
D-mannitol. 
 
Table 5.6 Main assignments of the peaks detected from the MS analysis. 
Observed m/z Proposed assignment 
POSITIVE MODE 
79.10 Background 
83.20 Background 
183.10 [Man + H]+ 
205.10 [Man + Na]+ 
387.20 [2 x Man + Na]+ 
NEGATIVE MODE 
179.2 [Man - 2H - H]− 
181.2 [Man − H]− 
217.2 [Man + 35Cl-]− 
219.1 [Man + 37Cl-]− 
361.4 [2 x Man − 2H -H]− 
363.4 [2 x Man − H]− 
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5.3.8 1H NMR analysis 
1H NMR analysis was performed on both a non-irradiated sample and a 250 kGy γ-irradiated 
sample of D-mannitol in an attempt to detect signals ascribable to the degradation products 
formed upon irradiation. The sample preparation and analysis details of the NMR experiment 
are described in Chapter 3. The comparison between Figure 5.39 and Figure 5.40 shows how 
the main features of the spectra are the same despite the irradiation process. All the main peaks 
were observed between 3.4 and 3.9 ppm and have previously been assigned.14 These values are 
characteristic for aliphatic protons located close to hydroxyl groups, which is the case of all the 
protons in the molecule. The hydroxyl group exerts a deshielding effect that shifts the chemical 
shift to higher ppm values than the ones typically detected for standard aliphatic protons. 
Nevertheless, a closer look at the spectra allowed the identification of new, low intensity peaks 
emerging from the irradiated D-mannitol spectrum. In particular, a spectral doublet and a singlet 
appeared respectively at ca. 1.2 and 1.4 ppm, while other signals can be observed at 3.3 and 3.9 
ppm.  
 
 
Figure 5.39 1H-NMR analysis of non-irradiated D-mannitol. 
H2O 
dd,1 
m,2 
d,3 
dd,1 
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Figure 5.40 1H-NMR analysis of 250 kGy γ-irradiated D-mannitol. 
 
 
5.4 Discussion 
5.4.1 Evolution of the radicals from nitrogen temperature to r.t. 
5.4.1.1 Detection of radical I at 77 K 
The analysis of the CW EPR spectra of cold irradiated D-mannitol samples (Figure 5.7) showed 
the formation of a broad doublet which was labelled as radical I. The EPR parameters of the 
paramagnetic species were extracted by simulation with EasySpin12 and are reported in Table 
5.1.  
The analysis of the extracted parameters provides valuable information regarding the structure 
of the paramagnetic species. To begin, the g-values of the detected radicals can be used to 
determine whether the paramagnetic species is carbon-centred or oxygen-centred. It is generally 
accepted that the closer the unpaired electron is to an oxygen atom, the greater the g-value of 
the radical will be.15 For g-values < 2.003, a C-centred radical is expected. Values in the range 
H2O 
dd,1 
m,2 
d,3 
dd,1 
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of 2.003-2.004 typically indicate the unpaired electron to be located on a carbon atom adjacent 
to an oxygen. Finally, for g-values greater than 2.004 oxygen-centred radicals are expected. In 
the case of radical I, the calculated g-factor of 2.0033 falls in the range of values typical for 
carbon-centred radicals adjacent to an oxygen atom, which is the case of each of the carbon 
atoms in the molecule. 
Furthermore, some considerations on the magnitude of both the isotropic and anisotropic 
components of the hyperfine coupling can help to distinguish the type of proton coupled to the 
paramagnetic centre. In the case of radical I, although the anisotropic component of the 
hyperfine coupling was not calculated nor extracted by simulation, from the observation of the 
roadmap (Figure 5.8) and powder spectra (Figure 5.7B), it is possible to attribute the coupling 
to a rather small anisotropic contribution. The small anisotropic feature of the hyperfine 
coupling is indicative of a coupling with a β-proton, for which the anisotropy rarely exceeds 
10% of the isotropic hyperfine interaction.16 The isotropic part of the hyperfine coupling of a 
β-proton is described in Equation 5.1: 
𝑎𝛽
𝐻 = 𝑏0 + 𝑏2 𝑐𝑜𝑠
2 𝜑     Eq. 5.1 
where: φ is the dihedral angle between the plane through the C–C bond and the pz orbital where 
the unpaired electron is located, and the plane through the C–C bond and the C–Hβ bond; 
b2 ≫ b0, with b0 being 0 to +10 MHz.16 Typical values for b0 and b2 are 9 and 122 MHz.17 The 
dependence of the isotropic hyperfine couplings on the dihedral angle described in Equation 
5.1 is well depicted in Figure 5.41.  
As previously mentioned in Section 2.2.3, predicting the effects of ionising radiations on 
organic molecules is a rather complicated matter. As the energy of the radiation is absorbed and 
quickly spreads out over the entire molecule, one would expect it to cause the rupture of the 
weakest bond in the molecule, provided that the energy of the radiation exceeds the energy of 
the molecular bond. Nevertheless, C–H bond rupture generally dominates in respect to C–C 
rupture,18 despite the former (4.3-4.6 eV) being a stronger bond than the latter (3.8-3.9 eV)19 
and both being at an inferior energy than the average energy of γ-rays emitted from a 60Co 
source (1.25 MeV).20 Additionally, the C–H bond rupture is not necessarily localised to the 
weakest bond.18 
Thus, starting from the assumption that radicals trapped in irradiated aliphatic compounds are 
usually the result of C–H bond rupture, followed by the formation of a π-orbital consisting 
mainly of the carbon atom 2p-orbital,16 two possible structures of radical I are proposed, with 
the paramagnetic species originating from abstraction of an α-proton from either C3 or C4. 
Indeed, if the unpaired electron were to be located on either C2 or C5, a total of three β-proton 
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couplings should have been detected, while one only can be inferred by the spectrum; in the 
case of C1 and C6 instead, one α-proton and one β-proton coupling would have been detected, 
but the data allow us to exclude involvement of any α-proton coupling. In the case of C3 and 
C4, only two β-proton couplings should be detected. Here, we discuss the magnitude of the 
β-proton coupling that should be detected for the unpaired electron located on C3 (or C4) and 
coupling to the proton bound in α position in C4 (or C3).  
 
Figure 5.41 Influence of the dihedral angle φ on the β-proton coupling, as described in Equation 5.1. 
 
 
Figure 5.42 Proposed chemical structures for radical I. 
 
Figure 5.43 shows the Newman projections of the D-mannitol molecule considering both the 
cases where the unpaired electron is localized on C3 (A) or C4 (B). The X-ray crystallographic 
analysis of the non-irradiated crystal indicates the dihedral angle between the α-protons in C3 
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and C4 to be 61.81°. After irradiation and rupture of the C–Hα bond, the change of hybridization 
from sp3 to sp2 would trigger a structural rearrangement, involving the rotation of the OH group 
in α position (blue) about the C3–C4 bond to be planar with HOH2CHOHC. Consequently, the 
pz orbital (green) where the unpaired electron is located would also rotate. As a result of the 
rotation, the angle between the pz orbital and the β-proton would measure ca. 45°, yielding an 
isotropic hyperfine coupling of approximately 70.1 MHz. This value is in very good agreement 
with the observed coupling of ca. 73 MHz obtained from the fitting of the crystal spectra in 
Figure 5.7A. Nevertheless, only one dominating β-proton coupling is detected while two 
β-protons should be coupled to the unpaired electron. It is therefore assumed that the second 
β-proton lies close to a perpendicular plane to the pz orbital where the unpaired electron is 
located so that, according to Equation 5.1, the resulting coupling is negligible and 
indistinguishable under the broad lines.  
 
Figure 5.43 Newman projections along C3–C4 with the unpaired electron localised in C3 (A) and C4–C3 with the 
unpaired electron in C4 (B). 
 
The coupling with the proton belonging to the α-OH group should also potentially be detected 
on the protonated samples. The dihedral angle between the plane through the C3–O bond and 
the pz orbital and the plane through the same C–O bond and the hydroxylic proton is 39.16° on 
the non-irradiated crystal structure. If this angle were to be maintained after the change in 
hybridization, it would have produced a coupling of the order of 82 MHz. The fact that such 
coupling had not been observed, suggests that the O–H bond lies on the plane of the sp2 
hybridized orbitals, hence forming a 90° angle with the pz orbital. In this situation, the 
contribution to the isotropic coupling component would solely derive from b0, therefore being 
too small to be detectable considering the broadening of the lines. This is also corroborated by 
the similarity between the protonated and partially deuterated spectra (Figure 5.7), thus 
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confirming that no hydroxylic protons (or deuterons) with large hyperfine couplings are 
coupled to the unpaired electron. 
It has been previously mentioned that the molecule of D-mannitol presents a C2 two-fold 
symmetry axis perpendicular to the C3–C4 bond, meaning that by a 180° rotation the same 
molecule is obtained. Additionally, an approximate C2 molecular symmetry is maintained in 
the orthorhombic crystal structure as well.11 It therefore appears that only minimal differences 
in terms of β-proton coupling can be expected from proton abstraction from either C3 and C4, 
implying that the proposed structures for radical I shown in Figure 5.42 essentially represent 
the same radical. 
5.4.1.2 Formation of radical II at 120 K 
The annealing of the samples to 120 K revealed a change of the EPR spectra, which was 
interpreted as the formation of a new paramagnetic species named radical II (Figure 5.10). The 
extracted parameters reported in Table 5.2 showed a g-value > 2.004 for radical II, which 
indicates that the unpaired electron for this species is located on an oxygen atom. The 
comparison between protonated and partially deuterated samples offered useful information 
toward the determination of the structure of radical II. No major differences were observed 
from the analysis of the spectra of both protonated and partially deuterated single crystals 
(Figure 5.12A), suggesting the absence of hydroxylic protons nearby the paramagnetic centre 
of the newly formed species. Nevertheless, the analysis of the irradiated powders highlighted 
some changes due to deuteration of the sample (Figure 5.12B), which can be ascribed to an 
interaction with a distant hydroxylic proton, that induces appreciable changes only on the EPR 
powder spectra.  
The sum of these considerations suggests that radical II is formed after the abstraction of a 
proton from the hydroxylic group of either C1 or C6. These in fact represent the only positions 
in the molecule where the unpaired electron could be located to couple with two different 
protons. Indeed, for any other position in the molecule, only one proton would be available for 
coupling with the oxygen-centred unpaired electron. The geometry of the molecule does not 
allow unequivocal assignment of either of these structures to radical II, for which however only 
minor differences are expected according to the C2 molecular symmetry. 
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Figure 5.44 Proposed chemical structures for radical II. 
 
The mechanism by which radical II is formed is unclear. Interestingly, the analysis of the 
mannitol molecule highlights the presence of numerous intramolecular short contact bonds, i.e. 
any contact shorter than the sum of the van der Waals Radii of the atoms involved. In particular, 
short contact bonds are observed respectively between the proton in C3 and the oxygen bonded 
to C1, and the proton in C4 and the oxygen in C6 (Figure 5.45). These observations suggest the 
possibility of intramolecular rearrangements, with the unpaired electron initially located on a 
carbon atom at the centre of the aliphatic chain (radical I) moving to an oxygen atom, thus 
leading to the formation of radical II. 
 
Figure 5.45 Molecule of D-mannitol highlighting intermolecular short contact bonds (cyan) and the protons in C3 
(orange) and C4 (yellow). 
 
5.4.1.3 Formation of radical III at 170 K 
Further annealing of the samples proceeded in steps until reaching 170 K, at which temperature 
the EPR spectrum underwent an irreversible transformation (Figure 5.15). The analysis of the 
spectrum before and after this mutation suggested the presence of an additional paramagnetic 
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species with a 4-line feature, radical III. The g-factor extracted from an EasySpin12 simulation 
was found to be of ~ 2.004 and was considered not high enough to belong to an oxygen-centred 
radical (Table 5.3). Additionally, no major differences were registered between protonated and 
partially deuterated samples (Figure 5.17). According to these considerations, radical III was 
interpreted as a carbon-centred paramagnetic species coupling to two protons bound to carbon 
atoms. Thus, the structure of radical III was assigned to the radical formed from abstraction of 
a proton from either C1 or C6, with the unpaired electron coupling to one α- and one β-proton 
(Figure 5.46). 
 
Figure 5.46 Proposed chemical structures for radical III. 
 
5.4.1.4 Decrease of concentration of radical II and III at 200 K 
When the temperature was raised to 200 K, the spectral features rapidly changed (Figure 5.19). 
The change in the spectrum registered at this temperature was tentatively associated with a 
change in the relative concentration of the paramagnetic species already present at 170 K. The 
EPR spectrum was therefore simulated considering only these three species (Figure 5.21). The 
good agreement between the experimental data and the resulting spectral simulation seemed to 
confirm this hypothesis, suggesting that, although the signal intensity of the overall spectrum 
decreased by annealing from 170 to 200 K, the concentration of both radical II and radical III 
decreased by approximately 25% and 20% respectively in comparison to the species associated 
with radical I. 
5.4.1.5 Dominant β-proton coupling at 240 K 
As the temperature was raised to 240 K, the EPR spectrum was dominated even more by the 
broad doublet with similar characteristics to radical I, namely a broad β-proton coupling and 
g-value ascribable to a C-centred radical (Figure 5.22). This was confirmed by the roadmap of 
the partially deuterated crystal that shows almost no anisotropic character of the hyperfine 
coupling, which is typical for β-protons (Figure 5.23). Although the spectral features of the 
dominant radical are similar to those of radical I, it is likely that the said species represent a 
different radical, formed upon annealing of the samples, rather than a kinetically unfavourable 
reformation of radical I. Other minor species can be also observed, especially in partially 
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saturated conditions (Figure 5.23). These species are likely to be radical II and radical III, 
whose concentration was further decreasing as the temperature was raised. Despite this, a 
satisfactory simulation of the spectrum including a lower contribution from such species could 
not be obtained, suggesting the presence of other radicals emerging at this temperature. The 
double integrated areas of the simulated radicals were corrected by the temperature according 
to the Curie law (Figure 5.47). The resulting plot showed radical II and III remaining at the 
same concentration from their first detection up to 200 K, with the simultaneous increasing of 
the large isotropic doublet radical. However, the total concentration of the radical species is not 
supposed to increase as the temperature increases, therefore this effect was attributed to a 
change in the performance of the spectrometer in the said temperature range. This can occur 
while the EPR cavities dries out during the annealing experiments, eliminating the water formed 
from icing of the setup. Thus, the data were replotted assuming the total radical concentration 
to be maintained constant in this temperature range (Figure 5.48).  
The trend registered in the temperature range 80–200 K is in line with a further decrease in the 
concentration of radical II and III at 240 K, as proposed. Furthermore, the differences observed 
between protonated and partially deuterated powders and crystals suggested the coupling to 
hydroxylic protons, although it was not possible to judge more specifically which OH group 
was involved in the interaction. 
 
 
Figure 5.47 Double integrated area of the paramagnetic species detected in the range 80–200 K, radical I (blue), 
radical II (red) and radical III (yellow) corrected by the Curie law. 
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Figure 5.48 Fraction of the paramagnetic species detected in the range 80–200 K, radical I (blue), radical II (red) 
and radical III (yellow), assuming the total radical concentration to be constant. 
 
5.4.1.6 Spectral evolution at 260 K 
Further annealing to 260 K resulted in spectral changes that reflected the presence of additional 
radical species becoming more dominant at this temperature compared to 240 K (Figure 5.25). 
The isotropic doublet was still a major component of the spectrum at 260 K. The comparison 
between the roadmap spectrum of D-mannitol at 260 K showed similarities with the partially 
MW-saturated roadmap spectrum obtained at 240 K (Figure 5.27), suggesting the same species 
being present at lower temperature and becoming more dominant with further annealing. The 
complexity of the spectra did not allow simulation of the single species involved and therefore 
a complete characterization of the radicals contributing to the EPR spectrum at this temperature 
was not possible. 
5.4.1.7 R.t. persistent species 
Lastly, the samples were annealed to r.t., ca. 295 K (Figure 5.28). At this temperature, when 
the crystals were aligned to a main crystallographic orientation, four main features were 
detected, with an additional splitting observable. The MW power saturation spectra of both 
crystals showed these species to quickly saturate as the MW power increases, and a 1:2:1 
three-line pattern to appear. Simulation of the species was attempted considering various 
possibilities, but was not successful. The presence of an isotropic doublet can still be inferred 
from the spectra, although in lower concentration compared to previous temperatures. Most 
likely, at r.t. such species is still present together with another species which is shifted to a 
higher g-value and therefore likely to be oxygen-centred radical, plus the 3-line species detected 
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at high MW powers. The presence of multiple species characterised by different g-values was 
also inferred from the multifrequency analysis of the X-irradiated powder (Figure 5.6). 
The quantification of radical species produced by direct irradiation at r.t. showed approximately 
a 3 times higher presence of persistent radical species for D-mannitol (Figure 5.4) compared to 
L-histidine for an irradiation dose of 25 kGy (see Chapter 4). The difference in the radical 
concentration diminished for higher doses, reaching a maximum difference of ca. 14 mM for 
250 kGy. The high susceptibility of D-mannitol to γ-irradiation at industrially relevant 
irradiation doses is an important finding, especially considering its high usage in parenteral 
formulations. 
5.4.2 Spin trapping experiments 
The r.t. persistent radical species formed from irradiation of D-mannitol exhibited a short 
lifetime in aqueous solution, as proved by the fact that no EPR signal could be detected from 
the analysis of irradiated powder dissolved in physiological solutions (Figure 5.32a). Despite 
this, a spin-adduct was detected when dissolving the irradiated powder directly in a solution of 
MNP. The spin-adduct formed exhibited a broad 3-line signal; no further splittings were 
observed, even by decreasing the modulation amplitude by a factor of 10 (from 0.1 mT to 
0.01 mT). This finding, together with the renowned specificity of MNP towards the trapping of 
carbon-centred species, suggested the spin-trapped radicals to be carbon-centred and lacking of 
protons to couple to in the α position. It is therefore proposed that the radical trapped by MNP 
corresponds to a newly formed species presenting similar features to those of radical I. Spin 
trapping was also tested with the nitrone spin trap DMPO in an attempt to trap O-centred radical 
species for which this class of spin trapping agent is more specific, however the presence of 
impurities in the spin trap solution interfering with the analysis did not allow the identification 
of additional spin trap adducts. 
In Chapter 4 it has been shown that L-histidine radicals can regenerate in solution in the 
presence of trace metals through a Fenton-type reaction. This behaviour was associated with 
the antioxidant properties of L-histidine, which is a well-known scavenger for different reactive 
oxygen species (ROS).21-25 Similarly, D-mannitol is known for being a scavenger of the 
hydroxyl radical,26-29 and could therefore be involved in a similar process. The regeneration of 
D-mannitol radicals in solution was therefore tested. Unlike the L-histidine case, D-mannitol 
radicals were not found to regenerate in solution under the same conditions (Figure 5.35a). This 
is a crucial finding for a broadly used excipient like D-mannitol, especially considering its use 
as a bulking agent, for which it can represent up to 90% w/w of lyophile formulations. 
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5.4.3 MS 
MS experiments were undertaken to help identify the degradants produced upon irradiation and 
learn about the fate of the radicals after dissolution. In fact, there are multiple mechanisms by 
which radicals can recombine in aqueous solution. Non-irradiated and irradiated mannitol 
samples were therefore analysed and the spectra obtained were compared to identify signals 
from the degradation products formed upon irradiation (Figure 5.37 and Figure 5.38). The 
comparison between the negative mode spectra highlighted the presence of a species of m/z 
179.20 which was detected only for the irradiated samples, whose signal was stronger for the 
sample that received the higher irradiation dose. This value corresponds to a negatively charged 
molecule of D-mannitol that has lost two protons. It was therefore proposed that the observed 
species was formed as a result of the irradiation process, which promoted the abstraction of a 
proton from the aliphatic chain of a molecule of D-mannitol and, either in the solid state or in 
solution, rearranged through a β-elimination mechanism. 
 
 
Figure 5.49 Proposed mechanism for the rearrangement of the radical leading to β-elimination. 
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5.4.4 NMR 
1H NMR experiments were carried out with the intent of obtaining useful information on the 
structure of the degradants formed from irradiation. The comparison between non-irradiated 
and irradiated 1H NMR spectra (Figure 5.39 and Figure 5.40) showed the presence of additional 
signals which can be correlated to the irradiation process. Although the low intensity of the 
signal and the low resolution of the spectrum limited an exhaustive analysis, some conclusions 
can be drawn from the chemical shift of the peaks. The chemical shift of the doublet and singlet 
at 1.2 and 1.4 ppm is typical of protons belonging to aliphatic chains. For these lower values to 
be obtained the deshielding effect brought by the OH groups must no longer be in place, 
suggesting that the peaks belong to a mannitol molecule where one of the OH groups has been 
eliminated. The doublet could therefore originate from a coupling to a proton bound to the 
carbon atom from which the OH group has been extracted, or from a fragmentation of the parent 
molecule. More low intensity signals were found in the range of 3.4–3.9 ppm and can be 
associated to protons close to OH groups. The fact that this is also the range where the rest of 
the peaks of the parent molecule lie, makes the assignment of the peaks rather challenging. 
These could in fact potentially belong to radical I-like species or be associated to the peaks 
detected at 1.2 and 1.4 ppm. These findings suggest that NMR is unsuitable for the direct 
analysis of similar samples. Such limitations can potentially be overcome by applying a 
separation step prior to the NMR analysis, e.g. chromatographic techniques like HPLC, thus 
allowing to selectively analyse the small content of degradation products.  
 
5.5 Conclusions 
In this Chapter, the effects of γ-radiation sterilization on the pharmaceutical excipient 
D-mannitol have been studied. Mannitol is the most utilised excipient in parenteral 
formulations, where it is mostly used as a bulk agent and as such can represent up to 90% w/w 
of the drug. To the best of our knowledge, the degradation products formed upon irradiation of 
the said excipient have not been characterised before, nor studies on spin trapped mannitol 
radicals reported.  
In this study, the evolution of the EPR active species formed after irradiation of the excipient 
in liquid nitrogen have been analysed in the range of 77–295 K by CW EPR spectroscopy. Our 
findings suggest that the primary effect of the ionising radiation on D-mannitol at this 
temperature is the abstraction of a proton from the aliphatic chain from either the carbon atom 
in position 3 or 4, leading to the formation of radical I. By first annealing to 120 K and 
subsequently to 170 K, a second and a third radical species are formed, radical II and radical 
Chapter 5. Irradiation of D-mannitol 
 
130 
 
III, respectively by abstraction of a proton from the hydroxylic groups bound to either C1 or 
C6 and directly from the C-atom either in position 1 or 6. Univocal assignment of a structure 
to each of the newly formed paramagnetic species was not possible. Further annealing to 200 K 
and 240 K showed a progressive decrease of all the previously formed species, with a new 
radical characterised by a large isotropic doublet becoming the more dominant species. When 
the temperature was increased to 260 K and finally to r.t., other paramagnetic species were 
observed in the spectrum which were interpreted as the formation of new radicals. The 
complexity of the EPR spectrum in this temperature range did not allow the identification of 
the newly formed species. At least three r.t. persistent radical species are believed to be present, 
being a species with characteristics similar to radical I, a second species oxygen-centred and a 
third species which emerged from the spectrum at high MW power. The characterisation of the 
radicals’ formation and evolution is essential for a thorough understanding of the radiation 
process in a multi-component system, particularly for a key excipient like mannitol, which 
exhibits rather complex EPR spectral features when irradiated. The quantification of the 
paramagnetic species at r.t. also showed, for industrially relevant radiation doses, a three times 
higher radical concentration compared to L-histidine. Spin trapping experiments offered 
important information about the reactivity of the radicals in solution. Not only a short lifetime 
of the species was assessed, but also the radical regeneration process that was witnessed for 
L-histidine was not observed for D-mannitol. Nevertheless, a spin trap adduct was detected by 
direct spin trapping with MNP. The use of other analytical techniques such as MS and NMR 
was tested in an attempt to obtain complementary information on the degradants formed upon 
irradiation. The MS analysis in particular highlighted the presence of a species 2 m/z units lower 
than the unaltered mannitol molecule, which was interpreted as the rearrangement of a 
C-centred radical formed by H abstraction, through elimination of a second proton with 
formation of a double bond. NMR also highlighted the presence of degradation products formed 
upon irradiation, but a full characterisation of such species was not possible due to intrinsic 
limitations of this magnetic resonance technique in this context. 
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Chapter 6  
Photoactivation of a Platinum(IV) 
Anticancer Complex 
 
The following publication in preparation is based on the present Chapter: 
Vallotto, C., Shaili, S., Shi, S., Butler, J.S., Wedge, C.J., Newton, M.E. & Sadler P.J. 
Photoactivatable platinum anticancer complex generates tryptophan radicals. To be submitted 
to Chem. Comm (2018). 
 
The octahedral platinum(IV) complex trans,trans,trans-[Pt(N3)2OH2(pyridine)2] is a potent 
cytotoxic anticancer compound when it is activated with blue or green light. The design and 
development of novel platinum anticancer agents is a priority considering that mechanisms of 
acquired or intrinsic resistance in cancer cells are undermining the potency of classic platinum 
anticancer compounds. This Chapter further investigates the mechanism of action of this novel 
compound and the biological target(s) of azidyl radicals in order to elucidate their in vivo 
reactivity. 
 
6.1 Introduction 
6.1.1 Cancer 
Cancer is considered the second leading cause of death globally, accounting for 8.8 million 
deaths in 2015, meaning that nearly 1 in 6 deaths worldwide is due to cancer. According to the 
World Health Organization (WHO), the number of new cases is expected to rise by about 70% 
over the next 2 decades.1 Cancer initiation is a multistep process, which has been correlated by 
numerous studies to free radicals and reactive species.2  
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) can originate in the 
organism respectively from reduction of molecular oxygen and oxidation of L-arginine. These 
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highly reactive species can induce damage to multiple biological structures, including DNA, 
lipids, membranes and proteins, with an average of 105 oxidative hits per day per cell in the 
human.3 The cell has therefore developed several resistance mechanisms, including nucleotide 
excision repair (NER), mismatch repair (MMR)4 and presence of antioxidants. The unbalance 
between prooxidant and antioxidant species in favour of the former is defined as oxidative 
stress.5 The possibility to take advantage of such reactive species to induce damage in tumour 
tissues has been previously explored. As discussed in the previous chapters, Electron 
Paramagnetic Resonance (EPR) is the technique of choice for the study of reactive radical 
species.6 In this Chapter the EPR spin trapping methodology is utilised to study the radical-
based mechanism of action of novel platinum(IV) diazo anticancer complexes. 
 
6.1.2 Metallo-organic compounds 
The use of metals in medicines can be dated back to ca. 1910, when Ehrlihc developed an 
arsenic-based antimicrobial agent, salvarsan, for the treatment of syphilis.7,8 Additionally, 
metals have been successfully used in the formulation of diagnostic agents for imaging of 
abnormal issues. The interest in metal complexes for both therapy and diagnosis is increasing, 
and approximately 50% of anticancer treatments nowadays involve the use of platinum-based 
compounds.9 
Next, an overview on the development of Pt-based anticancer compounds is presented, from 
the early platinum(II) complexes to the potent photo-activable trans,trans,trans-
[Pt(N3)2(OH)2(pyridine)2] complex. This promising photo-chemotherapy candidate that has 
been previously developed by the Sadler group10 is the subject of this work, which focuses in 
particular in investigating the mechanism of action of the said anticancer compound. 
 
6.1.3 Pt-based chemotherapeutics 
6.1.3.1 PtII complexes 
Platinum is characterised by oxidation states that range from 0 to +6, with the two most 
commonsoxidation states being +2 and +4. Platinum(II) complexes exhibit a planar structural 
geometry, with the lower d orbitals completely filled and the upper most orbital (dx2-y2) left 
empty (Figure 6.1). Amongst the various isotopes of Pt, 195Pt is the most abundant (33.8%)11 
isotope and being the only nuclear magnetically active with a spin of ½. The square planar 
geometry allows both cis and trans isomers.  
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Figure 6.1 Splitting of the d-orbitals of a square-planar PtII (d8) complex with strong donor ligands. 
 
Cis-diamminedichloroplatinum(II), also referred to as cis-platin or CDDP (1, Figure 6.2), is the 
most famous and successful metallodrug, accidentally discovered by Rosenberg in 1965.12 This 
platinum-based metallodrug is strongly active towards several types of cancer including 
ovarian, testicular and bladder cancer.13 
 
Figure 6.2 Structures of cis-platin (1) and trans-platin (2). 
 
The mechanism of action of CDDP relies on the difference between plasma and intracellular 
concentrations of chlorine. After intravenous injection, the complex remains stable because of 
the high concentration of chloride in the blood plasma (ca. 100 mM).14 After CDDP enters the 
cell through passive diffusion15 or by active uptake,16 it is subject to hydrolysis consequently to 
the lower chloride concentration (4 – 20 mM)14 and the active chrloroaqua species is formed 
(Figure 6.3). 
 
Figure 6.3 Hydrolysis of CDDP in the cytoplasm of the cell with formation of the active chloroaqua species and 
subsequent deprotonation of the complex. 
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Once the active CDDP chloroaqua species is formed, it reacts forming crosslinks with the DNA 
double strand, inducing unwinding and bending of the macromolecule which results in cell 
apoptosis.17 It has been reported that PtII preferentially binds to the N7 atom of the purine 
nucleobase guanine (G). The majority of the crosslinks formed are reported to be intrastrand 
1,2-d(GpG) crosslinks between two adjacent guanines (60-65 %) but also intrastrand crosslinks 
between guanine and adenine (A) occur (20-25 %), as well as interstrand crosslinks between 
opposite guanines.18 Although cis-platin is to date the most potent anticancer agent for the 
treatment of various cancers, important side-effects are associated to its administration. Such 
side-effects have been attributed to the formation of PtII-S species with physiological sulfur-
based molecules, such as glutathione (GSH) and sulphur-containing amino acids like 
methionine and cysteine.19 
Interestingly, trans-platin (2, Figure 6.2) did not show an anticancer activity as for the cis 
isomer, a finding that was associated to its inability to form 1,2-(GpG) intrastrand crosslinks 
which are the major product of cis-platin that induces cell apoptosis.20 
6.1.3.2 Second generation of PtII complexes 
A second generation of PtII complexes was developed in order to overcome the unwanted side 
effects of CDDP. The new class of anticancer metallodrugs presented more stable ligands, 
replacing labile ligands which were easily substituted by water. The structure of carboplatin (3, 
Figure 6.4) presents a 1,1-cyclobutanedicarboxylate substituting the two chloride ligands in 
CDDP. This structural change resulted in an increased stability of the compound, but at the 
same time a reduced activity with consequent need of higher dosage. Carboplatin has been 
approved world-wide for the treatment of cancer, replacing CDDP as the treatment of choice 
for ovarian cancer. 
 
Figure 6.4 Structure of the second generation PtII complexes carboplatin (3) and oxaliplatin (4). 
 
Another example of an approved second generation PtII complex is oxaliplatin (4, Figure 6.4). 
This compound was found to overcome cis-platin resistance by the presence of a bulky 1,2-
diaminocycloexhane (DACH) group which prevents the binding of DNA repair proteins. Other 
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second generation complexes are nedaplatin, lobaplatin and heptaplatin, yet to be approved by 
the FDA but already in clinical use in Japan, China and South Korea.21 
 
6.1.3.3 PtIV complexes 
PtIV complexes present an octahedral, 5d6 geometry (Figure 6.5). Such compounds are 
considered “prodrugs”, being generally substitution inert and thermally stable in the +4 
oxidation state, thus avoiding unwanted side reactions. The mechanism of activation of these 
compounds involves the intracellular reduction of the metal to generate reactive PtII species, 
which exhibit a pronounced cytotoxic activity.  
 
Figure 6.5 Splitting of the d-orbitals of an octahedral PtIV (d6) complex with strong donor ligands. 
Several PtIV complexes were developed, including the promising satraplatin (5, Figure 6.6). 
This compound is reduced by intracellular metal-containing redox proteins to produce the 
active PtII form. Although satraplatin has not been approved by FDA yet, it has been involved 
in several clinical trials21,22 and it has been investigated both in the treatment of prostate cancer23 
and in combination therapy.24 
 
Figure 6.6 Structure of the PtIV octahedral complex satraplatin (5). 
 
Despite the progresses made in limiting the unwanted reactions of these compounds, PtII species 
are still non-specifically generated throughout the body by reaction with reducing agents, hence 
inducing damages in non-cancer tissues. The need for more specific therapeutic agents led to 
the development of targeted delivery systems. 
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6.1.4 Targeted delivery 
In order to increase the efficiency of the platinum compounds and limit the unwanted side 
effects, targeted delivery systems have been developed. These systems consist in incorporating 
the metallo-organic complex into a scaffold that protects the compound from premature 
hydrolysis and allows specific delivery to its biological target, tipically the DNA of the cancer 
cell.  
Targeted delivery can be distinguished in passive or active. With passive drug delivery, the 
chemotherapeutic agent is incorporated in scaffolds such as nanoparticles or liposomes, and 
reaches the tumour site by exploiting the enhanced permeability and retention effect.25 
Active drug delivery is mediated by receptor-binding molecules that are attached to the nano-
scaffold to produce a specific uptake of the system into the tumour cell through receptor 
mediated internalisation. A number of receptors have been used for active delivery, including 
folate (FR), epidermal growth factor (EGF), androgen (AR) and transferrin (TfR) receptors, 
which are often overexpressed in certain tumour cells. 
Although passive and active delivery represented an important advancement in the development 
of specific chemotherapeutic systems, the development of drug resistance mechanisms remains 
a major issue for platinum anticancer complexes. In order to overcome these resistance 
mechanisms, alternative therapeutic therapies such as phototherapy have been developed. 
 
6.1.5 Phototherapy 
The term phototherapy describes the exposure to specific wavelengths of light to treat specific 
medical disorders. More specifically, photodynamic therapy (PDT) is a form of phototherapy 
that involves the use of light in combination with a light-sensitive compound, also called photo-
sensitiser (PS).26,27 The administration of the PS in the patient is followed by activation of the 
same by irradiation at a specific wavelength, so inducing the cytotoxic effect in the region of 
interest. Longer wavelengths (> 600 nm) are preferred in PDT for their ability to penetrate 
deeper into tissues (Figure 6.7).28 
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Figure 6.7 Depth of penetration of different wavelengths (figure adapted from ref. 28). 
 
The mechanism by which PDT exerts its action involves i) a photo-sensitiser, often porphyrins 
which absorb in the 600-800 nm;29 ii) light; iii) molecular oxygen (3O2) which is also required 
to induce the cytotoxic effect. The PS is photo-excited from a ground (S0) state to a single 
excited (S1) state, at which point can be dissipated through different pathways. Amongst them, 
a triplet excited (T1) state is believed to be involved in the process. In particular, PDT has been 
reported to be induced by quenching of the T1 state, which can happen through two different 
processes, type I and type II, both proceeding during PDT. Type I mechanism involves either 
an electron or hydrogen transfer between the T1 state and a molecular substrate, leading to the 
formation of radical species which in turn reacts with 3O2 to form ROS. Type II mechanism 
involves instead direct interaction of T1 with 3O2, which results in formation of the cytotoxic 
singlet oxygen (1O2). 
Although PDT is still being used in cancer therapy for the advantage of being a non-invasive 
procedure, several disadvantages are limiting its application. Firstly, the fact that numerous 
cancer tissues are characterised by oxygen deficiency (hypoxia)30 is a major drawback for PDT, 
which requires molecular oxygen to induce its cytotoxic effect. Secondly, some PS have a 
clearance time of several weeks, thus limiting the patient’s exposure to daylight for months.29 
Finally, resistance mechanisms are associated with PDT, involving the inactivation of` ROS 
mediated by antioxidant enzymes31 and the stabilisation of damaged proteins through the action 
of heat shock proteins (HSP).32 
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6.1.6 Photo-chemotherapy 
Differently from PDT, the photo-activation process of chemotherapeutics does not involve the 
presence of molecular oxygen to exert its action, being defined as a type III mechanism. This 
section describes the development of kinetically inert PtIV photo-activable complexes. 
6.1.6.1 PtIV diiodo complexes 
The first photo-activable PtIV diiodo complexes were developed by Bednarski.33 These 
complexes presented an ethylene-diamine ligand as opposed to the ammine ligands in cis-platin, 
in order to stabilise the complex and avoid photo-isomerisation. The complex cis,trans-
[Pt(en)(Cl)2(I)2] (6, Figure 6.8) was synthesised, where iodine was selected as opposed to more 
electronegative atoms (Cl, Br) for the ability to absorb longer wavelengths.33  
 
Figure 6.8 Structures of early photo-activable PtIV-diiodo complexes. 
 
However, the complex was found to exhibit an equivalent dark and light cytotoxicity which 
was attributed to its high reduction potential (ca. 75 E/mV). The chlorido ligands were 
substituted with hydroxido-based ligands, resulting in a lower reduction potential and LMCT 
band at ca. 400 nm. Nevertheless, these complexes were found to undergo reduction from PtIV 
to PtII by biological reducing agents rendering them not specific to tumour cells,33 so that 
alternative ligands to iodides were investigated. 
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6.1.6.2 PtIV diazo complexes 
Transition metal complexes containing azido ligands have been reported to be light sensitive, 
independently from the transition metal centre utilised. Photo irradiation of the platinum diazido 
complex trans-[Pt(CN)4(N3)2]2- at 300 nm was reported to induce a simultaneous two one-
electron reduction of the PtIV centre, producing azidyl radicals (●N3), as confirmed by EPR.34 
Interestingly, the irradiation of cis-[Pt(PPh3)2(N3)2] led to the formation of hexaazabenzene (N6) 
and [Pt(PPh3)2]. The observation of bubbles in the solution was attributed to the decomposition 
of N6 into nitrogen gas: 
N6 → 3(N2) 
A second generation of PtIV photo-activable diazo complexes was developed by the Sadler 
group (Figure 6.9). Both cis (10) and trans (11) exhibited dark stability in the presence of 
intracellular reducing agents,35 and were found to produce bubbles upon photo-irradiation with 
365 nm UVA.36 In a later study, trans diamine diazido PtIV complexes were found to display a 
greater photo-cytotoxicity compared to their cis-isomers, an effect that was attributed to a 
different intra cellular target or a different mechanism of DNA attack.37 
 
Figure 6.9 Structures of platinum(IV) diamine diazo complexes. 
 
Despite the promising characteristics of these complexes, the photo-activation at 365 nm was a 
limit to the in vivo applications of the compounds. In order to lower the energy of the LMCT 
band of the PtIV diazo complexes involved, amine groups were substituted with π-acceptor 
pyridine ligands (Figure 6.10). Single substitution (complex 12) did not lower the LMCT band 
energy, but contributed in decreasing the half maximal inhibitory concentration (IC50) value 
from 99.2 μM to 1.9 μM in A2780 ovarian cancer cells, an effect that was attributed to the 
formation of alternative PtII-DNA adducts. Photo-irradiation of complex 12 in the presence of 
5’-guanosine monophosphate (5’-GMP) showed formation of both mono and bis-adducts,38 
suggesting the presence of a novel mechanism of action which could overcome resistance 
mechanisms. In vivo irradiation also showed anti-cancer activity of the complex, which was 
reported to occur through an autophagic pathway instead of apoptosis.39 
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Figure 6.10 Structure of mono-pyridine (12), bis-pyridine (13) and bis-pyridine-TEMPO platinum(IV) diazo 
complexes. 
 
Replacement of the second ammine ligand with a pyridine led to the production of 
trans,trans,trans-[Pt(N3)2(OH)2(pyridine)2] (complex 13, Figure 6.10), which is the subject of 
this work. Complex 13 was the first photo-activable PtIV diazo anticancer complex to be 
activated with UVA, blue and green light. The complex exhibited a LMCT band at 294 nm, 
which decreased upon irradiation and was attributed to the loss of azide ligands.40 
The photo-cytotoxicity of complex 13 was demonstrated in various cancer cell lines. Photo-
irradiation of the complex in the presence of 5’-GMP showed the formation of bubbles, as well 
as a number of PtII adducts which were characterised by 195Pt NMR spectroscopy.40 To date, 
complex 13 is one of the most potent platinum(IV) diazo photo-activable anticancer complexes. 
Conjugation of complex 13 with the nitroxide spin label 2,2,6,6-tetramethylpiperidine 1-oxyl 
(TEMPO) led to the production of trans,trans,trans-[Pt(N3)2(OH)(OCOCH2CH2CONH-
TEMPO)(py)2] (complex 14, Figure 6.10). This complex exhibited a phototoxicity comparable 
to complex 13, respectively displaying a IC50 of 5.9 ± 0.2 and 7.1 ± 0.4 μM against A2780 
human ovarian carcinoma cells. Both complexes were found much more cytotoxic than CDDP 
(IC50 > 80 μM).41 
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Figure 6.11 UV-visible spectra of complex 13 (62.5 μM) prepared in phosphate buffer at pH 7.2 in the dark (black) 
and after 30 minutes of irradiation with 465 nm blue LED light (red). The dashed gray line indicates the LMCT band 
at 294 nm. Spectra were collected on a LAMBDA 1050 UV/Vis spectrophotometer in a 1 cm pathlength cuvette. 
 
6.1.6.3 Photo-degradation pathways of complex 13 
The decrease of the LMCT band at 294 nm obtained upon photo-irradiation of complex 13 has 
been previously assigned to the loss of azide ligands.40 This finding, together with the 
observation of bubbles formed upon irradiation of the platinum compound, suggested the 
release of azidyl radicals (●N3) with consequent dimerization of ●N3 to form N2. The release of 
●N3 as a consequence of the photo-activation of complex 13 was proved by spin trapping 
experiments. The irradiation of complex 13 in the presence of the nitrone spin trapping agent 
DMPO showed the formation of the DMPO-N3 spin adducts, which was generated upon release 
of ●N3 as confirmed by experiments with labelled 15N azides.42 Additionally, previous photo-
irradiation studies of complex 13 in the presence of 5’-GMP showed the formation of mono- 
and bi-functional PtII-GMP adducts, suggesting a stepwise loss of azide ligands.36,40,43 The 
irradiation of an analogue of complex 13, trans,trans,trans-[Pt(N3)2(OH)2(MA)(py)] (14, with 
MA = methylamine) has been reported to generate singlet oxygen (1O2) through ●OH 
dimerization and formation of H2O2, which upon disproportionation generated 1O2 and H2O.44 
It therefore appears that multiple degradation pathways of photo-activated complex 13 are 
possible (Figure 6.12).  
A similar photo-degradation pathway was reported for complex 14, where illumination of the 
compound with blue (420 nm) light led to the formation of multiple products involving the 
release of azidyl radicals and of the nitroxide radical, which was suggested to be partially 
responsible for the anticancer activity of the compound. 
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Figure 6.12 Photo-irradiation of complex 13 leading to the reduction of PtIV to PtII via two one-electron donations 
from (A) two azide; (B) two hydroxyl; (C) one azide and one hydroxyl ligands (figure adapted from ref. 10). 
 
6.1.6.4 Reactivity of azidyl radicals towards amino acids 
Like reactive oxygen species (ROS), reactive nitrogen species (RNS) are able to induce major 
damages in living organisms.45,46 The reactivity of azidyl radicals towards aromatic amino acids 
has been previously reported,47 as opposed to their non-reactivity towards aliphatic amino acids 
and nucleic acid derivatives.48 
Amino acids are organic compounds which play a major role in a variety of biochemical 
pathways. L-tryptophan is an essential amino acid (i.e. cannot be synthesised de novo by the 
human organism) precursor of a number of biomolecules, including neurotransmitters such as 
serotonin and hormones like melatonin.49 Pulse radiolysis studies reported ●N3 to react with 
L-trp leading to the formation of free azide (N3-) and a neutral tryptophan radical (L-trp●). The 
reaction was suggested to proceed through a one-electron transfer mechanism (Figure 6.13 B), 
as opposed to an hydrogen atom transfer mechanism (Figure 6.13 A) with formation of an 
intermediate tryptophan cation radical (L-trp●+) which, with a pka of 4.3, at physiological pH 
quickly deprotonates to form the L-trp neutral radical species.50 
Chapter 6. Photoactivation of a Platinum(IV) Anticancer Complex 
 
146 
 
 
Figure 6.13 Reaction between the azidyl radical and L-trp proceeding through A) hydrogen atom abstraction and B) 
one-electron transfer pathways. 
 
A previous spin trapping study conducted by Butler et al., reported the ability of L-trp to 
partially and completely suppress the formation of the DMPO-N3 spin adduct upon photo-
activation of complex 13.42 The lack of 1H NMR resonances attributable to the non-radical 
species formed from decomposition of DMPO-N3 further supported the quenching of the azidyl 
radicals.10 The detection of free azide (N3-) was in agreement with previous studies suggesting 
one-electron oxidation pathway.50 The photoprotective effect of L-trp was also tested on A2780 
human ovarian cancer cells, proving its ability to increase cell viability at low, physiologically 
relevant concentrations (μM).42 These findings suggested indoles and derivatives to be a 
favourable target for photo-released azidyl radicals when part of biological structures in the 
cell, inducing cell death through an additional pathway in alternative to DNA platination. 
 
6.1.6.5 Photo-irradiation in the presence of melatonin 
Melatonin (MLT), also known as N-acetyl-5-methoxytryptamine, is a hormone produced by 
the pineal gland in mammals that regulates the circadian rhythms in animals.  
Approved by the FDA as a dietary supplement,51 melatonin is commonly used in the treatment 
of insomnia52 and jet lag.53 The intracellular concentration of melatonin was reported to be 
tissue/organ dependent,54 while the plasma concentration is in the nanomolar range.55 Melatonin 
was reported to present antioxidant properties towards both ROS and RNS. The interaction of 
melatonin with the hydroxyl radical was reported to proceed through a one-electron oxidation, 
to produce a melatonin cation radical (MLT●+) which readily deprotonates at physiological pH 
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to give, similarly to L-trp, the melatonin neutral radical (MLT●).56 Moreover, the addition of 
the hydroxyl radical to the indole ring of melatonin has been reported.57 Antioxidant properties 
towards singlet oxygen (1O2) were also exhibited,58 but not towards the superoxide radical 
(O2●-).59 Regarding RNS, melatonin exhibited scavenging properties towards nitric oxide 
(NO●), peroxynitrite anion (ONOO-) and azidyl radical (●N3).  
Anti-tumour activity of MLT towards various types of cancer has also been reported, including 
breast60 and colon.61 Nevertheless, no serious side-effects deriving from administration of MLT 
in patients have been reported to date.62,63 
The quenching ability of MLT towards ●N3 released upon photo-activation of complex 13 has 
been previously investigated with the spin trapping methodology.10 Butler reported the 
simultaneous detection of both the DMPO-N3 spin adduct, partially quenched by MLT, and the 
DMPO-OH adduct, suggesting alternative activation pathways for complex 13 in the presence 
of MLT which involved the release of ●OH. High resolution mass spectrometry (HR-MS) 
experiments showed the formation of [Pt(OH2)(py)2(MLT)]2+ adducts, supporting the formation 
of a MLT● which binds to the platinum centres.10 These findings are corroborated by previous 
studies, which reported the ability of MLT to bind to various metal ions.64,65 Additionally, the 
formation of MLT-OH adducts was reported, accounting for the photo-protective effect of MLT 
despite the induced release of hydroxyl radicals. 
 
In this Chapter, photo-irradiation of trans,trans,trans-[Pt(N3)2(OH)2(pyridine)2] (complex 13) 
in the presence of indole derivatives was investigated with the spin trapping methodology. A 
deeper understanding of the dual mechanism of action by which platinum(IV) 
chemotherapeutic drugs perform their anticancer activity is essential in order to design more 
specific and therefore safe anticancer drugs. Additionally, experiments aimed to explore the 
cellular targets of this class of anticancer compounds were performed. 
 
6.2 Experimental 
Below are the experimental sample preparation and instrumentation set up specific to this 
Chapter. More details regarding instrumentation are described in Chapter 3. 
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6.2.1 Materials 
Trans,trans,trans-[Pt(N3)2(OH)2(py)2] (complex 13) was supplied by the Sadler group, having 
been synthesised as previously reported.10 L-tryptophan (L-trp), melatonin (MLT), L-histidine 
(L-his), pentagastrin (N-t-Boc-β-Ala-Trp-Met-Asp-Phe amide), acetonitrile (ACN), 
dimethylformamide (DMF), 5,5-dimethyl-1-pyrroline N-oxide (DMPO) and 2-methyl-2-
nitrosopropane (MNP) dimer were all purchased from Sigma Aldrich. Melatonin, pentagastrin, 
DMPO and MNP dimer were stored at -20 °C. Absolute ethanol (AR grade) was purchased 
from Fischer Scientific. 
 
6.2.2 Sample preparation 
Solutions containing combinations of complex 13 (5 mM), MNP (80 mM), L-tryptophan (40 
mM), L-histidine (100 mM) and melatonin (different concentrations) were prepared in 
phosphate buffer (p.b.) 50 mM at pH 7.2. MNP (1.6 M) was prepared by dissolution of the 
dimer in ACN and subsequent dilution 1:20 in water. Melatonin (200 mM) was either dissolved 
in ethanol (EtOH) and subsequently diluted 1:5 in water or dissolved directly in water. Samples 
ca. 100 μL were transferred using a plastic syringe with metal needle to a standard quality 
quartz tube with inner diameter of 1.0 mm and outer diameter of 2.0 mm (Wilmad LabGlass) 
and sealed with parafilm. Sample tubes were then positioned in the EPR cavity so that the 
sample solution was crossing the entire length of the cavity. Sample preparation was done under 
dim controlled lightning conditions and transfer to the EPR spectrometer was done in the dark 
in order to prevent the photo-activation of complex 13 prior to the beginning of the experiment. 
 
6.2.3 Instrumentation 
6.2.3.1 EPR spectroscopy 
All EPR spectra were recorded on a X-band Bruker EMX CW EPR spectrometer at ambient 
temperature (ca. 295 K). 
 
6.2.3.2 Irradiation 
The LED bulb was inserted at the end of a Teflon tube which was clamped to a support. The 
TM110 cavity is equipped with a grid on the front to allow optical access to the sample (ca. 80% 
transmission). The tube was therefore placed in contact with the grid of the EPR cavity in order 
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to convey all the light into it (Figure 6.14). In this work, the position of the LED was maintained 
throughout all the irradiation experiments. The LED bulb was connected to a current generator, 
which was switched on at the beginning of the irradiation. Either a 465 nm blue light 
(LED465E, Thorlabs) or a 528 nm green light (LED528E, Thorlabs) LED was used for 
irradiating the samples. The radiation power was measured with a power meter and was found 
to be 7.1 mW cm-2 for the 465 nm diode and 5.4 mW cm-2 for the 528 nm diode. 
 
Figure 6.14 Setup of the X-band EPR cavity for the irradiation experiments, showing the LED light bulb inserted at 
the end of a Teflon tube, which is clamped on a support (not shown in the figure). 
 
6.2.4 EPR simulations 
EPR spectral simulations were performed in Matlab using the EasySpin package.66 The garlic 
routine (appropriate for the fast-motional regime) was used for all the experiments. 
Simulations of the MNP-tryptophan (MNP-Trp) and the MNP-melatonin (MNP-MLT) spin 
adducts were performed by including the only hyperfine coupling arising from the nitroxidic 
nitrogen, which was considered to be fully isotropic. Simulation of the MNP-α-hydroxy-ethyl 
adduct was performed including the hyperfine couplings of both the nitroxidic nitrogen and the 
α-proton. Simulation of the DMPO-N3 nitrone spin adduct was performed considering 
couplings to the nitroxidic nitrogen, the β-proton of the spin trapping agent and the α-nitrogen 
of the trapped azidyl radical.  
EPR parameters of the MNP di-adduct di-tert-butyl nitroxide (DTBN) were obtained by fitting 
a spectrum acquired from a solution of MNP which had been illuminated overnight with a 
Chapter 6. Photoactivation of a Platinum(IV) Anticancer Complex 
 
150 
 
465 nm LED, in order to promote the formation of DTBN. Hyperfine couplings arising from 
both the nitroxidic nitrogen and statistical abundance of nearest neighbour 13C nuclei were 
included and considered to be fully isotropic.  
An isotropic g-tensor was used for all the simulations and dynamic effects were neglected. 
 
6.3 Results 
6.3.1 L-tryptophan 
The ability of L-trp to switch the cytotoxicity of complex 13 by quenching photo-generated 
azidyl radicals was previously reported by Butler et al.42 It was also suggested that the 
mechanism by which the process occurs involved one-electron oxidation of the amino acid. 
This assertion was supported by a previous pulse radiolysis study where transient tryptophan 
radical cation (L-trpH●+) was formed after reacting with azidyl radicals, subsequently 
deprotonating to give the neutral tryptophan radical (L-trp●).50 Nevertheless, the formation of a 
tryptophan radical intermediate formed as a result of photo-activation of platinum(IV) 
complexes has not yet being directly observed. In this work, spin trapping of L-trp● was 
attempted with the nitroso spin trap MNP. 
 
6.3.1.1 Spin trapping of complex 13 with MNP 
First, the photo-activation of complex 13 was tested in the presence of the spin trapping agent 
2-methyl-2-nitrosopropane (MNP). Nitroso spin trapping agents like MNP are known for their 
specificity towards the trapping of carbon-centred radicals, as described in Chapter 1.  
A solution of complex 13 (5 mM) in the presence of an excess of MNP (80 mM) in p.b. 50 mM 
at pH 7.2 was irradiated with a 465 nm blue LED, with the setup described in Section 6.2.3.2. 
No other signal than di-tert-butyl nitroxide (DTBN) was observed in the dark. The formation 
of the DTBN background signal in spin trapping experiments with MNP has been discussed 
previously in Chapter 4.  Photo-irradiation of the sample resulted in the progressive increase 
of the DTBN signal, the formation of which is known to be promoted by light67 (Figure 6.15). 
Additionally, several low intensity lines could be observed (Figure 6.16). The multiplicity of 
the lines and the fact that only a small amount of such unknown species was detected, suggested 
this paramagnetic species to be a small fraction of azidyl radicals being trapped by MNP. 
Nevertheless, previously reported hyperfine couplings for the MNP-N3 spin-adduct68 did not 
match the observed signal (Figure 6.16). 
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Figure 6.15 X-band CW EPR spectrum of a solution of complex 13 (5 mM) and MNP (80 mM) in p.b. 50 mM at 
pH 7.2, before and during continuous irradiation with a 465 nm blue LED. Each scan is the sum of 10 consecutive 
scans. Times reported refer to the time passed between the start of the irradiation and the end of the acquisition of 
the last scan included in the spectrum. 
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Figure 6.16 a) X-band CW EPR spectrum of a solution of complex 13 (5 mM) and MNP (80 mM) in p.b. 50 mM at 
pH 7.2, after 32 minutes of continuous irradiation with a 465 nm blue LED. The spectrum is the sum of 156 
consecutive scans.  indicate additional paramagnetic species other than DTBN. b) simulation of the MNP-N3 spin 
adduct obtained with previously reported hyperfine couplings (aN1,N2 = 1.29 mT; aN3 = 0.11 mT).68  
 
6.3.1.2 Spin trapping of L-trp radical with blue light 
Next, the irradiation of complex 13 in the presence of L-trp and MNP was investigated. A 
solution of complex 13 (5 mM) and MNP (80 mM) was prepared in the dark adding an excess 
of L-trp (40 mM) to the sample mixture. No EPR signal other than a low intensity DTBN triplet 
was detected in the dark (Figure 6.17). When the sample was irradiated with blue light, an 
additional 3-line species was detected. The lines of the newly formed signal are almost 
overlapping the spectrum of DTBN, but can be easily distinguished from it for being broader 
and characterised by a slightly smaller hyperfine coupling. This signal was attributed to the 
spin-adduct MNP-Trp, with a neutral L-trp radical is being trapped by the nitroso spin trapping 
agent. The EPR spectrum was simulated with Easyspin66 considering a combination of the 
MNP-Trp spin adduct and DTBN (Figure 6.18). The EPR parameters extracted by simulation 
(Table 6.1) were found to be in good agreement with previously published ones, where the 
tryptophan radical was formed from UV photolysis and subsequently trapped with MNP.69 
Previous EPR studies carried out at low temperatures suggested that photolysis of Trp induced 
the rupture of the N-H indole bond, following an electron rearrangement with the unpaired 
electron locating in position 3 of the indole ring (refer to Figure 6.39).70 In fact, if the unpaired 
electron were to be located in any other position in the molecule, additional hyperfine splitting 
would have been detected from the spin-trap adduct. 
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Figure 6.17 X-band CW EPR spectrum of a solution of complex 13 (5 mM), L-trp (40 mM) and MNP (80 mM) in 
p.b. 50 mM at pH 7.2, before and during continuous irradiation with a 465 nm blue LED. Each spectrum is the sum 
of 30 consecutive scans. Times reported refer to the time passed between the start of the irradiation and the end of 
the acquisition of the last scan included in the spectrum. 
 
To determine the concentration of the radical species detected, the contribution of the MNP-
Trp adduct and DTBN were separated by simulation and quantified by comparison with 
TEMPOL standard solutions as previously described in Chapter 3. The concentration of the 
spin adduct reached a maximum of 0.7 μM after ca. 16 minutes of irradiation and slowly 
decreased afterwards (Figure 6.19).  Considering that the quantification of the spin trap adducts 
has been obtained against a reference solution measured on low precision tubes, an absolute 
error on this and the following kinetics data of ca. 10-20%  can be indicatively estimated. When 
the irradiation stopped, a fraction of the spin-adduct could still be detected for over one hour. 
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Figure 6.18 (a) X-band EPR spectrum of MNP-Trp spin adduct formed from photo-irradiation of complex 13 (5 
mM), L-trp (40 mM) and MNP (80 mM) after 41 min of irradiation with 465 nm blue LED light; (b) EasySpin66 
simulation of the EPR spectrum for a combination of MNP-Trp spin adduct and DTBN; (c) simulation of the only 
MNP-Trp spin adduct (red) and of the only DTBN (blue). The relative weights of MNP-Trp and DTBN are 
respectively ca. 75% and 25%. 
 
Figure 6.19 Quantification of the MNP-Trp spin adduct (●) and DTBN (○) generated from the photo-activation of 
complex 13 (5 mM) in the presence of L-trp (40 mM) and MNP (80 mM) with 465 nm LED light prepared in p.b. 
50 mM at pH 7.2. 
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Table 6.1 EPR hyperfine couplings (mT) and g-values for the trapped L-trp radical (MNP-Trp) and the MNP di-
adduct di-tert-butyl nitroxide (DTBN), comparing the parameters determined in this study with previously published 
ones. 
Radical  𝒂𝐍𝐎
𝐍  𝒂 𝐂
𝟏𝟑
 
Linewidth 
(lwpp) 
g-value 
MNP-Trp 
This study 
(465 nm) 
1.61(1) - 
0.15 
2.0054(2) a 
This study 
(528 nm) 
1.62(1) - 
0.16 
2.0053(2) a 
Ref.69 1.58 - 0.16 - b 
DTBN 
This study 
(465 nm) 
1.71(1) 0.43(1) 
0.07 
2.0053(2) a 
Ref.69 1.72 -b -b -b 
a determined by comparison with a DPPH standard; b not determined. 
 
 
6.3.1.3 Spin trapping of L-trp radical with green light 
The photo-irradiation of complex 13 at longer wavelengths had been previously investigated.10  
Photo-activation of complex 13 and the consequent release of N3 radicals, trapped by DMPO, 
was obtained with green light (517 nm) although to a much lower extent.  
The photo-activation of complex 13 with 528 nm green LED light in the presence of L-trp was 
therefore investigated. A solution of complex 13 (5 mM) was prepared in p.b. 50 mM at pH 7.2 
in the presence of L-trp (40 mM) and MNP (80 mM).  The sample was kept in the dark and 
transferred into the EPR spectrometer. No signals other than the DTBN triplet were observed 
in the dark. The sample was then irradiated with 528 nm green light for several hours. As can 
be observed in Figure 6.20, a small weak 3-line signal was detected, and was attributed to the 
MNP-trp spin adduct.  
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Figure 6.20 X-band CW EPR spectrum of a solution of complex 13 (5 mM), L-trp (40 mM) and MNP (80 mM) in 
p.b. 50 mM at pH 7.2, before and during continuous irradiation with a 528 nm green LED. Each of the spectra 
obtained during illumination is the sum of the previous 250 consecutive scans, while the spectrum obtained in the 
dark is the sum of 10 consecutive spectra and was multiplied by a factor of 25. Times reported refer to the time 
passed between the start of the irradiation and the end of the acquisition of the last scan included in the spectrum. 
 
 The reduced rate of activation of the complex is illustrated in Figure 6.21, which reports the 
double integrated (D.I.) area of the detected radical species against the acquisition time of the 
experiment. The activation of complex 13 appeared to slowly increase up to approximately 3 
hours, after which the concentration of the MNP-trp spin adduct reached a plateau. The 
concentration of the said spin adduct was below the limit for a reliable quantification 
(≪ 0.1 μM), which was therefore not attempted. The low concentration of the MNP-trp spin 
adduct was attributed to a reduced photo-activation of complex 13 as previously reported,10 
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which could be partially ascribable to the lower irradiation power of 528 nm green LED light 
(5.4 mW cm-2) in comparison to the 465 nm blue LED light (7.1 mW cm-2). 
 
 
Figure 6.21 Detection the MNP-trp spin adduct (●) and DTBN (○) generated from the photo-activation of complex 
13 (5 mM) in the presence of L-trp (40 mM) and MNP (80 mM) with 528 nm LED prepared in p.b. 50 mM at pH 
7.2. 
 
6.3.2 Melatonin 
6.3.2.1 Spin trapping of melatonin radical (EtOH 20%) with blue light 
Next, the effects of photo-activation of complex 13 in the presence of melatonin (MLT) were 
tested.  
Solutions containing MLT (40 mM) in 20% EtOH with either MNP (80 mM) or complex 13 
(5 mM) were prepared in p.b. at pH 7.2. The photo-stability of MLT upon irradiation with 463 
nm light had been previously assessed by UV-Vis and 1H NMR analysis.10 No EPR signals 
were detected in the dark, other than the 3-line DTBN background signal which could be 
observed in the solution containing the spin trapping agent. Photo-irradiation with 465 nm blue 
light did not generate new EPR signals in the solution containing only melatonin and complex 
13. Instead, when melatonin was irradiated in the presence of MNP, not only the DTBN signal 
enhanced as a result of the illumination, but also a new, less intense, signal was detected (Figure 
6.22).  
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Figure 6.22 X-band CW EPR spectrum of a solution of MLT (40 mM) and MNP (80 mM) in p.b. 50 mM 20% EtOH 
at pH 7.2, after 26 minutes of continuous irradiation with a 465 nm blue LED. The spectrum is the sum of 118 
consecutive scans.  indicate additional paramagnetic species other than DTBN. 
 
A solution containing complex 13 (5 mM) was then prepared in the presence of both MLT 
(40 mM in 20% EtOH) and MNP (80 mM). No signals were detected in the dark also in this 
case. When the sample solution was irradiated with the 465 nm blue LED light a new, broad 3-
line signal was observed (Figure 6.23). The experiment was repeated decreasing the modulation 
amplitude by one order of magnitude (from 0.1 to 0.01 mT) in an attempt to detect additional 
hyperfine structure covered by the broadening of the lines, but no further splittings were 
observed (Figure 6.24). The EPR parameters of the species were extracted by simulation 
(Figure 6.25) and were found to be in good agreement with the previously detected MNP-trp 
spin adduct (Table 6.2). The detected paramagnetic species was therefore assigned to the 
formation of the MNP-MLT spin adduct, with MLT binding to MNP in position 3 of the indole 
ring, as for L-trp.  
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Figure 6.23 X-band CW EPR spectrum of a solution of complex 13 (5 mM), MLT (40 mM) and MNP (80 mM) in 
p.b. 50 mM 20% EtOH at pH 7.2, before and during continuous irradiation with a 465 nm blue LED. Each specrtum 
is the sum of 10 consecutive scans. Times reported refer to the time passed between the start of the irradiation and 
the end of the acquisition of the last scan included in the spectrum. 
 
Figure 6.24 X-band CW EPR spectrum of a solution of complex 13 (5 mM), MLT (40 mM) and MNP (80 mM) in 
p.b. 50 mM 20% EtOH at pH 7.2 irradiated with a 465 nm blue LED, using either 0.1 mT (black) or 0.01 mT (red) 
modulation amplitude. Each spectrum is the sum of 30 consecutive scans. The spectra were manually scaled to the 
same intensity for comparison. 
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Figure 6.25 (a) X-band EPR spectrum of MNP-MLT spin adduct formed from photo-irradiation of complex 13 
(5 mM), MLT (40 mM) and MNP (80 mM) in p.b. 50 mM 20% EtOH at pH 7.2 after 51 min of irradiation with 
465 nm blue LED light; (b) EasySpin66 simulation of the EPR spectrum for a combination of MNP-MLT spin adduct 
and DTBN; (c) simulation of the only MNP-MLT spin adduct (red) and of the only DTBN (blue). The relative 
weights of MNP-MLT and DTBN are respectively ca. 80% and 20%. 
 
 The concentration of the spin adduct was calculated by comparison with a TEMPOL standard, 
and the kinetics of the spin trap adduct were analysed (Figure 6.26). Interestingly, the kinetics 
of the MNP-MLT and MNP-trp appeared to substantially differ. Firstly, the concentration of 
the MNP-MLT adduct was found to be ca. 30 times higher compared to MNP-trp, with a 
maximum of 19.5 μM as opposed to the 0.7 μM obtained with L-trp. Secondly, the formation 
of the melatonin spin adduct appeared to be slower, with the maximum reached after 95 minutes 
of irradiation against the 16 minutes for L-trp . Additionally, a closer observation of the curve 
of formation of the MNP-MLT radical adduct showed a bump in the initial part of the 
experiment (ca. 15 min), which is suggestive of the co-participation of two distinct events, a 
feature that was not observed with L-trp. 
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Figure 6.26 Quantification of the MNP-MLT spin adduct (●) and DTBN (○) generated from the photo-activation of 
complex 13 (5 mM) in the presence of MLT (40 mM) and MNP (80 mM) in p.b. 50 mM 20% EtOH at pH 7.2 with 
465 nm LED light. 
 
6.3.2.2 Spin trapping of melatonin radical (H2O) with blue light 
The experiments conducted with MLT in 20% EtOH were repeated avoiding the use of EtOH 
as a solvent to exclude its involvement in the kinetics of MLT, which showed the concurrence 
of two distinct kinetic processes. EtOH was used in the first place to allow a high concentration 
of MLT in the sample solution. MLT is in fact scarcely soluble in H2O, consequently the 
concentration of MLT obtained in the absence of EtOH was ca. two orders of magnitude lower 
than what was obtained by solubilising the compound in EtOH (0.4 mM vs 40 mM).  
A solution of complex 13 was thereby prepared in the presence of MLT (0.4 mM) and MNP 
(80 mM) in p.b. 50 mM at pH 7.2. No signals other than the DTBN three lines were detected in 
the dark. As the sample solution was irradiated with 465 nm blue LED light, an additional 3-
line signal was detected and was found to progressively increase as the irradiation proceeded 
(Figure 6.27). As for the experiments performed with MLT in EtOH (20%), the signal was 
attributed to the formation of the MNP-MLT spin adduct, originated from the presence of an 
indole radical with the unpaired electron in position 3 of the indole ring.  
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Figure 6.27 X-band CW EPR spectra of a solution of complex 13 (5 mM), MLT (0.4 mM) and MNP (80 mM) in 
p.b. 50 mM at pH 7.2, before and during continuous irradiation with a 465 nm blue LED. Each spectrum is the sum 
of 10 consecutive scans. Times reported refer to the time passed between the start of the irradiation and the end of 
the acquisition of the last scan included in the spectrum. 
 
The parameters extracted by simulation were found to be in good agreement with the spin 
adducts detected from photo-activation of complex 13 in the presence of L-trp or MLT in 20% 
EtOH (Table 6.2). The analysis of the kinetics revealed the same profile detected for MLT in 
EtOH, with a faster adduct formation detected in the initial part of the irradiation experiment 
(Figure 6.28). The concentration of the spin adduct in this case was found to be 5-10 times 
lower than with the previous experiment performed in EtOH, which is to be expected as a 
consequence of the lower concentration of MLT in the sample solution. 
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Figure 6.28 Quantification of the MNP-MLT spin adduct (●) and DTBN (○) generated from the photo-activation of 
complex 13 (5 mM) in the presence of MLT (0.4 mM) and MNP (80 mM) in p.b. 50 mM at pH 7.2 with 465 nm 
LED light. 
 
 
Table 6.2 EPR hyperfine couplings (mT) and g-values for the trapped MLT radical (MNP-MLT) compared to the 
MNP-trp spin adduct and the MNP di-adduct di-tert-butyl nitroxide (DTBN). 
Radical  𝒂𝐍𝐎
𝐍  𝒂 𝐂
𝟏𝟑
 Linewidth g-value 
MNP-MLT 
(20% EtOH) 
This study 1.59(1) - 0.14(1) 2.0056(2) a 
MNP-MLT 
(H2O) 
This study 1.61(1) - 0.12(1) 2.0054(2) a 
MNP-trp 
This study 1.61(1) - 0.15(1) 2.0054(2) a 
Ref.69 1.58 - 0.16(1) - b 
DTBN 
This study c 1.70(1) c 0.51(1) c 0.08(1) c 2.0054(2) a,c 
Ref.69 1.72 - b - b - b 
a determined by comparison with a DPPH standard; b not determined; c determined for the experiment 
with MLT in EtOH (20%) 
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6.3.2.3 Photo-activation of complex 13 with MLT at longer wavelengths 
As for L-trp, the photo-activation of complex 13 in the presence of MLT was investigated at 
longer wavelengths. A solution of complex 13 (5 mM) was irradiated with 528 nm green LED 
light in the presence of MLT (40 mM) and MNP (80 mM), prepared in p.b. 50 mM 20% EtOH 
at pH 7.2. Differently from what was obtained with L-trp, in the presence of MLT no signals 
were detected other than the DTBN signal, suggesting that the MLT indole radical is not 
produced under these conditions (Figure 6.29). 
 
Figure 6.29 X-band CW EPR spectrum of a solution of complex 13 (5 mM), MLT (40 mM) and MNP (80 mM) in 
p.b. 50 mM 20% EtOH at pH 7.2 and irradiated with a 528 nm green LED (black) in comparison to irradiation with 
465 nm blue LED (dashed dotted blue). The spectrum obtained with green light irradiation is the sum of 200 scans, 
while the spectrum obtained with blue light irradiation is the sum of 8 scans. 
 
6.3.2.4 Detection of hydroxyl radicals 
To further investigate the mechanism of photo-activation of complex 13, the compound was 
analysed in the presence of EtOH (20%) but in the absence of MLT. EtOH is known to be a 
scavenger specific for the hydroxyl radical (OH●). The trapping of α-hydroxyl ethyl radical 
with DMPO, formed from reaction of OH● with EtOH was previously reported,10 and suggested 
a multi photo-decomposition pathway for complex 13 which also involves the formation of 
hydroxyl radicals. 
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A solution of complex 13 (5 mM) was therefore prepared in the presence of 20% EtOH 
(~ 34 M) and MNP (80 mM) in p.b. 50 mM at pH 7.2. The solution was therefore irradiated 
with a 465 nm blue LED, under continuous acquisition of the EPR spectrum. The photo-
activation of the platinum complex was found to induce the formation of a 6 line signal, partially 
overlapping with the 3-line signal assigned to DTBN, which was attributed to the formation of 
the α-hydroxyl ethyl radical (Figure 6.30).  
 
Figure 6.30 X-band CW EPR spectra of a solution of complex 13 (5 mM) in the presence of 20% EtOH and MNP 
(80 mM) in p.b. 50 mM at pH 7.2, before and during continuous irradiation with a 465 nm blue LED. Each spectrum 
is the sum of 10 consecutive scans. Times reported refer to the time passed between the start of the irradiation and 
the end of the acquisition of the last scan included in the spectrum. 
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The EPR spectral parameters of the paramagnetic species were extracted by simulation with 
EasySpin66 (Figure 6.31) and are reported in Table 6.3. The extracted parameters were found 
to be in good agreement with previously reported parameters for the trapped α-hydroxyl ethyl 
radical,71,72 confirming the formation of the above mentioned radical following the photo-
activation of complex 13. The kinetics of formation and decay of the MNP-EtOH spin trap 
adduct are shown in Figure 6.32. The spin adduct concentration reached a maximum of ca. 1.9 
μM after 25 minutes of continuous irradiation with 465 nm LED light, and then slowly 
decreased until the irradiation was stopped. 
 
 
Figure 6.31 (a) X-band EPR spectrum obtained from photo-irradiation of complex 13 (5 mM), in the presence of 
EtOH 20% and MNP (80 mM) in p.b. 50 mM at pH 7.2 after 10 min of irradiation with 465 nm blue LED light; (b) 
EasySpin66 simulation of the EPR spectrum for a combination of MNP-EtOH spin adduct and DTBN; (c) simulation 
of the only MNP-EtOH spin adduct (red) and of the only DTBN (blue). The relative weights of MNP-EtOH and 
DTBN are respectively ca. 46% and 54%. 
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Table 6.3 EPR hyperfine couplings (mT) and g-values for the trapped α-hydroxyl ethyl radical (MNP-EtOH) and 
the MNP di-adduct di-tert-butyl nitroxide (DTBN). 
Radical  𝒂𝐍𝐎
𝐍  𝒂 𝐂
𝟏𝟑
 𝒂𝛂
𝐇 g-value 
MNP-EtOH 
This study 1.56(1) - 0.18(1) 2.0054(2) a 
Ref.71,72 1.55 - 0.18 - b 
DTBN 
This study 1.71(1) 0.48(1) - 2.0054(2) a 
Ref.69 1.72 -b - -b 
a determined by comparison with a DPPH standard; b not determined 
 
 
 
 
Figure 6.32 Quantification of the MNP-EtOH spin adduct (●) and DTBN (○) generated from the photo-activation 
of complex 13 (5 mM) in the presence of  EtOH (20%) and MNP (80 mM) in p.b. 50 mM at pH 7.2 with 465 nm 
LED light. 
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6.3.3 L-histidine 
L-histidine is known for being, like the amino acid L-trp, an efficient mediator of electron 
transfer in proteins.73 According to its reduction potential (E0 = 1.17 V),74 histidine is a slightly 
stronger oxidant than tryptophan (E0 = 1.015 V),75 but weaker than the azidyl radical (E0 = 1.33 
V).76 The reduction potentials therefore suggest that an electron transfer from L-his to the azidyl 
radicals is still favourable. Thus, the possibility that L-his could modulate the cytotoxicity of 
complex 13 was investigated.  
A solution of L-his (100 mM) with MNP (80 mM) and complex 13 (5 mM) was prepared in 
p.b. at pH 7.2 in the dark. The photo-activation of complex 13 led only to the formation of 
DTBN (Figure 6.33). It therefore appeared that, unlike L-trp and MLT, L-his does not interact 
with the azidyl radicals released upon photo-degradation of complex 13.  
 
 
Figure 6.33 X-band EPR spectrum obtained from photo-irradiation of complex 13 (5 mM), in the presence of L-his 
(100 mM) and MNP (80 mM) in p.b. 50 mM at pH 7.2 after 65 min of irradiation with 465 nm blue LED light. 
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6.3.4 Pentagastrin 
To further investigate the formation of L-trp● as a result of the photo-activation of complex 13, 
the photo-activation of the Pt-compound was performed in the presence of a trp-containing 
peptide, pentagastrin. 
 
6.3.4.1 Spin trapping with MNP in the presence of pentagastrin 
A solution of complex 13 (5 mM) was irradiated in the presence of pentagastrin (18 mM in 
DMF 70%) and MNP (80 mM) in p.b. 50 mM at pH 7.2. No signals other than the DTBN triplet 
were detected in the dark. As the photo-irradiation was initiated, the DTBN signal was found 
to increase with time (Figure 6.34). A closer observation of the EPR spectrum showed the 
presence of additional, low intensity species. The multiplicity of the trapped radical suggested 
that it originates from the trapping of a N-centre radical.  
 
 
Figure 6.34 X-band CW EPR spectra of a solution of complex 13 (5 mM), pentagastrin (18 mM in DMF 70%) and 
MNP (80 mM) in p.b. 50 mM at pH 7.2, before and during continuous irradiation with a 465 nm blue LED. Each 
spectrum  is the sum of 25 consecutive scans. Times reported refer to the time passed between the start of the 
irradiation and the end of the acquisition of the last scan included in the spectrum. 
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The experiment was repeated in the absence of pentagastrin (Figure 6.35). The same features 
were detected also in this case ( ), although some lines were found to be more intense ( ). 
Both signals were therefore attributed to the solvent, implying that no radicals deriving from 
pentagastrin as a result of the photo-activation of complex 13 were trapped. 
 
 
Figure 6.35 X-band CW EPR spectra of a solution of complex 13 (5 mM), and MNP (80 mM) in p.b. 50 mM 70% 
DMF at pH 7.2 in the presence (black) and absence (blue) of pentagastrin (18 mM) after 75 minutes of continuous 
irradiation with a 465 nm blue LED. Each spectrum is the sum of 300 consecutive scans.  and  indicate 
additional paramagnetic species formed upon irradiation. 
 
6.3.4.2 Spin trapping with DMPO 
Following the inability to spin trap and thereby detect indole radicals generated from the photo-
activation of complex 13 in the presence of pentagastrin, the same experiments were repeated 
using DMPO as a spin trapping agent in place of MNP. DMPO is known for its specificity 
towards the trapping of oxygen- and nitrogen-centred transient radicals, and it is therefore the 
spin trapping agent of choice for the detection of azidyl radicals. DMPO has been previously 
used to spin trap photo-released azidyl radicals in the presence and absence of L-trp, thereby to 
measure of the photo-protective effect of the said amino acid.42 The effects of the presence of 
pentagastrin on the trapping of azidyl radicals released upon photo-degradation of complex 13 
were therefore examined.  
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A solution of complex 13 (5 mM) prepared with DMPO (10 mM) in p.b. 50 mM 70% DMF at 
pH 7.2 was irradiated with 465 nm blue LED light in the presence and absence of pentagastrin 
(20 mM). No signals were detected in the dark. In the absence of pentagastrin, the photo-
activation of complex 13 was found to induce the formation of a 12-line signal of pattern 
1:1:1:2:2:2:2:2:2:1:1:1, which was assigned to the DMPO-N3 spin adduct as previously 
reported.42 The detected splitting arises from the coupling to the nitroxidic nitrogen, the β-
proton of the spin trap structure and the α-nitrogen of the azidyl radical, giving 18 lines which 
partially overlap. The EPR parameters extracted by simulation (Table 6.4) were found to be in 
reasonably good agreement with previously reported works,42,77 despite differences of the 
magnitude of the couplings which can be attributed to the different solvents used to prepare the 
samples and will be discussed in Section 6.4.5. 
 
Figure 6.36 X-band CW EPR spectra of a solution of complex 13 (5 mM), pentagastrin (20 mM) and DMPO (10 
mM) in p.b. 50 mM 70% DMF at pH 7.2, before and during continuous irradiation with a 465 nm blue LED. Each 
spectrum is the sum of 25 consecutive scans. Times reported refer to the time passed between the start of the 
irradiation and the end of the acquisition of the last scan included in the spectrum. 
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The same experiment was then repeated preparing a sample which also contained pentagastrin 
(20 mM). As shown in Figure 6.36, the presence of pentagastrin produced a pronounced 
decrease in the concentration of the DMPO-N3 spin adduct, to ca. the 30% of what was detected 
in the absence of pentagastrin. The kinetics of formation and degradation of the spin adduct in 
the two cases (presence and absence of pentagastrin) are reported in Figure 6.38. In the presence 
of pentagastrin (20 mM), the concentration of the DMPO-N3 formed as a consequence of the 
photo-degradation of complex 13 did not exceed 0.9 μM. On the contrary, in the absence of 
pentagastrin, the concentration of the spin adduct progressively increased upon irradiation up 
to ca. 2.3 μM. As the photo-irradiation was stopped, the signal rapidly decreased as the spin 
trap adduct decomposed. Such results represent a strong evidence that pentagastrin does interact 
with the azidyl radicals released upon photo-activation of complex 13, similarly to L-trp and 
MLT. 
 
Figure 6.37 (a) X-band EPR spectrum obtained from photo-irradiation of complex 13 (5 mM) in the presence of 
DMPO (10 mM) prepared in p.b. 50 mM 70% DMF at pH 7.2, after 43 min of irradiation with 465 nm blue LED 
light; the spectrum is the sum of 70 slices; (b) EasySpin66 simulation of the EPR spectrum with the parameters 
reported in Table 6.1. The line diagram for the DMPO-N3 spin adduct is also shown. 
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Figure 6.38 Quantification of the DMPO-N3 spin adduct in the presence (●) and absence (○) of pentagastrin (20 
mM) generated from the photo-activation of complex 13 (5 mM) in the presence of DMPO (10 mM) in p.b. 50 mM 
70% DMF at pH 7.2 with 465 nm LED light.  
 
 
Table 6.4 EPR hyperfine couplings (mT) and g-values for the azidyl radical nitrone spin adduct (DMPO-N3). 
Radical  𝒂𝐍𝐎
𝐍  𝒂𝛃
𝐇 𝒂𝐍𝛂
𝐍  g-value 
DMPO-N3 
This study 
(DMF 70%) 
1.38(1) 1.30(1) 0.31(1) 2.0055(2) a 
Ref.77 
(DMF 50%) 
1.38 1.39 0.30 -b 
Ref.42 
(H2O) 
1.45 1.49 0.32 -b 
a determined by comparison with a DPPH standard; b not determined 
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6.4 Discussion 
6.4.1 Detection of MNP-indole radicals 
The formation of MNP-tryptophan radical adducts from flash photolysis in solution has been 
previously reported. The observed spin trap adducts were suggested to be originated from a 
carbon-centred tryptophan radical, with the unpaired electron located in position 3 of the indole 
ring.69 Indeed, if the unpaired electron were to be located in any other position of the molecule, 
hyperfine couplings to nearby protons would have been expected. Additionally, the increased 
stability of a tertiary radical over primary and secondary radicals supports the suggested 
structure.  
Previously published pulse radiolysis studies proved that the reaction between reactive radical 
species such as ●N3 and tryptophan proceeds through a direct electron transfer between the 
amino acid and the RNS, as opposed to a hydrogen atom transfer.50 Additionally, it was 
proposed that photolysis of the tryptophan initially takes place at the indole N-H bond with 
formation of a N-centred radical, followed by an electron rearrangement to leave the unpaired 
electron in position 3 of the indole ring.70 The sum of these considerations is in Figure 6.39: 
 
 
Figure 6.39 Reaction between the azidyl radical and indole derivatives proceeding through one-electron transfer 
pathway and successful rearrangement to produce the C3-centred indole radical. R1 = H (trp); OCH3 (MLT). R2 = 
CH2CH(NH2)COOH (trp); CH2CH2NHCOCH3 (MLT). 
 
The ability of L-tryptophan (L-trp) to quench azidyl radicals formed from photo-activation of 
complex 13 has been previously reported. It has been suggested that the presence of the amino 
acid does not prevent the release of such RNS from photo-degradation of the metallo-organic 
compound, but quenches the formation of the DMPO-N3 spin adduct at low, biologically 
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relevant concentrations.42 Although L-trp radical is a strong oxidant (Eo = 1.015 V at pH 7),78 
it is weaker than the azidyl radical (Eo = 1.33 V),76 and therefore an electron transfer between 
the two species is favourable. The mechanism by which tryptophan destroys the azidyl radicals 
was suggested to proceed through a one-electron oxidation, with formation of an intermediate 
tryptophan radical.10 Nevertheless, previous studies failed in detecting such tryptophan 
intermediate. 
In this work, photo-activation of complex 13 in the presence of L-trp was tested with the nitroso 
spin trap MNP, a spin trapping agent specific for the trapping of reactive C-centred radicals. 
The irradiation of complex 13 with 465 nm blue LED light with MNP and L-trp led to the 
detection of a 3-line signal (Figure 6.17), which was assigned to the radical spin adduct formed 
from the trapping of a L-tryptophan radical (L-trp●), with the unpaired electron located in 
position 3 of the indole ring. The spectral parameters extracted by simulation are in good 
agreement with previously reported work where tryptophan radical was formed from flash 
photolysis in solution69 (Table 6.1).  
Photo-activation of complex 13 was also tested in the presence of melatonin (MLT). The ability 
of this indole derivative of L-trp to quench the formation of DMPO-N3 during photo-irradiation 
of complex 13 was previously reported.10 Photo-activation of complex 13 in the presence of 
MLT and MNP was shown to produce a radical with the same features of the MNP-trp spin 
adduct (Figure 6.23). The similarity between the two spectra suggested that the nitroso spin 
trapping agent trapped the radical at the same position of the indole ring. 
Interestingly, major differences were found in the kinetic profiles of formation of the MNP-trp 
and MNP-MLT spin adducts. To start, the concentration of the spin trapped MLT radical was 
found to be ca. 30 times higher than the concentration of the MNP-trp adduct. An explanation 
for this pronounced difference can be found from the comparison between the reduction 
potentials of L-trp (Eo = 1.015 V)78 and MLT (Eo = 0.73 V).79 In fact, despite both species 
possessing a reduction potential lower than azidyl radical (Eo = 1.33 V),76 the much lower 
reduction potential of MLT suggests that an electron transfer from MLT to the azidyl radical is 
more favourable than from L-trp. Secondly, the formation of the MNP-MLT spin adduct 
appeared to be more sustained compared to the analogous trp adduct, with the maximum 
reached after 95 min compared to 16 min (Figure 6.19 and Figure 6.26), an effect that can be 
ascribed to an increased stability of the MNP-MLT spin adduct compared to the MNP-trp 
adduct. Additionally, a bump can be seen in the first part of the kinetic profile of formation of 
the MNP-MLT spin adduct, regardless the presence or absence of EtOH (Figure 6.26 and Figure 
6.28). The data therefore suggest the co-participation of two distinct events that cause the 
formation of the MLT radical, readily trapped by MNP. 
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6.4.2 Formation of hydroxyl radical 
Photo-activation of complex 13 in the presence of EtOH and MNP led to the detection of a 
nitroso spin adduct which was ascribed to the trapping of the α-hydroxyl ethyl radical. EtOH is 
a well known hydroxyl radical (●OH) scavenger, and therefore the formation of an ethanol 
radical was attributed to the interaction of the alcohol with ●OH released upon photo-
degradation of the Pt-complex. These findings suggested the presence of multiple degradation 
pathways for complex 13, involving not only the release of azidyl radicals, but hydroxyl 
radicals too. The complex kinetics of formation of the melatonin radical can therefore be 
interpreted as the interaction of this indole derivative with both ●N3 and ●OH, both concurring 
to the formation of MLT radicals which are readily trapped by MNP. 
 
6.4.3 Longer wavelength of activation 
Photo-irradiation of complex 13 with 528 nm green light was tested. Activation at longer 
wavelengths is of interest because of their ability to penetrate deeper into tissues, thereby 
broadening the clinical range of applicability of this photo-activable anticancer compound. 
The wavelength of activation used in previously reported EPR studies was 465 nm. Previous 
UV-Vis investigations found photo-activation of complex 13 still occurring at 517 nm green 
LED light, although to ca. 20 fold lower extent compared to activation with 465 nm blue light.42 
In this work, complex 13 was irradiated using 528 nm green LED light in the presence of the 
nitroso spin trap MNP and either L-trp or MLT. In the presence of L-trp, the formation of the 
MNP-indole radical adduct was still observed, although to a much lower rate (Figure 6.21). The 
reduced photo-activation of the complex can partially be attributed to the lower irradiation 
power of the green light (5.4 mW cm-2 at 528 nm) compared to blue (7.1 mW cm-2 at 465 nm).  
Interestingly, irradiation of complex 13 with green light in the presence of MLT did not lead to 
the detection of any radical spin adduct. This finding was unexpected considering that the 
amount of MNP-MLT adduct detected from irradiation with blue light was ca. 30 fold higher 
in comparison to the MNP-trp adduct. 
 
6.4.4 Photo-protective effect of pentagastrin 
The cytotoxicity of complex 13 was previously suggested to involve a dual attack on cancer 
cells carried out by the reactive platinum(II) and azidyl radicals, both produced upon photo-
activation of the compound.42 Alhough PtII is known to perpetrate its cytotoxic effect through 
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platination of DNA, the unreactivity of N3 radicals towards nucleic acids and derivatives was 
previously reported.48 On the other hand, azidyl radicals were found to be reactive towards 
aromatic functionalised amino acids.47  
Pentagastrin was selected as a tryptophan-containing small peptide to test its effects on the 
photo-activation of complex 13. In the presence of MNP, no spin trap adducts ascribable to the 
peptide were detected (Figure 6.35), suggesting either a non-susceptibility of azidyl radicals 
towards the peptide or the inability of the nitroso spin trap to bind to any pentagastrin radical 
product formed from interaction with the RNS.  
Therefore, irradiation of complex 13 in the presence of pentagastrin was tested using the nitrone 
spin trap DMPO. In the absence of pentagastrin, a 1:1:1:2:2:2:2:2:2:1:1:1 twelve-line spectrum 
was detected, and was readily attributed to the DMPO-N3 adduct as previously reported.42 The 
differences between the spectral parameters of the detected spin adduct compared to previously 
reported ones will be discussed in Section 6.4.5. Instead, the presence of pentagastrin was found 
to quench the formation of the DMPO-N3 spin adduct (Figure 6.36). It therefore appears that, 
even as part of a small peptidic chain, tryptophan still preserves its photoprotective effect 
towards azidyl radicals. The impossibility to detect a tryptophan radical intermediate through 
spin trapping with MNP was attributed to a decreased accessibility to the amino acid within the 
peptidic chain, which could still be available for the oxidative attack brought by N3 radicals but 
not for trapping with the nitroso spin trap. These findings suggest that azidyl radicals may exert 
their cytotoxic activity by carrying out an oxidative attack on L-trp residues in proteins, with 
the consequent disruption of the cell homeostasis leading to cell death. 
 
6.4.5 Hyperfine coupling constants 
Differences between the spectral parameters of the spin trap adducts detected in this work and 
the parameters previously reported for the same species have been observed. The hyperfine 
splittings of a spin adduct are strongly influenced by the solvent used for the experiment. In 
general, an increase in the polarity of the solvent is related to an increased spin density in the 
nitroxidic nitrogen, with a consequent increase of the nitrogen hyperfine splitting.71 
Accordingly, the β-hydrogen splitting is expected to decrease, although this is not always the 
case. It therefore appears that the best way to identify a spin adduct is still by comparison with 
previously identified adducts in the same solvent. Table 6.4 represents an exemplification of 
the variation of the hyperfine couplings for the DMPO-N3 spin adduct obtained by changing 
the solvent. A decrease of both the aNNO and aHβ couplings are reported when the solvent 
changes from H2O42 to DMF 50%,77 respectively of 0.07 and 0.1 mT. Thus, a further decrease 
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of the polarity of the solvent is expected to further decrease the hyperfine couplings. Therefore, 
the decrease of the aHβ coupling of 0.09 mT observed in this work for a sample solution of 70% 
DMF is consistent with previously reported data. 
 
6.4.6 Mechanism of photo-activation of complex 13 
As discussed at the beginning of this Chapter, complex 13 has the potential to release both ROS 
and RNS upon irradiation (Figure 6.12). This work provides further evidences on the formation 
of both N3 and OH radicals upon photo-activation of the PtIV-compound. The detection of the 
α-hydroxyl ethyl radical, spin trapped with MNP, provided a direct evidence for the photo-
release of the hydroxyl radical which is readily quenched by ethanol. Similarly, melatonin has 
been reported to possess the ability to quench  not only RNS, but ROS too.80–82 The kinetics of 
formation of the MNP-MLT spin adduct also suggest that MLT radical is formed from 
interaction with both N3 and OH radicals, through two kinetically distinct pathways. 
 
6.4.7 Amino acid radicals 
The detection of the L-trp radical intermediate formed from interaction with azidyl radicals 
verifies the theory of an oxidative attack brought by the RNS towards this aromatic amino acid. 
Consequently, two considerations can be made. Firstly, the cytotoxicity of this class of 
anticancer compounds will depend on the presence of target aromatic amino acids and 
derivatives. Therefore, it is important to consider the serum levels of metabolites such as 
tryptophan and melatonin in the patient, as they will influence the antitumoral action of the 
drug. The serum levels of melatonin are known to vary during the day, with the maximum 
production during sleep hours.83 Therefore, the optimum time for the administration of similar 
drugs must be determined in order to achieve the maximum therapeutic effect. These 
considerations fall under the emerging field of Chronopharmacology.84 Interestingly, the serum 
L-trp levels in some cancer patients have been found to be depleted in comparison with normal 
controls,85,86 a finding that suggests an increased efficacy of phototherapy with complex 13 in 
similar cases. It also appears that the potency of the anticancer compound may be fine-tuned by 
coordinated administration of L-trp, a strategy that can potentially help to prevent unwanted 
side effects of chemotherapy which is a major issue for the Pt complex class of anticancer drugs. 
Secondly, this work shines a light in respect to the target of the RNS released from photo-
activation of complex 13. Whilst the targets for the reactive PtII are known to be nucleic acids 
and derivatives, azidyl radicals have previously been found to be unreactive towards DNA, but 
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reactive towards aromatic amino acids.47 Amino acids like tryptophan and tyrosine are involved 
in important electron transfer pathways in proteins.87,88 A disruption of such pathways may 
strongly impair cellular homeostasis leading to cell death. This work showed how azidyl 
radicals can be quenched by both free L-trp and derivatives and tryptophan containing peptides, 
providing a further evidence towards the identification of the cellular target of such RNS. 
 
6.5 Conclusions 
In this Chapter, the mechanism of action and intracellular targets of the photo-activable 
platinum(IV) complex trans,trans,trans-[Pt(N3)2OH2(pyridine)2] (complex 13) were 
investigated with the spin trapping methodology. The cytotoxic activity of complex 13 has been 
reported to rely on a dual mechanism of action, involving simultaneous  DNA platination 
carried out by the photo-reduced PtII centre and an oxidative attack brought by azidyl radicals 
(●N3) released upon photo-activation of the compound. The presence of indole derivatives such 
as L-trp and MLT has been previously reported to produce a photo-protective effect to be 
ascribed to the quenching of ●N3. The interaction between the indole derivatives and the RNS 
released upon photo-activation of complex 13 has been suggested to proceed through a one-
electron oxidation mechanism, with formation of a transient indole radical, which has not been 
observed before.  
In this work, transient L-trp and MLT radicals have been detected by performing EPR spin 
trapping experiments with the nitroso spin trapping agent MNP. Photo-activation of complex 
13 in the presence of L-trp and MNP resulted in direct detection of the MNP-trp radical spin 
adduct. The formation of L-trp adducts was observed from both irradiation with blue (465 nm) 
and green (528 nm) LED light. On the contrary, the MNP-MLT spin adduct was observed only 
from activation of complex 13 with blue light, producing a ca. 30 fold higher EPR signal 
compared to MNP-trp. The kinetics of formation of the MNP-MLT adduct suggested the 
presence of two kinetically different processes. Irradiation of complex 13 in the presence of 
EtOH and MNP resulted in the trapping of the α-hydroxy-ethyl radical, which is known to be 
formed specifically from interaction of the alcohol with hydroxyl radicals (●OH). These 
findings confirmed the presence of multiple photo-degradation pathways for complex 13, 
involving the release of both azidyl and hydroxyl radicals. 
Photo-activation of complex 13 in the presence of the tryptophan-containing peptide 
pentagastrin was tested to determine the ability of L-trp to quench azidyl radicals as part of a 
small peptidic chain. It has been suggested that the cytotoxic effect of ROS/RNS relies on the 
interaction of the radicals with biological structures containing aromatic amino acids. Spin 
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trapping experiments with MNP failed to detect MNP-pentagastrin spin adducts, suggesting 
either the absence of a photo-protective effect or the inability of the nitroso spin trapping agent 
to trap peptide radicals generated from interaction with photo-released ●N3. The nitrone spin 
trap DMPO was therefore used to test the effect of pentagastrin on the formation of the DMPO-
N3 spin adduct upon irradiation of complex 13. The presence of pentagastrin gave a decrease 
of ca. 70% in the amount of DMPO-N3 detected, suggesting that the peptide is able to quench 
photo-released azidyl radicals. 
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Chapter 7  
Conclusions and Future Work 
 
This thesis focused on the investigation of novel applications of electron paramagnetic 
resonance (EPR) spectroscopy in the pharmaceutical field. The versatility of this powerful 
biophysical technique presents a wide range of possible uses for EPR in all the very different 
phases of pharmaceutical research and development, from drug design to drug development 
and product formulation. These are all areas where to date EPR has been much underutilised. 
In the first part of this work, EPR has been used to study the effects of γ-irradiation for the 
sterilization of pharmaceutical excipients as an alternative to the classic sterilization methods. 
The radicalic degradation products formed upon irradiation of the excipients were characterised 
and their reactivity was evaluated. These studies showed the great potential of EPR in assessing 
the stability of pharmaceutical products. In the second part of this work, the spin trap 
methodology was applied to investigate the reactivity of photo-irradiated platinum(IV) 
complexes. The mechanism of action of a promising candidate of this class of anticancer drugs 
was at the centre of this investigation, contributing to the overall understanding of the reactivity 
of this compound and its generated photo-products. 
 
7.1 Conclusions 
Chapter 4 focuses on the investigation of the effects of γ-radiation sterilization on the 
pharmaceutical excipient L-histidine (L-his). This amino acid is typically used in 
pharmaceutical and biopharmaceutical formulations as a buffering agent and a stabiliser.  The 
analysis of the γ-irradiated solid powders at r.t. highlighted the formation of persistent 
C-centred radical species at a concentration of approximately 2.5 mM at 25 kGy. The influence 
of a different irradiation source was also evaluated by studying the effects of X-rays on L-his. 
X-irradiation of the powder was found to produce the same main paramagnetic species, with 
only small spectral differences that were attributed to the dissimilar irradiation conditions, 
resulting in the formation of minor radical species at different concentrations. Single crystal 
analysis confirmed the main radical species to be the product of deamination, as previously 
reported,1 being a common degradation pathway for amino acids. The analysis of the EPR 
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spectra of an L-his single crystal also highlighted the presence of secondary species, as 
suggested by the powder spectra. Simulations of the roadmaps were performed, combining 
previously published hyperfine coupling tensors and g-tensors extracted from simulation of the 
powder spectra, achieving reasonably good agreement with the experimental data. Multi-
frequency analysis (9–263 GHz) highlighted the anisotropic feature of the g-value of the 
deamination radical, but the presence of secondary minor species interfering with the analysis 
prevented the extraction of the Hamiltonian parameters through global fitting of the multi-
frequency data. Low temperature irradiation was performed to characterise the (assumed) 
primary radical species formed as a result of the irradiation process, and to study the evolution 
of the said species into the ones persistent at r.t. This is a necessary step to assess the 
compatibility between the various ingredients forming multi-component systems, in particular 
to avoid transient radical-driven degradation of the active pharmaceutical ingredient (API). 
Indeed, not only direct degradation of the API(s) due to irradiation, but also indirect degradation 
brought by interaction with the excipients’ radical species must be considered. The analysis of 
the low temperature irradiated L-his single crystal at 80 K showed the presence of a three-line 
EPR spectrum, which was ascribed to a previously reported L-his carboxyl anion.1 At 120 K, 
such radical species were found to irreversibly evolve into the L-his deamination radical from 
both the L-his crystal and powder samples. The annealing in steps of low temperature irradiated 
L-his highlighted the formation of an unreported transient paramagnetic species, which quickly 
disappeared upon further heating.  
Finally, the reactivity of the radicals in solution was assessed by means of spin trapping 
experiments. Histidine-containing formulations are often of the parenteral type, meaning that 
the product needs to be solubilised prior to administration to the patient. Thus, assessing the 
behaviour of the radicals in solution is paramount to assess the safety of the irradiated drug. 
The solid state persistent radicals were found to have a short lifetime in solution, as expected 
for this type of C-centred radicals. Spin trapping with the nitroso spin trapping agent MNP 
allowed trapping and characterisation of the L-his deamination radicals. Interestingly, the same 
L-his radical species could still be trapped when the spin-trap was added minutes after 
dissolution of the powder, in apparent contrast with the short lifetime of the radicals. It was 
therefore proposed that the deamination radicals are regenerated through a Fenton-type reaction 
involving the presence of trace metals and strong oxidant species, leading to the generation of 
reactive oxygen species (ROS) responsible for the regeneration of the radicals. This supposition 
was supported when a chelating agent was added to the sample mixture, the regeneration of the 
radicals was found to cease. The source of the metals needed for the Fenton chemistry was 
attributed to the metal needle of the syringe used to transfer the sample solution into the EPR 
tube for analysis, a characteristic confirmed by XRF analysis. Indeed, by using a glass Pasteur 
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pipette in place of the syringe and needle, the regeneration of the radical was not observed. The 
fact that similar medical needles might be used for the administration of the parenteral 
formulation confers great relevance to these findings. Avoiding the regeneration of the radicals 
in solution is necessary not only to eliminate the potential of radical-induced degradation of 
other drug components, but also to avoid direct toxicological issues due to unintentional 
injection of free radicals into patients. The characterisation of the degradation products of L-
his through widespread techniques such as electron spray ionisation mass spectroscopy (ESI-
MS) and proton nuclear magnetic resonance (1H NMR) was also attempted, but failed in 
detecting the additional species formed upon irradiation of the samples previously studied with 
EPR spectroscopy because of the limited sensitivity of these techniques compared to EPR. 
Chapter 5 focuses on the study of the effects of γ-irradiation sterilization on D-mannitol. 
Mannitol is the most used excipient in lyophilised formulations where it is utilised as a bulking 
agent and as such can constitute up to 90% w/w of the drug product. Knowing the effects of 
radiation sterilization on mannitol is therefore of great importance. To the best of our 
knowledge, studies identifying the radicalic degradation products formed upon irradiation of 
D-mannitol have not been reported to date, nor have spin trapping experiments of mannitol 
radicals in solution been described. In this work, the evolution of the primary radical species 
formed upon irradiation of D-mannitol at 77 K into the r.t. persistent species has been studied 
by CW EPR. Liquid nitrogen temperature irradiation of D-mannitol was found to induce the 
formation of a C-centred radical characterised by a large isotropic hyperfine coupling, radical 
I, which was assigned to the abstraction of a proton from either C3 or C4. Annealing of the 
samples to 120 K was found to induce the formation of a second, O-centred radical species, 
radical II, possibly formed upon abstraction of a proton from the hydroxyl bound to either C1 
or C6. Further annealing to 170 K resulted in the formation of a third radical species, radical 
III, which was suggested to arise from the abstraction of a proton from the carbon atom in 
position 1 or 6. By further annealing to 200 K and 240 K, an additional, unidentified radical 
species characterised by a large isotropic doublet was found to become more dominant in the 
EPR spectrum, while decreases of the other radical species were observed. The mutation of the 
EPR spectra first at 260 K and then at 295 K (r.t.) was interpreted as indicating the formation 
of new paramagnetic species, with at least three different radicals believed to be persistent at 
r.t. However, the complexity of the spectra in this temperature range did not allow a complete 
characterisation of the newly formed species. Interestingly, quantification of the r.t. persistent 
radical species showed an almost three times higher radical concentration for D-mannitol 
compared to L-his for a 25 kGy irradiation dose.  
The spin trapping methodology was applied to assess the reactivity of the radicals in solution. 
As for L-his, the r.t. radicals persistent in the solid state were not detected in solution in the 
Chapter 7. Conclusions and Future Work 
 
191 
 
absence of a spin trapping agent. Although direct dissolution of the irradiated powder in a spin 
trap solution of MNP resulted in the detection of a radical spin-trap adduct, the regeneration 
process that was witnessed for L-his was not observed for D-mannitol. These findings 
suggested such radical regeneration mechanism to be characteristic for L-his, and possibly 
related to the antioxidant properties of this amino acid that make it more susceptible to attacks 
from ROS. ESI-MS analysis of the D-mannitol irradiated powders resulted in the detection of 
a species with a molecular mass of 2 m/z units lower than the unaltered mannitol molecule, a 
species that was not observed in the MS spectrum of the non-irradiated powder. Such species 
was suggested to be the result of a C-centred radical formed by proton abstraction, subsequently 
rearranging through beta-elimination of a second proton and consequent formation of a double 
bond. 1H NMR spectra of the irradiated samples also highlighted the presence of degradation 
products formed upon irradiation, though a thorough characterisation of such species was not 
possible due to the low signal-to-noise and the overlap of the signals from the unaltered 
D-mannitol. 
Chapter 6 investigates the mechanism of action and the intracellular targets of the anticancer 
photo-activable platinum(IV) anticancer complex trans,trans,trans-[Pt(N3)2OH2(pyridine)2] 
(complex 13). It has been previously reported that complex 13 exerts its anticancer activity 
through a dual mechanism of action, involving both platination of DNA induced by the photo-
reduced PtII centre and the oxidative attack carried out by photo-released azidyl radicals (●N3).2,3 
The simultaneous presence of L-tryptophan (L-trp) was found to have a photo-protective effect 
in cancer cells.2 This effect was previously ascribed to the quenching of the azidyl radicals from 
the indole derivatives, which has been suggested to take place through a one-electron oxidation 
of the indoles with the consequential formation of a transient indole radical species. However, 
such species have not been detected before. Accordingly, it was also suggested that the cellular 
target of the above mentioned reactive nitrogen species (RNS) could be biological structures 
containing aromatic amino acids. In this work, the transient indole species formed from 
quenching of the azidyl radicals were successfully detected by means of CW EPR spin trapping 
experiments with the nitroso spin trap MNP. Photo-activation of complex 13 with blue (465 
nm) LED light in the presence of L-trp resulted in the detection of the MNP-trp radical adduct. 
Similarly, blue light irradiation of complex 13 in the presence of the indole derivative melatonin 
(MLT) and MNP resulted in the trapping of a similar indole radical, but to a much higher (~ 30 
times) extent compared to L-trp. Interestingly, irradiation at longer wavelengths (528 nm green 
LED light) allowed the detection of the indole spin trap adduct only for L-trp. Irradiation of 
complex 13 in the presence of the hydroxyl radical (●OH) scavenger ethanol resulted in the 
trapping of a α-hydroxy-ethyl radical, implying an alternative photo-activation pathways for 
complex 13 that involves the release of hydroxyl radicals. Additionally, to investigate the 
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intracellular target of photo-released RNS/ROS, complex 13 was photo-activated in the 
presence of the L-trp containing peptide pentagastrin. Although spin trapping with MNP did 
not result in the detection of an indole radical, spin trapping of ●N3 with the nitrone spin trap 
DMPO highlighted a reduced formation of the DMPO-N3 spin adduct in the presence of 
pentagastrin, suggesting the ability of the peptide to quench ●N3 radicals. 
 
7.2 Future work 
The first part of this work was concerned with the characterisation of the degradation products 
formed upon irradiation of two common excipients, L-histidine and D-mannitol. Assessing the 
behaviour of single ingredients of pharmaceutical products is the necessary first step towards 
the study of multi-component systems. Hence, a sample of the most common pharmaceutical 
excipients from all the classes used in the parenteral formulation of pharmaceutical products 
could be tested applying the same experimental procedures utilised in this work, which 
provided extremely valuable information on the identity and reactivity of the radicalic 
degradants. Future investigation could then focus on determining the effects of radiation 
sterilization on a complete pharmaceutical product, including one or more active 
pharmaceutical ingredients (APIs). In fact, it is known that the effects of ionising radiations 
cannot be predicted beforehand.4 Indeed, it has been shown that APIs can both be protected 
from the irradiation5 and have a protective effect towards other drug components.6 Thus, the 
production of a dataset illustrating the effects of radiation sterilization on the most recurrent 
single drug components would enormously facilitate the following study of complete drug 
products, and allow the formulation of pharmaceuticals according to a quality by design 
approach. EPR is surely the technique of choice for the study of paramagnetic degradation 
products formed upon irradiation. Nevertheless, this work showed that techniques such as NMR 
and MS can produce extremely valuable complementary information for the characterisation of 
the degradants. The weak point of such techniques is that, differently from EPR, they are not 
selective towards the degradants, thus the signal of such impurities is often hidden by the signal 
of the unaltered compound. Therefore, the use of separation techniques such as High 
Performance Liquid Chromatography (HPLC) should be tested in combination with MS and 
NMR to overcome this issue. 
The second part of this work focused on the investigation of the mechanism of action and the 
intracellular target of the photo-activable anticancer compound complex 13. Our findings 
suggested the intracellular targets for the RNS/ROS released upon photo-activation of the 
compound to be aromatic amino acid-containing biological structures. This work suggested that 
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the photo-protective effect induced by L-trp is still present when L-trp is incorporated into a 
small peptidic chain. Future investigations will aim to prove that this effect can still be observed 
in the presence of more complex structures, i.e. proteins. Additionally, the presence of multiple 
photo-degradation pathways for complex 13 was confirmed by indirect detection of hydroxyl 
radicals. Further work is required to reach a thorough understanding of the degradation 
pathways of such platinum complex. An additional method for the determination of the source 
of OH● radicals involves the synthesis of 17O-labelled (I = +5/2) complex 13. Trapping of the 
17OH● radical with DMPO would therefore produce an alternative EPR spectrum, providing 
valuable information on the release of the hydroxyl ligands from the above-mentioned 
platinum(IV) complex. 
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